www.fox44news.com Open in urlscan Pro
151.101.65.91 Public Scan

Go To Rescan
Add Verdict Report

URL:
https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-co...
Submission: On May 21 via manual (May 21st 2024, 1:49:07 pm UTC) from US — Scanned from US

Summary HTTP 209 Redirects Links 47 Behaviour Indicators

Summary

This website contacted 77 IPs in 2 countries across 57 domains to perform 209 HTTP transactions. The main IP is 151.101.65.91, located in San Francisco, United States and belongs to FASTLY, US. The main domain is www.fox44news.com. The Cisco Umbrella rank of the primary domain is 599430.
TLS certificate: Issued by R3 on April 3rd 2024. Valid for: 3 months.

This is the only time www.fox44news.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 54	151.101.65.91 151.101.65.91	54113 (FASTLY) (FASTLY)
4	2607:f8b0:400... 2607:f8b0:4004:c08::5f	15169 (GOOGLE) (GOOGLE)
1	18.165.98.6 18.165.98.6	16509 (AMAZON-02) (AMAZON-02)
12	2606:4700::68... 2606:4700::6813:b134	13335 (CLOUDFLAR...) (CLOUDFLARENET)
10	99.84.208.28 99.84.208.28	16509 (AMAZON-02) (AMAZON-02)
1	2606:4700:440... 2606:4700:4400::6812:29aa	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2600:9000:208... 2600:9000:208f:9e00:13:a391:88c0:21	16509 (AMAZON-02) (AMAZON-02)
2	172.64.144.166 172.64.144.166	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	35.190.10.96 35.190.10.96	15169 (GOOGLE) (GOOGLE)
2	2600:9000:24f... 2600:9000:24f3:fe00:18:1fcd:354:4b41	16509 (AMAZON-02) (AMAZON-02)
4	104.16.160.145 104.16.160.145	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	52.85.151.91 52.85.151.91	16509 (AMAZON-02) (AMAZON-02)
3	2600:1408:c40... 2600:1408:c400:e87::1e80	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
3	151.101.66.133 151.101.66.133	54113 (FASTLY) (FASTLY)
1	52.85.151.80 52.85.151.80	16509 (AMAZON-02) (AMAZON-02)
1	192.0.66.120 192.0.66.120	2635 (AUTOMATTIC) (AUTOMATTIC)
1 4	2606:4700:440... 2606:4700:4400::ac40:9b8d	13335 (CLOUDFLAR...) (CLOUDFLARENET)
4 6	3.162.103.38 3.162.103.38	16509 (AMAZON-02) (AMAZON-02)
2 2	216.200.232.249 216.200.232.249	30419 (PAEDAE-INC) (PAEDAE-INC)
1 2	34.238.186.72 34.238.186.72	14618 (AMAZON-AES) (AMAZON-AES)
1	2600:9000:24f... 2600:9000:24f4:5200:f:c7b3:ce40:93a1	16509 (AMAZON-02) (AMAZON-02)
2	192.0.76.3 192.0.76.3	2635 (AUTOMATTIC) (AUTOMATTIC)
2	2606:4700:440... 2606:4700:4400::ac40:9b77	13335 (CLOUDFLAR...) (CLOUDFLARENET)
6	52.21.84.14 52.21.84.14	14618 (AMAZON-AES) (AMAZON-AES)
1 3	18.165.100.155 18.165.100.155	16509 (AMAZON-02) (AMAZON-02)
1	2600:9000:230... 2600:9000:2305:1600:11:1ed0:3900:93a1	16509 (AMAZON-02) (AMAZON-02)
2	2607:f8b0:400... 2607:f8b0:4004:c19::61	15169 (GOOGLE) (GOOGLE)
3	151.101.129.44 151.101.129.44	54113 (FASTLY) (FASTLY)
6	142.250.31.156 142.250.31.156	15169 (GOOGLE) (GOOGLE)
2	2606:4700:440... 2606:4700:4400::ac40:9b3f	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	2600:9000:24f... 2600:9000:24f4:4a00:2:42d9:3100:93a1	16509 (AMAZON-02) (AMAZON-02)
6	2607:f8b0:400... 2607:f8b0:4004:c1b::5e	15169 (GOOGLE) (GOOGLE)
2	34.194.130.13 34.194.130.13	14618 (AMAZON-AES) (AMAZON-AES)
1	2a04:4e42:600... 2a04:4e42:600::714	54113 (FASTLY) (FASTLY)
1	172.67.203.105 172.67.203.105	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	99.86.191.237 99.86.191.237	16509 (AMAZON-02) (AMAZON-02)
1	34.199.54.80 34.199.54.80	14618 (AMAZON-AES) (AMAZON-AES)
5	172.253.62.154 172.253.62.154	15169 (GOOGLE) (GOOGLE)
1	52.85.151.43 52.85.151.43	16509 (AMAZON-02) (AMAZON-02)
2	2620:100:a00b... 2620:100:a00b::12	19750 (AS-CRITEO) (AS-CRITEO)
1	104.70.185.205 104.70.185.205	16625 (AKAMAI-AS) (AKAMAI-AS)
1 3	18.160.10.44 18.160.10.44	16509 (AMAZON-02) (AMAZON-02)
1	23.55.205.47 23.55.205.47	16625 (AKAMAI-AS) (AKAMAI-AS)
1 2	3.223.52.218 3.223.52.218	14618 (AMAZON-AES) (AMAZON-AES)
2 2	142.251.167.154 142.251.167.154	15169 (GOOGLE) (GOOGLE)
1	63.140.38.112 63.140.38.112	14618 (AMAZON-AES) (AMAZON-AES)
1	18.160.18.69 18.160.18.69	16509 (AMAZON-02) (AMAZON-02)
1	2600:9000:24f... 2600:9000:24f4:b200:2:42d9:3100:93a1	16509 (AMAZON-02) (AMAZON-02)
1	18.160.10.20 18.160.10.20	16509 (AMAZON-02) (AMAZON-02)
1	23.62.165.62 23.62.165.62	16625 (AKAMAI-AS) (AKAMAI-AS)
2	52.202.142.82 52.202.142.82	14618 (AMAZON-AES) (AMAZON-AES)
2	44.214.246.0 44.214.246.0	14618 (AMAZON-AES) (AMAZON-AES)
1	18.160.20.121 18.160.20.121	16509 (AMAZON-02) (AMAZON-02)
1	2600:9000:20a... 2600:9000:20aa:a600:5:82fd:2500:21	16509 (AMAZON-02) (AMAZON-02)
1	74.119.117.6 74.119.117.6	19750 (AS-CRITEO) (AS-CRITEO)
1	3.233.167.98 3.233.167.98	14618 (AMAZON-AES) (AMAZON-AES)
1	172.64.151.101 172.64.151.101	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	34.120.63.153 34.120.63.153	396982 (GOOGLE-CL...) (GOOGLE-CLOUD-PLATFORM)
1	3.208.91.57 3.208.91.57	14618 (AMAZON-AES) (AMAZON-AES)
1	34.198.96.69 34.198.96.69	14618 (AMAZON-AES) (AMAZON-AES)
2	2602:803:c002... 2602:803:c002:200::32	26667 (RUBICONPR...) (RUBICONPROJECT)
1 2	68.67.179.87 68.67.179.87	29990 (ASN-APPNEX) (ASN-APPNEX)
3	13.32.151.21 13.32.151.21	16509 (AMAZON-02) (AMAZON-02)
1	2600:9000:219... 2600:9000:2199:f400:11:b309:9100:21	16509 (AMAZON-02) (AMAZON-02)
1	3.5.27.142 3.5.27.142	14618 (AMAZON-AES) (AMAZON-AES)
2	99.83.154.140 99.83.154.140	16509 (AMAZON-02) (AMAZON-02)
2	2607:f8b0:400... 2607:f8b0:4004:c1d::84	15169 (GOOGLE) (GOOGLE)
1 2	52.46.143.56 52.46.143.56	16509 (AMAZON-02) (AMAZON-02)
1	3.236.169.12 3.236.169.12	14618 (AMAZON-AES) (AMAZON-AES)
4	2607:f8b0:400... 2607:f8b0:4004:c09::84	15169 (GOOGLE) (GOOGLE)
1	99.84.191.89 99.84.191.89	16509 (AMAZON-02) (AMAZON-02)
1	172.253.63.99 172.253.63.99	15169 (GOOGLE) (GOOGLE)
2 2	52.71.30.37 52.71.30.37	14618 (AMAZON-AES) (AMAZON-AES)
1	3.20.52.199 3.20.52.199	16509 (AMAZON-02) (AMAZON-02)
1	52.35.121.22 52.35.121.22	16509 (AMAZON-02) (AMAZON-02)
2	2620:100:a00b::4 2620:100:a00b::4	19750 (AS-CRITEO) (AS-CRITEO)
1	99.84.208.120 99.84.208.120	16509 (AMAZON-02) (AMAZON-02)
1	34.200.65.202 34.200.65.202	14618 (AMAZON-AES) (AMAZON-AES)
1	34.107.165.188 34.107.165.188	396982 (GOOGLE-CL...) (GOOGLE-CLOUD-PLATFORM)
209	77

54 151.101.65.91 (San Francisco, United States) 1 redirects

ASN54113 (FASTLY, US)

www.fox44news.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2607:f8b0:4004:c08::5f (Washington, United States)

ASN15169 (GOOGLE, US)

fonts.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 18.165.98.6 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-18-165-98-6.iad55.r.cloudfront.net

nxst.megpxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

12 2606:4700::6813:b134 (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.cookielaw.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

10 99.84.208.28 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-84-208-28.iad79.r.cloudfront.net

blue.fox44news.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:4400::6812:29aa (United States)

ASN13335 (CLOUDFLARENET, US)

3a6b0682-f3e1-4576-a706-5eb4101b9cc3.edge.permutive.app	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:208f:9e00:13:a391:88c0:21 (United States)

ASN16509 (AMAZON-02, US)

d3plfjw9uod7ab.cloudfront.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 172.64.144.166 (San Francisco, United States)

ASN13335 (CLOUDFLARENET, US)

cdn.confiant-integrations.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 35.190.10.96 (Kansas City, United States)

ASN15169 (GOOGLE, US)
PTR: 96.10.190.35.bc.googleusercontent.com

collector-pxcvbtpurj.px-cloud.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2600:9000:24f3:fe00:18:1fcd:354:4b41 (United States)

ASN16509 (AMAZON-02, US)

static.chartbeat.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 104.16.160.145 (None, )

ASN13335 (CLOUDFLARENET, US)

cdn.onesignal.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
onesignal.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 52.85.151.91 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-52-85-151-91.iad89.r.cloudfront.net

htlbid.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2600:1408:c400:e87::1e80 (Ashburn, United States)

ASN20940 (AKAMAI-ASN1, NL)

assets.adobedtm.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 151.101.66.133 (San Francisco, United States)

ASN54113 (FASTLY, US)

segment.psg.nexstardigital.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
weather.psg.nexstardigital.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 52.85.151.80 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-52-85-151-80.iad89.r.cloudfront.net

ak.sail-horizon.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 192.0.66.120 (San Francisco, United States)

ASN2635 (AUTOMATTIC, US)

www.nxsttv.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2606:4700:4400::ac40:9b8d (United States) 1 redirects

ASN13335 (CLOUDFLARENET, US)

mma.prnewswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
rt.prnewswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 3.162.103.38 (United States) 4 redirects

ASN16509 (AMAZON-02, US)
PTR: server-3-162-103-38.iad61.r.cloudfront.net

c212.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 216.200.232.249 (Frederick, United States) 2 redirects

ASN30419 (PAEDAE-INC, US)

pixel.mathtag.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 34.238.186.72 (Ashburn, United States) 1 redirects

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-238-186-72.compute-1.amazonaws.com

get.civicscience.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.civicscience.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:24f4:5200:f:c7b3:ce40:93a1 (United States)

ASN16509 (AMAZON-02, US)

d2zqfs55y95cft.cloudfront.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 192.0.76.3 (San Francisco, United States)

ASN2635 (AUTOMATTIC, US)

stats.wp.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
pixel.wp.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2606:4700:4400::ac40:9b77 (United States)

ASN13335 (CLOUDFLARENET, US)

geolocation.onetrust.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 52.21.84.14 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-52-21-84-14.compute-1.amazonaws.com

bob.dmpxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 18.165.100.155 (United States) 1 redirects

ASN16509 (AMAZON-02, US)
PTR: server-18-165-100-155.iad55.r.cloudfront.net

c.amazon-adsystem.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:2305:1600:11:1ed0:3900:93a1 (United States)

ASN16509 (AMAZON-02, US)

d3div1mtym39ic.cloudfront.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2607:f8b0:4004:c19::61 (Washington, United States)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 151.101.129.44 (San Francisco, United States)

ASN54113 (FASTLY, US)

cdn.taboola.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 142.250.31.156 (United States)

ASN15169 (GOOGLE, US)
PTR: bj-in-f156.1e100.net

pagead2.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2606:4700:4400::ac40:9b3f (United States)

ASN13335 (CLOUDFLARENET, US)

cookies-data.onetrust.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2600:9000:24f4:4a00:2:42d9:3100:93a1 (United States)

ASN16509 (AMAZON-02, US)

cdn-gl.imrworldwide.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2607:f8b0:4004:c1b::5e (Washington, United States)

ASN15169 (GOOGLE, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 34.194.130.13 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-194-130-13.compute-1.amazonaws.com

nexstar.blueconic.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a04:4e42:600::714 (United States)

ASN54113 (FASTLY, US)

mab.chartbeat.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 172.67.203.105 (United States)

ASN13335 (CLOUDFLARENET, US)

analyticssystems.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 99.86.191.237 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-86-191-237.iad79.r.cloudfront.net

cdn.segment.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.199.54.80 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-199-54-80.compute-1.amazonaws.com

ping.chartbeat.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 172.253.62.154 (United States)

ASN15169 (GOOGLE, US)
PTR: bc-in-f154.1e100.net

securepubads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 52.85.151.43 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-52-85-151-43.iad89.r.cloudfront.net

launchpad-wrapper.privacymanager.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2620:100:a00b::12 (United States)

ASN19750 (AS-CRITEO, US)

gum.criteo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.70.185.205 (Secaucus, United States)

ASN16625 (AKAMAI-AS, US)
PTR: a104-70-185-205.deploy.static.akamaitechnologies.com

s.ntv.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 18.160.10.44 (United States) 1 redirects

ASN16509 (AMAZON-02, US)
PTR: server-18-160-10-44.iad12.r.cloudfront.net

sb.scorecardresearch.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 23.55.205.47 (Ashburn, United States)

ASN16625 (AKAMAI-AS, US)
PTR: a23-55-205-47.deploy.static.akamaitechnologies.com

a.teads.tv	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 3.223.52.218 (Ashburn, United States) 1 redirects

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-223-52-218.compute-1.amazonaws.com

cm2.lotlinx.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
cm.lotlinx.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 142.251.167.154 (Farmingdale, United States) 2 redirects

ASN15169 (GOOGLE, US)
PTR: ww-in-f154.1e100.net

cm.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 63.140.38.112 (United States)

ASN14618 (AMAZON-AES, US)
PTR: ip-63-140-38-112.data.adobedc.net

axp.fox44news.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 18.160.18.69 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-18-160-18-69.iad12.r.cloudfront.net

launchpad.privacymanager.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:24f4:b200:2:42d9:3100:93a1 (United States)

ASN16509 (AMAZON-02, US)

cdn-gl.imrworldwide.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 18.160.10.20 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-18-160-10-20.iad12.r.cloudfront.net

config.aps.amazon-adsystem.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 23.62.165.62 (Ashburn, United States)

ASN16625 (AKAMAI-AS, US)
PTR: a23-62-165-62.deploy.static.akamaitechnologies.com

at.teads.tv	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.202.142.82 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-52-202-142-82.compute-1.amazonaws.com

jadserve.postrelease.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 44.214.246.0 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-44-214-246-0.compute-1.amazonaws.com

prod.us-east-1.cxm-bcn.publisher-services.amazon.dev	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 18.160.20.121 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-18-160-20-121.iad12.r.cloudfront.net

aax.amazon-adsystem.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:20aa:a600:5:82fd:2500:21 (United States)

ASN16509 (AMAZON-02, US)

dyv1bugovvq1g.cloudfront.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 74.119.117.6 (United States)

ASN19750 (AS-CRITEO, US)

bidder.criteo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.233.167.98 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-233-167-98.compute-1.amazonaws.com

tlx.3lift.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 172.64.151.101 (San Francisco, United States)

ASN13335 (CLOUDFLARENET, US)

htlb.casalemedia.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.120.63.153 (Kansas City, United States)

ASN396982 (GOOGLE-CLOUD-PLATFORM, US)
PTR: 153.63.120.34.bc.googleusercontent.com

prebid.media.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.208.91.57 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-208-91-57.compute-1.amazonaws.com

ads.yieldmo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.198.96.69 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-198-96-69.compute-1.amazonaws.com

g2.gumgum.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2602:803:c002:200::32 (United States)

ASN26667 (RUBICONPROJECT, US)

fastlane.rubiconproject.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 68.67.179.87 (North Bergen, United States) 1 redirects

ASN29990 (ASN-APPNEX, US)
PTR: 585.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net

ib.adnxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 13.32.151.21 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-13-32-151-21.iad66.r.cloudfront.net

geo.privacymanager.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:2199:f400:11:b309:9100:21 (United States)

ASN16509 (AMAZON-02, US)

d15kdpgjg3unno.cloudfront.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.5.27.142 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: s3-1-w.amazonaws.com

ams-pageview-public.s3.amazonaws.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 99.83.154.140 (United States)

ASN16509 (AMAZON-02, US)
PTR: aa7557bb34ea5624b.awsglobalaccelerator.com

api.sail-personalize.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2607:f8b0:4004:c1d::84 (Washington, United States)

ASN15169 (GOOGLE, US)

530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.46.143.56 (Ashburn, United States) 1 redirects

ASN16509 (AMAZON-02, US)

s.amazon-adsystem.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.236.169.12 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-236-169-12.compute-1.amazonaws.com

sqs.us-east-1.amazonaws.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2607:f8b0:4004:c09::84 (Washington, United States)

ASN15169 (GOOGLE, US)

tpc.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 99.84.191.89 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-84-191-89.iad89.r.cloudfront.net

ats-wrapper.privacymanager.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 172.253.63.99 (United States)

ASN15169 (GOOGLE, US)
PTR: bi-in-f99.1e100.net

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.71.30.37 (Ashburn, United States) 2 redirects

ASN14618 (AMAZON-AES, US)
PTR: ec2-52-71-30-37.compute-1.amazonaws.com

match.prod.bidr.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.20.52.199 (Columbus, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-3-20-52-199.us-east-2.compute.amazonaws.com

secure-dcr.imrworldwide.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 52.35.121.22 (Boardman, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-52-35-121-22.us-west-2.compute.amazonaws.com

global.imrworldwide.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2620:100:a00b::4 (United States)

ASN19750 (AS-CRITEO, US)

static.criteo.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 99.84.208.120 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-84-208-120.iad79.r.cloudfront.net

check.analytics.rlcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.200.65.202 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-200-65-202.compute-1.amazonaws.com

ups.analytics.yahoo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.107.165.188 (Kansas City, United States)

ASN396982 (GOOGLE-CLOUD-PLATFORM, US)
PTR: 188.165.107.34.bc.googleusercontent.com

api.rlcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
65	fox44news.com 1 redirects www.fox44news.com — Cisco Umbrella Rank: 599430 blue.fox44news.com — Cisco Umbrella Rank: 935748 axp.fox44news.com	1 MB
12	googlesyndication.com pagead2.googlesyndication.com — Cisco Umbrella Rank: 103 530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com tpc.googlesyndication.com — Cisco Umbrella Rank: 164	224 KB
12	cookielaw.org cdn.cookielaw.org — Cisco Umbrella Rank: 312	226 KB
7	doubleclick.net 2 redirects securepubads.g.doubleclick.net — Cisco Umbrella Rank: 205 cm.g.doubleclick.net — Cisco Umbrella Rank: 272	205 KB
7	amazon-adsystem.com 2 redirects c.amazon-adsystem.com — Cisco Umbrella Rank: 308 config.aps.amazon-adsystem.com — Cisco Umbrella Rank: 630 aax.amazon-adsystem.com — Cisco Umbrella Rank: 419 s.amazon-adsystem.com — Cisco Umbrella Rank: 327	7 KB
6	privacymanager.io launchpad-wrapper.privacymanager.io — Cisco Umbrella Rank: 2615 launchpad.privacymanager.io — Cisco Umbrella Rank: 2008 geo.privacymanager.io — Cisco Umbrella Rank: 1924 ats-wrapper.privacymanager.io — Cisco Umbrella Rank: 2107	99 KB
6	gstatic.com fonts.gstatic.com	93 KB
6	dmpxs.com bob.dmpxs.com — Cisco Umbrella Rank: 11718	3 KB
6	c212.net 4 redirects c212.net — Cisco Umbrella Rank: 19722	2 KB
5	imrworldwide.com cdn-gl.imrworldwide.com — Cisco Umbrella Rank: 3937 secure-dcr.imrworldwide.com — Cisco Umbrella Rank: 3581 global.imrworldwide.com — Cisco Umbrella Rank: 7553	64 KB
5	cloudfront.net d3plfjw9uod7ab.cloudfront.net d2zqfs55y95cft.cloudfront.net d3div1mtym39ic.cloudfront.net dyv1bugovvq1g.cloudfront.net d15kdpgjg3unno.cloudfront.net	160 KB
4	prnewswire.com 1 redirects mma.prnewswire.com — Cisco Umbrella Rank: 42441 rt.prnewswire.com — Cisco Umbrella Rank: 83567	110 KB
4	onesignal.com cdn.onesignal.com — Cisco Umbrella Rank: 4680 onesignal.com — Cisco Umbrella Rank: 1554	83 KB
4	googleapis.com fonts.googleapis.com — Cisco Umbrella Rank: 33	7 KB
3	scorecardresearch.com 1 redirects sb.scorecardresearch.com — Cisco Umbrella Rank: 191	4 KB
3	criteo.com gum.criteo.com — Cisco Umbrella Rank: 444 bidder.criteo.com — Cisco Umbrella Rank: 587	627 B
3	taboola.com cdn.taboola.com — Cisco Umbrella Rank: 1034	399 KB
3	nexstardigital.net segment.psg.nexstardigital.net — Cisco Umbrella Rank: 16106 weather.psg.nexstardigital.net — Cisco Umbrella Rank: 19307	123 KB
3	adobedtm.com assets.adobedtm.com — Cisco Umbrella Rank: 425	66 KB
3	chartbeat.com static.chartbeat.com — Cisco Umbrella Rank: 1718 mab.chartbeat.com — Cisco Umbrella Rank: 2854	26 KB
2	rlcdn.com check.analytics.rlcdn.com — Cisco Umbrella Rank: 4063 api.rlcdn.com — Cisco Umbrella Rank: 1037	664 B
2	criteo.net static.criteo.net — Cisco Umbrella Rank: 664	31 KB
2	bidr.io 2 redirects match.prod.bidr.io — Cisco Umbrella Rank: 596	1013 B
2	sail-personalize.com api.sail-personalize.com — Cisco Umbrella Rank: 3500	498 B
2	amazonaws.com ams-pageview-public.s3.amazonaws.com — Cisco Umbrella Rank: 9492 sqs.us-east-1.amazonaws.com — Cisco Umbrella Rank: 5816	1 KB
2	adnxs.com 1 redirects ib.adnxs.com — Cisco Umbrella Rank: 257	2 KB
2	rubiconproject.com fastlane.rubiconproject.com — Cisco Umbrella Rank: 506	2 KB
2	amazon.dev prod.us-east-1.cxm-bcn.publisher-services.amazon.dev — Cisco Umbrella Rank: 3647	128 B
2	postrelease.com jadserve.postrelease.com — Cisco Umbrella Rank: 1096	2 KB
2	lotlinx.com 1 redirects cm2.lotlinx.com — Cisco Umbrella Rank: 22306 cm.lotlinx.com — Cisco Umbrella Rank: 18021	532 B
2	teads.tv a.teads.tv — Cisco Umbrella Rank: 1561 at.teads.tv — Cisco Umbrella Rank: 6185	4 KB
2	blueconic.net nexstar.blueconic.net — Cisco Umbrella Rank: 19346	2 KB
2	onetrust.io cookies-data.onetrust.io — Cisco Umbrella Rank: 11791	85 B
2	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 39	166 KB
2	onetrust.com geolocation.onetrust.com — Cisco Umbrella Rank: 533	550 B
2	wp.com stats.wp.com — Cisco Umbrella Rank: 2906 pixel.wp.com — Cisco Umbrella Rank: 2883	3 KB
2	civicscience.com 1 redirects get.civicscience.com — Cisco Umbrella Rank: 15268 www.civicscience.com — Cisco Umbrella Rank: 5390	170 B
2	mathtag.com 2 redirects pixel.mathtag.com — Cisco Umbrella Rank: 2546	1 KB
2	px-cloud.net collector-pxcvbtpurj.px-cloud.net — Cisco Umbrella Rank: 19068	1 KB
2	confiant-integrations.net cdn.confiant-integrations.net — Cisco Umbrella Rank: 1603	181 KB
1	yahoo.com ups.analytics.yahoo.com — Cisco Umbrella Rank: 435	764 B
1	google.com www.google.com — Cisco Umbrella Rank: 2
1	gumgum.com g2.gumgum.com — Cisco Umbrella Rank: 1511	331 B
1	yieldmo.com ads.yieldmo.com — Cisco Umbrella Rank: 590	373 B
1	media.net prebid.media.net — Cisco Umbrella Rank: 1111	1 KB
1	casalemedia.com htlb.casalemedia.com — Cisco Umbrella Rank: 477	670 B
1	3lift.com tlx.3lift.com — Cisco Umbrella Rank: 536	691 B
1	ntv.io s.ntv.io — Cisco Umbrella Rank: 3777	180 KB
1	chartbeat.net ping.chartbeat.net — Cisco Umbrella Rank: 1476	201 B
1	segment.com cdn.segment.com — Cisco Umbrella Rank: 1845	525 B
1	analyticssystems.net analyticssystems.net — Cisco Umbrella Rank: 11268	495 B
1	nxsttv.com www.nxsttv.com — Cisco Umbrella Rank: 193873	3 KB
1	sail-horizon.com ak.sail-horizon.com — Cisco Umbrella Rank: 3699	34 KB
1	htlbid.com htlbid.com — Cisco Umbrella Rank: 8046	133 KB
1	permutive.app 3a6b0682-f3e1-4576-a706-5eb4101b9cc3.edge.permutive.app — Cisco Umbrella Rank: 17505	171 KB
1	megpxs.com nxst.megpxs.com — Cisco Umbrella Rank: 17774	981 B
0	rtk.io Failed sync.rtk.io Failed
209	57

	Domain	Requested by
54	www.fox44news.com	1 redirects www.fox44news.com
12	cdn.cookielaw.org	www.fox44news.com cdn.cookielaw.org d3plfjw9uod7ab.cloudfront.net
10	blue.fox44news.com	www.fox44news.com blue.fox44news.com d3plfjw9uod7ab.cloudfront.net
6	fonts.gstatic.com	fonts.googleapis.com
6	pagead2.googlesyndication.com	www.fox44news.com securepubads.g.doubleclick.net pagead2.googlesyndication.com
6	bob.dmpxs.com	www.fox44news.com d3plfjw9uod7ab.cloudfront.net
6	c212.net	4 redirects www.fox44news.com
5	securepubads.g.doubleclick.net	d3plfjw9uod7ab.cloudfront.net securepubads.g.doubleclick.net www.fox44news.com pagead2.googlesyndication.com
4	tpc.googlesyndication.com	d3plfjw9uod7ab.cloudfront.net www.fox44news.com
4	fonts.googleapis.com	www.fox44news.com
3	geo.privacymanager.io	www.fox44news.com
3	sb.scorecardresearch.com	1 redirects www.fox44news.com
3	cdn-gl.imrworldwide.com	www.fox44news.com cdn-gl.imrworldwide.com d3plfjw9uod7ab.cloudfront.net
3	cdn.taboola.com	www.fox44news.com cdn.taboola.com
3	c.amazon-adsystem.com	1 redirects c.amazon-adsystem.com
3	mma.prnewswire.com	www.fox44news.com
3	assets.adobedtm.com	www.fox44news.com d3plfjw9uod7ab.cloudfront.net
2	static.criteo.net	htlbid.com static.criteo.net
2	match.prod.bidr.io	2 redirects
2	s.amazon-adsystem.com	1 redirects d3plfjw9uod7ab.cloudfront.net
2	530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com	securepubads.g.doubleclick.net d3plfjw9uod7ab.cloudfront.net
2	api.sail-personalize.com	www.fox44news.com
2	ib.adnxs.com	1 redirects www.fox44news.com
2	fastlane.rubiconproject.com	www.fox44news.com
2	prod.us-east-1.cxm-bcn.publisher-services.amazon.dev	c.amazon-adsystem.com
2	jadserve.postrelease.com	d3plfjw9uod7ab.cloudfront.net www.fox44news.com
2	cm.g.doubleclick.net	2 redirects
2	gum.criteo.com	cdn.taboola.com d3plfjw9uod7ab.cloudfront.net
2	onesignal.com	cdn.onesignal.com d3plfjw9uod7ab.cloudfront.net
2	nexstar.blueconic.net	blue.fox44news.com d3plfjw9uod7ab.cloudfront.net
2	cookies-data.onetrust.io	cdn.cookielaw.org
2	www.googletagmanager.com	www.fox44news.com
2	geolocation.onetrust.com	cdn.cookielaw.org
2	pixel.mathtag.com	2 redirects
2	segment.psg.nexstardigital.net	www.fox44news.com
2	cdn.onesignal.com	www.fox44news.com cdn.onesignal.com
2	static.chartbeat.com	www.fox44news.com
2	collector-pxcvbtpurj.px-cloud.net	www.fox44news.com
2	cdn.confiant-integrations.net	www.fox44news.com cdn.confiant-integrations.net
1	api.rlcdn.com	www.fox44news.com
1	ups.analytics.yahoo.com	www.fox44news.com
1	check.analytics.rlcdn.com	www.fox44news.com
1	global.imrworldwide.com
1	secure-dcr.imrworldwide.com
1	www.google.com	d3plfjw9uod7ab.cloudfront.net www.fox44news.com
1	ats-wrapper.privacymanager.io	d3plfjw9uod7ab.cloudfront.net
1	sqs.us-east-1.amazonaws.com	d15kdpgjg3unno.cloudfront.net
1	ams-pageview-public.s3.amazonaws.com	www.fox44news.com
1	d15kdpgjg3unno.cloudfront.net	d3plfjw9uod7ab.cloudfront.net
1	weather.psg.nexstardigital.net	www.fox44news.com
1	g2.gumgum.com	www.fox44news.com
1	ads.yieldmo.com	www.fox44news.com
1	prebid.media.net	www.fox44news.com
1	htlb.casalemedia.com	www.fox44news.com
1	tlx.3lift.com	www.fox44news.com
1	bidder.criteo.com	www.fox44news.com
1	dyv1bugovvq1g.cloudfront.net	www.fox44news.com
1	aax.amazon-adsystem.com	c.amazon-adsystem.com
1	at.teads.tv	www.fox44news.com
1	config.aps.amazon-adsystem.com	d3plfjw9uod7ab.cloudfront.net
1	launchpad.privacymanager.io	launchpad-wrapper.privacymanager.io
1	axp.fox44news.com	www.fox44news.com
1	cm.lotlinx.com	www.fox44news.com
1	cm2.lotlinx.com	1 redirects
1	a.teads.tv	www.googletagmanager.com
1	s.ntv.io	d3plfjw9uod7ab.cloudfront.net
1	launchpad-wrapper.privacymanager.io	d3plfjw9uod7ab.cloudfront.net
1	ping.chartbeat.net	www.fox44news.com
1	www.civicscience.com	www.fox44news.com
1	pixel.wp.com	www.fox44news.com
1	cdn.segment.com	www.fox44news.com
1	analyticssystems.net	www.fox44news.com
1	mab.chartbeat.com	static.chartbeat.com
1	d3div1mtym39ic.cloudfront.net	www.fox44news.com
1	stats.wp.com	www.fox44news.com
1	d2zqfs55y95cft.cloudfront.net	www.fox44news.com
1	get.civicscience.com	1 redirects
1	rt.prnewswire.com	1 redirects
1	www.nxsttv.com	www.fox44news.com
1	ak.sail-horizon.com	www.fox44news.com
1	htlbid.com	www.fox44news.com
1	d3plfjw9uod7ab.cloudfront.net	www.fox44news.com
1	3a6b0682-f3e1-4576-a706-5eb4101b9cc3.edge.permutive.app	www.fox44news.com
1	nxst.megpxs.com	www.fox44news.com
0	sync.rtk.io Failed	d3plfjw9uod7ab.cloudfront.net
209	85

This site contains links to these domains. Also see Links.

Domain
nxslink.fox44news.com
www.newsnationnow.com
products.bestreviews.com
jobs.fox44news.com
www.prnewswire.com
c212.net
mma.prnewswire.com
publicfiles.fcc.gov
apps.apple.com
play.google.com
www.facebook.com
twitter.com
www.instagram.com
www.youtube.com
www.haystack.tv
www.nexstar.tv
www.covers.com
www.thehill.com
www.bestreviews.com
www.nexstardigital.com
www.onetrust.com

Subject Issuer	Validity	Valid
*.fox44news.com R3	`2024-04-03` - `2024-07-02`	3 months	crt.sh
upload.video.google.com GTS CA 1C3	`2024-05-06` - `2024-07-29`	3 months	crt.sh
nxst.megpxs.com Amazon RSA 2048 M01	`2023-09-07` - `2024-10-05`	a year	crt.sh
cookielaw.org Cloudflare Inc ECC CA-3	`2024-03-01` - `2024-12-31`	10 months	crt.sh
blue.ourquadcities.com Amazon RSA 2048 M03	`2024-03-07` - `2025-04-06`	a year	crt.sh
permutive.app Cloudflare Inc ECC CA-3	`2024-03-05` - `2024-12-31`	10 months	crt.sh
*.cloudfront.net Amazon RSA 2048 M01	`2023-10-10` - `2024-09-19`	a year	crt.sh
confiant-integrations.net GTS CA 1P5	`2024-05-14` - `2024-08-12`	3 months	crt.sh
*.px-cloud.net Sectigo RSA Domain Validation Secure Server CA	`2023-08-15` - `2024-09-13`	a year	crt.sh
*.chartbeat.com Thawte TLS RSA CA G1	`2024-05-15` - `2025-06-06`	a year	crt.sh
onesignal.com GTS CA 1P5	`2024-04-01` - `2024-06-30`	3 months	crt.sh
htlbid.com Amazon RSA 2048 M01	`2023-09-21` - `2024-10-18`	a year	crt.sh
assets.adobedtm.com DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2023-07-11` - `2024-08-10`	a year	crt.sh
*.psg.nexstardigital.net R3	`2024-04-13` - `2024-07-12`	3 months	crt.sh
ak.sail-horizon.com Amazon RSA 2048 M02	`2023-12-04` - `2024-12-30`	a year	crt.sh
nxsttv.com R3	`2024-04-22` - `2024-07-21`	3 months	crt.sh
prnewswire.com E1	`2024-05-07` - `2024-08-05`	3 months	crt.sh
*.wp.com Sectigo ECC Domain Validation Secure Server CA	`2023-11-28` - `2024-12-28`	a year	crt.sh
onetrust.com Cloudflare Inc ECC CA-3	`2023-11-13` - `2024-11-12`	a year	crt.sh
*.dmpxs.com Amazon RSA 2048 M03	`2024-01-07` - `2025-02-03`	a year	crt.sh
*.google-analytics.com GTS CA 1C3	`2024-05-06` - `2024-07-29`	3 months	crt.sh
*.taboola.com DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2023-10-23` - `2024-11-22`	a year	crt.sh
*.g.doubleclick.net GTS CA 1C3	`2024-05-06` - `2024-07-29`	3 months	crt.sh
onetrust.io GTS CA 1P5	`2024-05-02` - `2024-07-31`	3 months	crt.sh
*.imrworldwide.com GlobalSign RSA OV SSL CA 2018	`2024-01-02` - `2025-02-02`	a year	crt.sh
*.gstatic.com GTS CA 1C3	`2024-05-06` - `2024-07-29`	3 months	crt.sh
*.blueconic.net Amazon RSA 2048 M02	`2024-05-08` - `2025-06-06`	a year	crt.sh
analyticssystems.net Cloudflare Inc ECC CA-3	`2023-12-26` - `2024-12-25`	a year	crt.sh
*.segment.com Amazon RSA 2048 M03	`2023-11-14` - `2024-12-13`	a year	crt.sh
*.civicscience.com Amazon RSA 2048 M03	`2024-03-05` - `2025-04-03`	a year	crt.sh
*.chartbeat.net Thawte TLS RSA CA G1	`2023-11-20` - `2024-12-20`	a year	crt.sh
*.privacymanager.io Amazon RSA 2048 M01	`2023-07-27` - `2024-08-24`	a year	crt.sh
*.criteo.com DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2024-04-15` - `2024-07-10`	3 months	crt.sh
*.ntv.io DigiCert TLS RSA SHA256 2020 CA1	`2023-08-28` - `2024-08-28`	a year	crt.sh
*.scorecardresearch.com Sectigo RSA Organization Validation Secure Server CA	`2023-12-11` - `2024-12-10`	a year	crt.sh
teads.tv R3	`2024-04-12` - `2024-07-11`	3 months	crt.sh
c.amazon-adsystem.com Amazon RSA 2048 M01	`2023-12-30` - `2024-12-04`	a year	crt.sh
axp.nexstardigital.com DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2023-10-03` - `2024-11-02`	a year	crt.sh
config.aps.amazon-adsystem.com Amazon RSA 2048 M02	`2024-01-21` - `2025-02-19`	a year	crt.sh
*.postrelease.com Amazon RSA 2048 M02	`2023-10-27` - `2024-11-23`	a year	crt.sh
prod.us-east-1.cxm-bcn.publisher-services.amazon.dev Amazon RSA 2048 M02	`2023-11-27` - `2024-12-25`	a year	crt.sh
alt1-3ps.amazon-adsystem.com Amazon RSA 2048 M03	`2024-03-29` - `2025-04-28`	a year	crt.sh
*.3lift.com Amazon RSA 2048 M02	`2024-03-13` - `2025-04-10`	a year	crt.sh
casalemedia.com E1	`2024-04-19` - `2024-07-18`	3 months	crt.sh
prebid.media.net GTS CA 1D4	`2024-04-17` - `2024-07-16`	3 months	crt.sh
*.yieldmo.com Amazon RSA 2048 M01	`2023-08-14` - `2024-09-12`	a year	crt.sh
dev.eks.va.adexchange.gumgum.com Amazon RSA 2048 M02	`2023-11-17` - `2024-12-15`	a year	crt.sh
*.rubiconproject.com DigiCert TLS RSA SHA256 2020 CA1	`2024-03-04` - `2025-04-03`	a year	crt.sh
*.adnxs.com GeoTrust ECC CA 2018	`2024-02-14` - `2025-03-16`	a year	crt.sh
*.s3.amazonaws.com Amazon RSA 2048 M01	`2023-10-10` - `2024-07-03`	9 months	crt.sh
api.sail-personalize.com Amazon RSA 2048 M02	`2024-03-25` - `2025-04-22`	a year	crt.sh
s.amazon-adsystem.com Amazon RSA 2048 M01	`2024-04-24` - `2025-04-17`	a year	crt.sh
queue.amazonaws.com Amazon RSA 2048 M01	`2024-01-18` - `2024-12-28`	a year	crt.sh
tpc.googlesyndication.com GTS CA 1C3	`2024-05-06` - `2024-07-29`	3 months	crt.sh
*.google.com GTS CA 1C3	`2024-05-06` - `2024-07-29`	3 months	crt.sh
*.criteo.net DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2024-04-25` - `2024-07-19`	3 months	crt.sh
analytics.rlcdn.com Amazon RSA 2048 M02	`2023-06-27` - `2024-07-24`	a year	crt.sh
ups.analytics.yahoo.com DigiCert SHA2 High Assurance Server CA	`2024-05-21` - `2024-11-13`	6 months	crt.sh
*.rlcdn.com Sectigo RSA Domain Validation Secure Server CA	`2024-02-06` - `2025-03-05`	a year	crt.sh

This page contains 10 frames:

Primary Page: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Frame ID: D7FC185599F9E17A6E6D31C28F8357FF
Requests: 192 HTTP requests in this frame

Frame: https://cdn-gl.imrworldwide.com/novms/html/ls.html
Frame ID: 01DBC6CE830E7A91A1A519706B86D037
Requests: 1 HTTP requests in this frame

Frame: https://530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 3860C0958D3FE09A1411A1C5D0568B0F
Requests: 1 HTTP requests in this frame

Frame: https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=gg_n-index_n-MediaNet_ox-db5_n-cadent_n-undertone_n-sharethrough_n-simpli.fi_ym_rbd_n-vmg_n-nativo_an-db5_sovrn_3lift&dcc=t
Frame ID: 13559BF8454A4E37AEE2361377E0B393
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: 962771114FC94CFCDF72723125AB52A6
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: AF5BDCBB91C5E63BD7649F99BAAAF8DD
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvbTRE-Ocnz8C66G67uT-IJdCkh9fbteN653LjDPjtURDtkhLT29E5JEqqQdosthnJWVsjQmqpx5cTPCqEeeZsr6mOxrjMF6SeGf7f8NpHQzuDvwoYYBJ0Zfw_VT-1DYTWp8f7EB5Y0JgEHtc7eSnfDnfmz3oSe8oLfpaETdOF3uiQ-VFhQ5HgV2nz3LdAfJ8elcT41iRWgxS1mEzguBcCxK26RDtDNV5K7ynRCuGnOts6tYYiINpuSCz2kmX5KtDt0lG4Oiw8QFMc6XBVO-ndYZ5OrTm9GFFcwzve-zdwrEek0zSrN0PwxQAC4uYE_Dz17bhOo9v7USi0JL8hkORN3Zb3vc07Kyh_VtI060OZK5ze1zYZlKpaZ6-Y&sai=AMfl-YQz4YB8m9b_Oj59n03TsOe8clvksgMLd4VamZoV-VcX2PbV6RRGKfGIciMOjTk4AM95K6p7eIaU2OJW458iDvyart-l_XgVD8X50mCMA-dGWHiRkC4BJThMnUUPpvgQ_6zEfh2Koi3488QScbTOxA&sig=Cg0ArKJSzCKoRmce2UmQEAE&uach_m=%5BUACH%5D&adurl=
Frame ID: 3C60C4D1D74E1FF84868BE73142A3057
Requests: 10 HTTP requests in this frame

Frame: https://530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 3FD5FB9240FE127C4E3EFEB22543F288
Requests: 1 HTTP requests in this frame

Frame: https://sync.rtk.io/cs
Frame ID: C20E1EAF2CBF25F641115357AFE37741
Requests: 1 HTTP requests in this frame

Frame: https://gum.criteo.com/syncframe?origin=publishertag&topUrl=www.fox44news.com&us_privacy=1---&gpp=DBABBg~BUoAAAKA.QA&gpp_sid=8
Frame ID: 6E9B3797F7CDC87FF51F6808A2D6F2FF
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

DC Medicaid Becomes the First Medicaid Plan to Cover the Nerivio® REN Wearable, a Non-Drug Treatment for Migraine

Page URL History Show full URLs

https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first... HTTP 301
https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first... Page URL

Detected technologies

WordPress (CMS) Expand

Overall confidence: 100%
Detected patterns

/wp-(?:content|includes)/

AppNexus (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

adnxs\.(?:net|com)

Chartbeat (Analytics) Expand

Overall confidence: 100%
Detected patterns

chartbeat\.js

Google AdSense (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

googlesyndication\.com/

Google Font API (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtm\.js

OneSignal (Marketing automation) Expand

Overall confidence: 100%
Detected patterns

cdn\.onesignal\.com

OneTrust (Cookie compliance) Expand

Overall confidence: 100%
Detected patterns

cdn\.cookielaw\.org
otSDKStub\.js

PerimeterX (Security) Expand

Overall confidence: 100%
Detected patterns

Prebid (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

adnxs\.com/[^"]*(?:prebid|/pb\.js)

Rubicon Project (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

https?://[^/]*\.rubiconproject\.com

comScore (Analytics) Expand

Overall confidence: 100%
Detected patterns

<iframe[^>]* (?:id="comscore"|scr=[^>]+comscore)|\.scorecardresearch\.com/beacon\.js|COMSCORE\.beacon
\.scorecardresearch\.com/beacon\.js|COMSCORE\.beacon

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

jQuery Migrate (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]migrate(?:-([\d.]+))?(?:\.min)?\.js(?:\?ver=([\d.]+))?

Page Statistics

209
Requests

94 %
HTTPS

29 %
IPv6

57
Domains

85
Subdomains

77
IPs

2
Countries

4081 kB
Transfer

15436 kB
Size

227
Cookies

47 Outgoing links

These are links going to different origins than the main page.

URL: https://nxslink.fox44news.com/join/6p6/signup?website_signup=true
Title: Sign Up

Search URL Search Domain Scan URL

URL: https://www.newsnationnow.com/
Title: News Nation Now

Search URL Search Domain Scan URL

URL: https://products.bestreviews.com/best-deals/
Title: BestReviews Daily Deals

Search URL Search Domain Scan URL

URL: http://jobs.fox44news.com/
Title: Jobs

Search URL Search Domain Scan URL

URL: http://nxslink.fox44news.com/join/6u5/signup&hash=604df4ff97b3fc1e11ae9125965929cc
Title: Email Alerts and Newsletters

Search URL Search Domain Scan URL

URL: https://www.prnewswire.com/news/theranica
Title: Theranica

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=496103498&u=https%3A%2F%2Ftheranica.com%2F&a=Theranica
Title: Theranica

Search URL Search Domain Scan URL

URL: https://mma.prnewswire.com/media/2417234/Theranica_Nerivio.html

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=1906254631&u=https%3A%2F%2Fdc.gov%2Fservice%2Fmedicaid&a=DC+Medicaid
Title: DC Medicaid

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=2795944181&u=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Ffull%2F10.1080%2F13696998.2023.2205751&a=study
Title: study

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=2783360398&u=https%3A%2F%2Fstatic1.squarespace.com%2Fstatic%2F5886319ba5790a66cf05d235%2Ft%2F65f9f55ca8db93352c2fa844%2F1710880098690%2FSurveySummaryReportMM-HMPF-March2024.pdf&a=report
Title: report

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=797682291&u=http%3A%2F%2Fnerivio.com%2F&a=Nerivio.com
Title: Nerivio.com

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=3304177309&u=http%3A%2F%2Fwww.nerivio.com%2F&a=Nerivio+REN+wearable
Title: Nerivio REN wearable

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=1032856188&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D1643272277%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D2574028521%2526u%253Dhttps%25253A%25252F%25252Ftheranica.com%25252F%2526a%253Dtheranica.com%26a%3Dtheranica.com&a=%C2%A0

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=2926843881&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D1643272277%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D2574028521%2526u%253Dhttps%25253A%25252F%25252Ftheranica.com%25252F%2526a%253Dtheranica.com%26a%3Dtheranica.com&a=theranica.com
Title: theranica.com

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=3215456350&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D2142579643%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D1102063594%2526u%253Dhttps%25253A%25252F%25252Fnerivio.com%25252F%2526a%253Dnerivio.com%26a%3Dnerivio.com&a=%C2%A0

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=1326293856&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D2142579643%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D1102063594%2526u%253Dhttps%25253A%25252F%25252Fnerivio.com%25252F%2526a%253Dnerivio.com%26a%3Dnerivio.com&a=nerivio.com
Title: nerivio.com

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=4229163391&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D3852885753%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D2973071726%2526u%253Dhttps%25253A%25252F%25252Fwww.linkedin.com%25252Fcompany%25252Ftheranica-bio-electronics%25252F%25253ForiginalSubdomain%25253Dil%2526a%253DLinkedIn%26a%3DLinkedIn&a=LinkedIn
Title: LinkedIn

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=1337964126&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D1542488288%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D1209103663%2526u%253Dhttps%25253A%25252F%25252Ftwitter.com%25252FTheranica%25253Fref_src%25253Dtwsrc%2525255Egoogle%2525257Ctwcamp%2525255Eserp%2525257Ctwgr%2525255Eauthor%2526a%253DTwitter%26a%3DTwitter&a=%C2%A0

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=426602035&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D1542488288%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D1209103663%2526u%253Dhttps%25253A%25252F%25252Ftwitter.com%25252FTheranica%25253Fref_src%25253Dtwsrc%2525255Egoogle%2525257Ctwcamp%2525255Eserp%2525257Ctwgr%2525255Eauthor%2526a%253DTwitter%26a%3DTwitter&a=X+(formerly+Twitter)
Title: X (formerly Twitter)

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=3124306669&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D2455546204%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D783130203%2526u%253Dhttps%25253A%25252F%25252Fwww.instagram.com%25252Fnerivio%25252F%25253Fhl%25253Den%2526a%253DInstagram%26a%3DInstagram&a=%C2%A0

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=2867216250&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D2455546204%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D783130203%2526u%253Dhttps%25253A%25252F%25252Fwww.instagram.com%25252Fnerivio%25252F%25253Fhl%25253Den%2526a%253DInstagram%26a%3DInstagram&a=Instagram
Title: Instagram

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=1589967644&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D2193000039%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3794991-1%2526h%253D1425107388%2526u%253Dhttps%25253A%25252F%25252Fwww.facebook.com%25252FNerivioXTheranica%2526a%253DFacebook%26a%3DFacebook&a=Facebook
Title: Facebook

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=2996509510&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D3614579381%26u%3Dhttps%253A%252F%252Fwww.nomatterwhat.tech%252F%26a%3D%2523NoMatterWhat&a=%C2%A0

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=4171032-1&h=4218896041&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4093359-1%26h%3D3614579381%26u%3Dhttps%253A%252F%252Fwww.nomatterwhat.tech%252F%26a%3D%2523NoMatterWhat&a=%23NoMatterWhat
Title: #NoMatterWhat

Search URL Search Domain Scan URL

URL: https://mma.prnewswire.com/media/2011113/Theranica_Logo.html

Search URL Search Domain Scan URL

URL: https://www.prnewswire.com/news-releases/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine-302150532.html
Title: https://www.prnewswire.com/news-releases/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine-302150532.html

Search URL Search Domain Scan URL

URL: https://publicfiles.fcc.gov/tv-profile/KWKT-TV#details
Title: KWKT FCC Public File

Search URL Search Domain Scan URL

URL: https://publicfiles.fcc.gov/tv-profile/KYLE-TV#details
Title: KYLE FCC Public File

Search URL Search Domain Scan URL

URL: https://apps.apple.com/ao/app/kwkt-fox44/id980043976
Title: Get the iOS app

Search URL Search Domain Scan URL

URL: https://play.google.com/store/apps/details?id=com.newssynergy.mycentx&hl=enr
Title: Get the Android app from Google Play

Search URL Search Domain Scan URL

URL: https://www.facebook.com/FOX44tv/

Search URL Search Domain Scan URL

URL: https://twitter.com/KWKTFOX44

Search URL Search Domain Scan URL

URL: https://www.instagram.com/FOX44News/

Search URL Search Domain Scan URL

URL: https://www.youtube.com/channel/UCzsavUS_jn2fXbc9yHkFCfA

Search URL Search Domain Scan URL

URL: https://www.haystack.tv/channel/kyle/
Title: Haystack .cls-1 { fill: none; } .cls-2 { fill: #fff; }

Search URL Search Domain Scan URL

URL: https://www.nexstar.tv/

Search URL Search Domain Scan URL

URL: https://www.nexstar.tv/privacy-policy/
Title: Privacy Policy

Search URL Search Domain Scan URL

URL: https://www.nexstar.tv/terms-of-use/
Title: Terms Of Use

Search URL Search Domain Scan URL

URL: https://www.covers.com/
Title: Covers

Search URL Search Domain Scan URL

URL: https://www.nexstar.tv/fcc-applications/
Title: FCC Applications

Search URL Search Domain Scan URL

URL: https://www.thehill.com/
Title: The Hill

Search URL Search Domain Scan URL

URL: https://www.bestreviews.com/
Title: BestReviews

Search URL Search Domain Scan URL

URL: https://www.newsnationnow.com/licensing-nexstars-local-and-national-television-news-footage/
Title: Content Licensing

Search URL Search Domain Scan URL

URL: https://www.nexstardigital.com/
Title: Nexstar Digital

Search URL Search Domain Scan URL

URL: https://www.nexstar.tv/corporate-social-responsibility/journalistic-integrity/
Title: Journalistic Integrity

Search URL Search Domain Scan URL

URL: https://www.onetrust.com/products/cookie-consent/

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine HTTP 301
https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 52

https://c212.net/c/img/favicon.png?sn=LA18851&sd=2024-05-21 HTTP 302
https://pixel.mathtag.com/sync/img?redir=https%3A%2F%2Fc212.net%2Fc%2Fsync%3Fu%3DL2MvaW1nL2Zhdmljb25faW1hZ2UucG5n%26c%3DUS%26dmpId%3D1%26pid%3D%5BMM_UUID%5D HTTP 302
https://c212.net/c/sync?u=L2MvaW1nL2Zhdmljb25faW1hZ2UucG5n&c=US&dmpId=1&pid=865d664c-a64c-4000-b856-6472404e23e6 HTTP 302
https://c212.net/c/img/favicon_image.png

Request Chain 53

https://rt.prnewswire.com/rt.gif?NewsItemId=LA18851&Transmission_Id=202405210815PR_NEWS_USPR_____LA18851&DateId=20240521 HTTP 302
https://c212.net/c/pix/?t=0&h=1142403200&ej=eyJzbiI6IkxBMTg4NTEiLCJzZCI6IjIwMjQwNTIxIiwidCI6InJ0IiwiciI6Imh0dHBzOlwvXC93d3cuZm94NDRuZXdzLmNvbVwvIn0= HTTP 302
https://pixel.mathtag.com/sync/img?redir=https%3A%2F%2Fc212.net%2Fc%2Fsync%3Fu%3DL2MvaW1nLzF4MS5naWY%2Fc2V0PTE%3D%26c%3DUS%26dmpId%3D1%26pid%3D%5BMM_UUID%5D HTTP 302
https://c212.net/c/sync?u=L2MvaW1nLzF4MS5naWY/c2V0PTE=&c=US&dmpId=1&pid=36ee664c-a64b-4200-87c5-b9a623130cad HTTP 302
https://c212.net/c/img/1x1.gif?set=1

Request Chain 54

https://get.civicscience.com/jspoll/5/csw-polyfills.js?ver=1.1 HTTP 302
https://d2zqfs55y95cft.cloudfront.net/jspoll/5/csw-polyfills.js?ver=1.1

Request Chain 76

https://c.amazon-adsystem.com/aax2/apstag.js HTTP 301
https://d3div1mtym39ic.cloudfront.net/aax2/apstag.js

Request Chain 123

https://cm2.lotlinx.com/live/141000/sync?hms HTTP 302
https://cm.g.doubleclick.net/pixel?google_sc=&google_nid=lemonfree&google_hm=ZDIzNWNlMmYxZDc2ZTYwYzQzN2ZiOTk4&google_ula=500446778&google_redir=https%3A%2F%2Fcm.lotlinx.com%2Flive%2F141000%2Fendsync HTTP 302
https://cm.g.doubleclick.net/pixel?google_sc=&google_nid=lemonfree&google_hm=ZDIzNWNlMmYxZDc2ZTYwYzQzN2ZiOTk4&google_ula=500446778&google_redir=https%3A%2F%2Fcm.lotlinx.com%2Flive%2F141000%2Fendsync&google_tc= HTTP 302
https://cm.lotlinx.com/live/141000/endsync?google_ula=500446778,0

Request Chain 139

https://sb.scorecardresearch.com/b?c1=2&c2=6036439&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1716299340703&ns_c=UTF-8&cs_ucfr=&cs_fpid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&cs_fpit=c&cs_fpdm=*null&cs_fpdt=*null&c7=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&c8=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable%2C%20a%20Non-Drug%20Treatment%20for%20Migraine&c9= HTTP 302
https://sb.scorecardresearch.com/b2?c1=2&c2=6036439&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1716299340703&ns_c=UTF-8&cs_ucfr=&cs_fpid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&cs_fpit=c&cs_fpdm=*null&cs_fpdt=*null&c7=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&c8=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable%2C%20a%20Non-Drug%20Treatment%20for%20Migraine&c9=

Request Chain 180

https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=gg_n-index_n-MediaNet_ox-db5_n-cadent_n-undertone_n-sharethrough_n-simpli.fi_ym_rbd_n-vmg_n-nativo_an-db5_sovrn_3lift HTTP 302
https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=gg_n-index_n-MediaNet_ox-db5_n-cadent_n-undertone_n-sharethrough_n-simpli.fi_ym_rbd_n-vmg_n-nativo_an-db5_sovrn_3lift&dcc=t

Request Chain 197

https://ib.adnxs.com/getuid?https%3A%2F%2Fbob.dmpxs.com%2Fmagnetar_attract%3Fbob_tag_id%3Dbob_001%26apnx_uid%3D%24UID HTTP 302
https://bob.dmpxs.com/magnetar_attract?bob_tag_id=bob_001&apnx_uid=7109922249490532377

Request Chain 198

https://match.prod.bidr.io/cookie-sync/nextardigital HTTP 303
https://match.prod.bidr.io/cookie-sync/nextardigital?_bee_ppp=1 HTTP 303
https://bob.dmpxs.com/magnetar_attract?bx_uid=AAE2RE7MmU0AABRLhY-U5A

209 HTTP transactions
5 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request / Show response
www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Redirect Chain

https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine
https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/

369 KB
65 KB

493ms
493ms

Document
text/html

151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx / WordPress VIP <https://wpvip.com>
Resource Hash: 9a3d49d2c2afcc97d0656982ccd4de0bfb58c18fe125c6f9f901639872daa943

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

accept-ranges: bytes
cache-control: max-age=300, must-revalidate
content-encoding: gzip
content-type: text/html; charset=UTF-8
date: Tue, 21 May 2024 13:48:58 GMT
fastly-restarts: 1
host-header: a9130478a60e5f9135f765b23f26593b
link: <https://www.fox44news.com/wp-json/>; rel="https://api.w.org/"
server: nginx
state: PASS
vary: Accept-Encoding
via: 1.1 varnish
x-cache: EXPIRED, MISS
x-cache-hits: 0
x-hacker: If you're reading this, you should visit wpvip.com/careers and apply to join the fun, mention this header.
x-powered-by: WordPress VIP <https://wpvip.com>
x-rq: yyz3 85 187 443
x-served-by: cache-yyz4527-YYZ
x-timer: S1716299338.452816,VS0,VE464

Redirect headers

accept-ranges: bytes
content-type: text/html; charset=UTF-8
date: Tue, 21 May 2024 13:48:58 GMT
fastly-restarts: 1
host-header: a9130478a60e5f9135f765b23f26593b
location: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
server: nginx
state: PASS
vary: X-Country-Code
via: 1.1 varnish
x-cache: EXPIRED, MISS
x-cache-hits: 0
x-hacker: If you're reading this, you should visit wpvip.com/careers and apply to join the fun, mention this header.
x-powered-by: WordPress VIP <https://wpvip.com>
x-redirect-by: WordPress
x-rq: yyz3 85 188 443
x-served-by: cache-yyz4527-YYZ
x-timer: S1716299338.102274,VS0,VE320

GET
H2 200 css
fonts.googleapis.com/ 42 KB
3 KB 442ms
62ms Stylesheet
text/css 2607:f8b0:4004:c08::5f
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,400i,600,600i,700,700i,900,900i|Source+Serif+Pro:400,600,700,900|Roboto+Condensed:400,700|Lora:400,700&display=swap

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c08::5f Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

755d8ccb92de1cefc66b7df8d88c143338c4df751b5b8e7ea0aec367b49cb958

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Tue, 21 May 2024 13:13:40 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Tue, 21 May 2024 13:48:59 GMT

GET
H2 200 init.js Show response
www.fox44news.com/CvbtpUrj/ 168 KB
67 KB 39ms
37ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/CvbtpUrj/init.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash: 8eb0b2d85ef760553a62692610a43822acc8e4b933ba0feef63371a706aaa0e8

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:58 GMT
content-encoding: gzip
via: 1.1 varnish, 1.1 google, 1.1 varnish
age: 279
x-cache: HIT
content-length: 67954
x-served-by: cache-yyz4527-YYZ
x-timer: S1716299339.953562,VS0,VE8
etag: "29e7f-pPUcoRDOFLMQAp7pzOfEeJbgUxw"
x-px-hash: MjYyZjRiNmRjMDU2YjVkY2YzNjAzMjM5Nzc0Yzc3N2YzYTJkNDU5YzNiZmNjODJhYWQ3NWM4NzM0YTU3MjEwMQ==
vary: Accept-Encoding
active-cdn: fastly
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: active-cdn,x-served-by
cache-control: max-age=600
state: HIT-CLUSTER
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 ndn.js Show response
nxst.megpxs.com/ 1 KB
981 B 478ms
54ms Script
application/javascript 18.165.98.6
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://nxst.megpxs.com/ndn.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.165.98.6 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-165-98-6.iad55.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 0fae7cb122b33949c45effba227d872943f35d08e48c352a1d92e8bd1936d9d6

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 05:22:21 GMT
content-encoding: gzip
via: 1.1 3aec3b44fb976422e513a356ccd76eb8.cloudfront.net (CloudFront)
last-modified: Tue, 11 Oct 2022 18:34:30 GMT
server: AmazonS3
x-amz-cf-pop: IAD55-P4
age: 30399
etag: W/"4e766e8c28018b0e03961b6117903c22"
vary: Accept-Encoding, Origin
x-cache: Hit from cloudfront
content-type: application/javascript
x-amz-cf-id: HPynmx1dYxP0dCL1OJOvWzJ6FJqcwqBcmCeJfzvoCN9YnMGItM4t5Q==

GET
H2 200 otSDKStub.js Show response
cdn.cookielaw.org/scripttemplates/ 21 KB
7 KB 435ms
56ms Script
application/javascript 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/otSDKStub.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6a2f825beb3b540a044cdb0515177c34497aa2ce92e335bf1498fa42bb5baf88

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: Dw6K+rTuf8kOuPIEBw1QQA==
age: 52926
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 6881
x-ms-lease-status: unlocked
last-modified: Mon, 20 May 2024 02:18:27 GMT
server: cloudflare
etag: 0x8DC7873228719CE
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: 24f1ef92-c01e-0034-3dd0-aaeec1000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 887506f6cd274bc0-BUF

GET
H2 200 otCCPAiab.js Show response
cdn.cookielaw.org/opt-out/ 22 KB
6 KB 437ms
58ms Script
application/javascript 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/opt-out/otCCPAiab.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a7b7120dffd25546c93c1367b9c86a3dc87e71d2c89ebb39163a71eb3b659f01

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:48:59 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: ERttG9+iQk1LCPjR495NRw==
age: 43269
x-ms-lease-status: unlocked
last-modified: Tue, 22 Feb 2022 22:01:18 GMT
server: cloudflare
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: 1cbc1a24-b01e-0048-511f-2424b4000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 887506f6dd2a4bc0-BUF

GET
H2 200 udl.js Show response
www.fox44news.com/wp-content/plugins/universal-data-layer/js/ 13 KB
4 KB 30ms
30ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/universal-data-layer/js/udl.js?ver=1.3.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 59fc07c5d57122ebf637258179066424dbef0e465316647e6350384a26b5c5cd

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:58 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Fri, 05 Jan 2024 21:56:11 GMT
server: nginx
x-timer: S1716299339.953309,VS0,VE1
etag: W/"65987afb-35f3"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 script.js Show response
blue.fox44news.com/ 163 KB
50 KB 167ms
49ms Script
text/javascript 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/script.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

b0688d0087e14d9ee406feb8b371816c02cb8236392f7a6a82c5922e7405ff34

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:45:22 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
age: 217
x-cache: Hit from cloudfront
p3p: policyref="", CP="DSP"
content-length: 50484
x-xss-protection: 1; mode=block
last-modified: Tue, 21 May 2024 13:45:16 GMT
server: -
etag: e711e86f2881778984dd0062ee20d713
content-type: text/javascript; charset=utf-8
cache-control: public, no-cache="Set-Cookie", max-age=600
x-robots-tag: noindex, nofollow
x-amz-cf-id: 1CCJHpmEoTGCm2hAXTJS4prDup5Pp62PjDcRuajMTREyNXembhWcbw==
expires: Tue, 21 May 2024 13:55:22 GMT

GET
H2 200 3a6b0682-f3e1-4576-a706-5eb4101b9cc3-web.js Show response
3a6b0682-f3e1-4576-a706-5eb4101b9cc3.edge.permutive.app/ 844 KB
171 KB 140ms
45ms Script
application/javascript 2606:4700:4400::6812:29aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://3a6b0682-f3e1-4576-a706-5eb4101b9cc3.edge.permutive.app/3a6b0682-f3e1-4576-a706-5eb4101b9cc3-web.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:4400::6812:29aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 648ddfb4d1d5781616c70b3798058b30eecb138a7a7a72c642ee2a25af063ca1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: br
cf-cache-status: HIT
x-goog-meta-oid: 3a6b0682-f3e1-4576-a706-5eb4101b9cc3
age: 0
x-guploader-uploadid: ABPtcPptGoTYv6ew90e61ILkewzQJjJsxlXw485iUJ2OAvZyjXYfW0t0eAj_PPr8188KMRkWMTQ
x-goog-storage-class: REGIONAL
x-goog-metageneration: 1
x-goog-stored-content-encoding: br
content-length: 174807
last-modified: Mon, 20 May 2024 17:18:55 GMT
server: cloudflare
etag: "da048beba62e4856f36cbc420a6aa260"
vary: Accept-Encoding
x-goog-generation: 1716225535119054
content-type: application/javascript
x-goog-hash: crc32c=vgBx9Q==, md5=2gSL66YuSFbzbLxCCmqiYA==
cache-control: public, max-age=900
x-goog-stored-content-length: 174807
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 887506f8eec24bd5-BUF
expires: Tue, 21 May 2024 14:03:59 GMT

GET
H2 200 31b9b552-f32e-4036-8364-726eb992b71d.js Show response
d3plfjw9uod7ab.cloudfront.net/ 103 KB
27 KB 156ms
49ms Script
application/javascript 2600:9000:208f:9e00:13:a391:88c0:21
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:208f:9e00:13:a391:88c0:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: f865d19f8c5e2835687717e6a6c67dbbe949f16d7696bc6e8218cfa72f8d8232

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: FkulqNFvYS3uHUeou_vpTFzZYZ5Vt7HY
content-encoding: gzip
via: 1.1 b5a3a07d269412210ea111017ec1157e.cloudfront.net (CloudFront)
date: Tue, 21 May 2024 13:46:15 GMT
last-modified: Wed, 15 May 2024 03:16:29 GMT
server: AmazonS3
x-amz-cf-pop: IAD79-C3
age: 165
x-amz-server-side-encryption: AES256
etag: W/"ee0307af0cb8d654bf04cd72bc6e9521"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
cache-control: max-age=3600, public
x-amz-cf-id: NC3Fj7RQEe8lR1nWq4EetGkgWzZAjRbQ7xUw1QNtOXgEnLKu20TWIA==

GET
H3 200 config.js Show response
cdn.confiant-integrations.net/Y2Nn8JmiAY8HpnF4sl5n7J71jaI/gpt_and_prebid/ 355 KB
80 KB 86ms
42ms Script
text/javascript 172.64.144.166
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.confiant-integrations.net/Y2Nn8JmiAY8HpnF4sl5n7J71jaI/gpt_and_prebid/config.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 172.64.144.166 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 18613d6e3eb37d7db27938dc51c9d5b4e06525adff4d8b5b02e455ace6727c39

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
cf-cache-status: HIT
x-amz-request-id: MR46JDMN2BBX1361
age: 622
x-amz-server-side-encryption: AES256
alt-svc: h3=":443"; ma=86400
content-length: 81189
x-amz-id-2: eYo0K33oBmHiZ/VoI33PXVT+PyaIUMWMXYaAtMFczrk8J2MET93RhAoE1oaX6QOiqIDLYe7Bma0=
last-modified: Tue, 21 May 2024 04:27:20 GMT
server: cloudflare
etag: "cb6e4873301e216421ca986b176332d2"
vary: Accept-Encoding
content-type: text/javascript
cache-control: public, max-age=900, stale-while-revalidate=3600
accept-ranges: bytes
cf-ray: 887506f89f30a21d-YYZ

POST
H2 200 collector Show response
collector-pxcvbtpurj.px-cloud.net/api/v2/ 540 B
795 B 425ms
120ms XHR
application/json 35.190.10.96
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://collector-pxcvbtpurj.px-cloud.net/api/v2/collector
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.190.10.96 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS: 96.10.190.35.bc.googleusercontent.com
Software: /
Resource Hash: f477ae44b2c2b8ecd246dae757b6de73fffa12bf819429b3ff947e432340c4e4

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-type: application/x-www-form-urlencoded

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 google
access-control-allow-methods: GET,HEAD,PUT,PATCH,POST,DELETE
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
access-control-allow-credentials: true
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 540

GET
H2 200 chartbeat_mab.js Show response
static.chartbeat.com/js/ 24 KB
10 KB 174ms
50ms Script
application/x-javascript 2600:9000:24f3:fe00:18:1fcd:354:4b41
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://static.chartbeat.com/js/chartbeat_mab.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:24f3:fe00:18:1fcd:354:4b41 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: nginx /
Resource Hash: 28b614cc061632a0d8cb17953fc9342ce119ef471b3ff02c2379881a031a185b

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 18:32:04 GMT
content-encoding: gzip
via: 1.1 9b00405a1ff669043791884b75822050.cloudfront.net (CloudFront)
last-modified: Thu, 21 Dec 2023 01:18:23 GMT
server: nginx
x-amz-cf-pop: IAD55-P2
age: 69415
etag: W/"6583925f-5f13"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/x-javascript
cache-control: max-age=86400
cross-origin-resource-policy: cross-origin
x-amz-cf-id: MNhGiXXfe_yqzlXeIRpzL653YWByx9ODpIu0nuK0Bvru_BR2SpVKDQ==
expires: Tue, 21 May 2024 18:32:04 GMT

GET
H3 200 OneSignalSDK.js Show response
cdn.onesignal.com/sdks/ 9 KB
3 KB 92ms
48ms Script
application/javascript 104.16.160.145
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.onesignal.com/sdks/OneSignalSDK.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

104.16.160.145 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4191d89ec03bce5dc273716075335e31851031184b0fff0ab9fc900a8442019f

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 google
content-encoding: br
cf-cache-status: HIT
server: cloudflare
strict-transport-security: max-age=15552000; includeSubDomains
age: 2281
etag: W/"a87c48d211877c49b878679b2e3cdab8"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=259200
cf-ray: 887506f89e5bac30-YYZ
access-control-allow-headers: OneSignal-Subscription-Id
alt-svc: h3=":443"; ma=86400
expires: Fri, 24 May 2024 13:48:59 GMT

GET
H2 200 style.min.css
www.fox44news.com/wp-includes/css/dist/block-library/ 108 KB
14 KB 75ms
72ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-includes/css/dist/block-library/style.min.css?ver=6.4.4
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 0085adfd2d08a45f62a06d8f3f969ddc4a94ebe8d226511db90aa038f11ed180

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Tue, 07 May 2024 21:39:06 GMT
server: nginx
x-timer: S1716299339.319916,VS0,VE1
etag: W/"663a9f7a-1ae43"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 view.css
www.fox44news.com/wp-content/client-mu-plugins/jetpack/jetpack_vendor/automattic/jetpack-videopress/build/block-editor/blocks/video/ 602 B
382 B 83ms
81ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/client-mu-plugins/jetpack/jetpack_vendor/automattic/jetpack-videopress/build/block-editor/blocks/video/view.css?minify=false&ver=34ae973733627b74a14e
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: d749579e51cf490ba27a6782bcfe07c52e44ffa8e3fbb4db7a4dded9d0d9ef29

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Mon, 29 Apr 2024 15:27:24 GMT
server: nginx
x-timer: S1716299339.320327,VS0,VE2
etag: W/"662fbc5c-25a"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 mediaelementplayer-legacy.min.css
www.fox44news.com/wp-includes/js/mediaelement/ 11 KB
3 KB 81ms
79ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-includes/js/mediaelement/mediaelementplayer-legacy.min.css?ver=4.2.17
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: b7908a015a567ec2363011df2475368dbff34360e9da3fdff50604d6395fb646

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Tue, 09 Apr 2024 22:11:43 GMT
server: nginx
x-timer: S1716299339.320280,VS0,VE1
etag: W/"6615bd1f-2bf8"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 wp-mediaelement.min.css
www.fox44news.com/wp-includes/js/mediaelement/ 4 KB
1 KB 83ms
81ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-includes/js/mediaelement/wp-mediaelement.min.css?ver=6.4.4
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 2e10d353ff038c2cad3492fc17801af3e6ef2669c9e9713bdb78b1dcb104c4fe

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Tue, 07 May 2024 21:39:07 GMT
server: nginx
x-timer: S1716299339.320440,VS0,VE1
etag: W/"663a9f7b-105a"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 related-posts-block-styles.min.css
www.fox44news.com/wp-content/mu-plugins/search/elasticpress/dist/css/ 222 B
332 B 80ms
78ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/mu-plugins/search/elasticpress/dist/css/related-posts-block-styles.min.css?ver=4.2.2
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 9790593b4acafa770479511a888914881594976c5dcad980c82e781c5625ff44

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 varnish
last-modified: Mon, 15 Apr 2024 20:19:20 GMT
server: nginx
x-timer: S1716299339.320406,VS0,VE1
etag: "661d8bc8-de"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
content-length: 222
x-cache-hits: 0

GET
H2 200 os-custom-link.css
www.fox44news.com/wp-content/plugins/onesignal/dist/ 1 KB
497 B 80ms
71ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/onesignal/dist/os-custom-link.css?ver=3.7
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 1537ea59fe760513e81e0d92603da1eac49e37a8f3d97e6597614ce0850cd43e

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Mon, 30 Jan 2023 19:11:07 GMT
server: nginx
x-timer: S1716299339.331709,VS0,VE1
etag: W/"63d8164b-516"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 civic-science.css
www.fox44news.com/wp-content/plugins/lakana/inc/civic-science/styles/ 295 B
433 B 87ms
77ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/lakana/inc/civic-science/styles/civic-science.css?ver=1.0.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 829c75bbb354d9251d5906bc18fd74e7aa595402e23d4deddab5e77b0ef005de

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 varnish
last-modified: Thu, 12 Oct 2023 14:02:35 GMT
server: nginx
x-timer: S1716299339.331680,VS0,VE2
etag: "6527fc7b-127"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
content-length: 295
x-cache-hits: 0

GET
H2 200 main.css
www.fox44news.com/wp-content/plugins/hurrytimer/assets/css/ 8 KB
2 KB 84ms
75ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/hurrytimer/assets/css/main.css?ver=%202.10.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: b09fd06fe4fd02a72d86f8818f825cc056bb945324fac79c8b537018fd6f4a14

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Wed, 15 May 2024 16:26:56 GMT
server: nginx
x-timer: S1716299339.331664,VS0,VE1
etag: W/"6644e250-1ff0"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 widget.subscribe.css
www.fox44news.com/wp-content/plugins/sailthru-widget/css/ 2 KB
919 B 84ms
75ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/sailthru-widget/css/widget.subscribe.css?ver=1.1.2
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 26e8db41813f87bb61da1529be0ca2d88fd523807d5125bf293025539754fce2

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Mon, 30 Jan 2023 19:11:08 GMT
server: nginx
x-timer: S1716299339.331655,VS0,VE1
etag: W/"63d8164c-9ef"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 display.css
www.fox44news.com/wp-content/plugins/sailthru-widget/css/ 26 KB
4 KB 84ms
76ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/sailthru-widget/css/display.css?ver=1.1.9
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 8ac3b01858af293c009824161f59ad07c3d3ccb5d7d340afa2b6a43ad77bdc80

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Tue, 16 Jan 2024 17:12:38 GMT
server: nginx
x-timer: S1716299339.331774,VS0,VE1
etag: W/"65a6b906-667c"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 css
fonts.googleapis.com/ 42 KB
3 KB 155ms
63ms Stylesheet
text/css 2607:f8b0:4004:c08::5f
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Source+Sans+Pro%3A400%2C400i%2C600%2C600i%2C700%2C700i%2C900%2C900i%7CSource+Serif+Pro%3A400%2C600%2C700%2C900%7CRoboto+Condensed%3A400%2C700%7CLora%3A400%2C700&display=swap&ver=1.0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c08::5f Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

755d8ccb92de1cefc66b7df8d88c143338c4df751b5b8e7ea0aec367b49cb958

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Tue, 21 May 2024 13:30:42 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Tue, 21 May 2024 13:48:59 GMT

GET
H2 200 global.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 758 KB
57 KB 104ms
96ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/global.min.css?ver=d2f04c4e99525672bbdb
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 2ca24d0bcbf3e2bacbf51ffbbf54c0857a2ada0475428163067142c450451054

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357886,VS0,VE3
etag: W/"663262c5-bd82e"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 common.chunk.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 34 KB
11 KB 107ms
99ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/common.chunk.min.css?ver=82469b6441aa34fe0f14
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 84c07ce31f9f0d9094c47fae70dd5a178e9e606a76cd67acfb0a83045eb8d7e0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357864,VS0,VE3
etag: W/"663262c5-87a6"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 weatherIcons.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 318 KB
29 KB 121ms
114ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/weatherIcons.min.css?ver=768525159cba87fdca0d
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: a1228a3f0175495b0475e87bdea3b7d6a64a994d36b0ac85dc12325f81d543ab

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357854,VS0,VE3
etag: W/"663262c5-4f815"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 article.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 19 KB
4 KB 98ms
90ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/article.min.css?ver=24d1f3d7a80275fde883
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: eebbd68da0fbbb7159bc85533d934bc87dffd0c5a66f6199af5a4290213dd33c

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357835,VS0,VE2
etag: W/"663262c5-4d50"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 video-playlist.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 32 KB
4 KB 100ms
93ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/video-playlist.min.css?ver=be4569272312ca2f74b3
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 73c236f710de58ff27a2bdce6eac00d61be9ec55e83ec9ad99f5d7c3e3483b2a

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357819,VS0,VE2
etag: W/"663262c5-801b"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 closings.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 8 KB
2 KB 85ms
78ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/closings.min.css?ver=14434c3050a28649f4a3
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 0e91865cce426a8fb5201fe14f75d4fa8727137d5bc717d71c038be646d2bd70

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357807,VS0,VE1
etag: W/"663262c5-20f5"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 weather.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 21 KB
4 KB 98ms
92ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/weather.min.css?ver=41b622381e12c1b50fb7
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: ec38ad34e178c55c997c7140182869ae1b54bef7afa97699b630d700d8edb43c

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357781,VS0,VE2
etag: W/"663262c5-52c0"
vary: Accept-Encoding
state: PASS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 liveblog-iframe.min.css
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/ 66 B
152 B 85ms
79ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/liveblog-iframe.min.css?ver=85c4cc9cf0cb750d2695
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 0bdfc7f3e9c8b431d658e20bd4c07b213121603b6209fc56a056364726b8ca83

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 varnish
last-modified: Wed, 01 May 2024 15:41:57 GMT
server: nginx
x-timer: S1716299339.357757,VS0,VE1
etag: "663262c5-42"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
content-length: 66
x-cache-hits: 0

GET
H2 200 jetpack.css
www.fox44news.com/wp-content/client-mu-plugins/jetpack/css/ 98 KB
18 KB 93ms
88ms Stylesheet
text/css 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/client-mu-plugins/jetpack/css/jetpack.css?ver=12.4
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 1f6eb5e8892e492cabc182a081b182e89af45ce7cb4706141446f1d707c6742f

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Thu, 12 Oct 2023 14:02:34 GMT
server: nginx
x-timer: S1716299339.357747,VS0,VE1
etag: W/"6527fc7a-186ca"
state: PASS
x-cache: HIT, MISS
content-type: text/css
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 htlbid.js Show response
htlbid.com/v3/fox44news.com/ 494 KB
133 KB 237ms
129ms Script
application/javascript 52.85.151.91
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://htlbid.com/v3/fox44news.com/htlbid.js?ver=1.0.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 52.85.151.91 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-52-85-151-91.iad89.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: b982a7758db493860e60ad3fddeb7b3e7e2fe51a67780fd6150e13fec879bb2b

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: br
via: 1.1 9c90b41a9e5ac2856624d29ed4da4234.cloudfront.net (CloudFront)
last-modified: Mon, 13 May 2024 12:34:33 GMT
server: AmazonS3
x-amz-cf-pop: IAD89-C3
x-amz-server-side-encryption: AES256
etag: W/"a13fa976adbeac08f99c2d49781f5f61"
vary: Accept-Encoding
x-cache: RefreshHit from cloudfront
content-type: application/javascript
cache-control: max-age=600
x-amz-cf-id: kEyG2VeJ9FeL5NHu6oenUIQSpn-SQAauig461JIELn1GYoSZ1rNEaQ==

GET
H2 200 htlbid-advertising.min.js Show response
www.fox44news.com/wp-content/plugins/nxst-advertising/dist/ 11 KB
4 KB 85ms
80ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/nxst-advertising/dist/htlbid-advertising.min.js?ver=1.0.2
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 92702eaa96ceeb0ce0f386849d912f90088dd97f98ddd33d099f9b74a7722a93

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Wed, 17 Apr 2024 17:39:45 GMT
server: nginx
x-timer: S1716299339.357737,VS0,VE1
etag: W/"66200961-2c42"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 ad-referral-source.js Show response
www.fox44news.com/wp-content/plugins/lakana/inc/ad-referral-source/js/ 2 KB
911 B 94ms
89ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/lakana/inc/ad-referral-source/js/ad-referral-source.js?ver=1.0.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 6f63f4c537bc568f1084f47fa718432cc639e7b71bafb27eeb7a75c120a3448d

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Thu, 20 Apr 2023 18:48:07 GMT
server: nginx
x-timer: S1716299339.357704,VS0,VE1
etag: W/"644188e7-910"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 jquery.min.js Show response
www.fox44news.com/wp-includes/js/jquery/ 86 KB
30 KB 129ms
124ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-includes/js/jquery/jquery.min.js?ver=3.7.1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: cb6f2d32c49d1c2b25e9ffc9aaafa3f83075346c01bcd4ae6eb187392a4292cf

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Tue, 07 May 2024 21:39:07 GMT
server: nginx
x-timer: S1716299339.358541,VS0,VE4
etag: W/"663a9f7b-15601"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 jquery-migrate.min.js Show response
www.fox44news.com/wp-includes/js/jquery/ 13 KB
5 KB 128ms
124ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.4.1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 5274f11e6fb32ae0cf2dfb9f8043272865c397a7c4223b4cfa7d50ea52fbde89

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Tue, 07 May 2024 21:39:07 GMT
server: nginx
x-timer: S1716299339.358525,VS0,VE4
etag: W/"663a9f7b-3509"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 mobile-display.js Show response
www.fox44news.com/wp-content/plugins/civic-science/js/ 650 B
397 B 88ms
83ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/civic-science/js/mobile-display.js?ver=1.1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: b050f524be910fb72a28067de9bf26917c29598dbbcd7778288c865d606d2573

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Mon, 30 Jan 2023 19:11:07 GMT
server: nginx
x-timer: S1716299340.584225,VS0,VE1
etag: W/"63d8164b-28a"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 launch-25e943fdd407.min.js Show response
assets.adobedtm.com/3f27c430a962/d33d8acd711c/ 210 KB
65 KB 145ms
45ms Script
application/x-javascript 2600:1408:c400:e87::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/3f27c430a962/d33d8acd711c/launch-25e943fdd407.min.js?ver=1.0.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2600:1408:c400:e87::1e80 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 7033ceb836b88bac11cde312641af95753e1abaab9039dc5bf91928be5898474

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
last-modified: Fri, 17 May 2024 18:27:54 GMT
server: AkamaiNetStorage
etag: "cf8cc60d8bf5f37134eca25a728b9975:1715970474.843253"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.fox44news.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 66348
expires: Tue, 21 May 2024 14:48:59 GMT

GET
H2 200 adobeanalytics.js Show response
segment.psg.nexstardigital.net/ 88 KB
29 KB 114ms
28ms Script
application/x-javascript 151.101.66.133
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL

https://segment.psg.nexstardigital.net/adobeanalytics.js?ver=1.0.0

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

151.101.66.133 San Francisco, United States, ASN54113 (FASTLY, US),

Reverse DNS

Software

AmazonS3 /

Resource Hash

fffbeb90da1b9a476177d69cbd7c38d831ac4732a1382c347f57eca841c54f6d

Security Headers

Name	Value
Strict-Transport-Security	max-age=300

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
strict-transport-security: max-age=300
x-amz-request-id: 2ENGHNXX0EV6MZWF
age: 3286
x-amz-meta-codebuild-buildarn: arn:aws:codebuild:us-east-1:564329123274:build/prod-frontend-segment:94913451-824c-47b5-85fd-1115bb6c8dee
x-cache: HIT
x-amz-meta-codebuild-content-md5: 882885996aa3fda6935d1f6d983cf7e9
content-length: 29360
x-amz-id-2: HNrpTSWR8QdxH17GOflSh+0PVhnfL3A3BH9mky+mrTbRaHXsanbwU7VtvEYxldyNNlrDL2sgQdY=
x-served-by: cache-yyz4542-YYZ
last-modified: Wed, 15 May 2024 19:01:09 GMT
server: AmazonS3
x-timer: S1716299339.413561,VS0,VE0
etag: "20e4bd195609b7a703f37c75d482eaaa"
vary: Accept-Encoding
content-type: application/x-javascript
x-amz-meta-codebuild-content-sha256: 494c53bdfc6a638427e32491a1690c92cca065c9bb894b76062fab0e7bb622b5
access-control-allow-origin: *
accept-ranges: bytes
x-cache-hits: 32

GET
H2 200 segment.js Show response
segment.psg.nexstardigital.net/ 328 KB
93 KB 114ms
29ms Script
application/x-javascript 151.101.66.133
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL

https://segment.psg.nexstardigital.net/segment.js?ver=19

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

151.101.66.133 San Francisco, United States, ASN54113 (FASTLY, US),

Reverse DNS

Software

AmazonS3 /

Resource Hash

cb8eb2dd71fccedb3192752b2872b3689074acb38db90ebb236f2470559b690a

Security Headers

Name	Value
Strict-Transport-Security	max-age=300

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
strict-transport-security: max-age=300
x-amz-request-id: D2F88WF67XN34RWX
age: 2087
x-amz-meta-codebuild-buildarn: arn:aws:codebuild:us-east-1:564329123274:build/prod-frontend-segment:94913451-824c-47b5-85fd-1115bb6c8dee
x-cache: HIT
x-amz-meta-codebuild-content-md5: 882885996aa3fda6935d1f6d983cf7e9
content-length: 94739
x-amz-id-2: 8wZGo5NYXpcgBgTHGf0uLSAMXTdxKVPjD1SAs9C+XD5u7I/6TMpCY4kMWSMU+ZEMemvoFUrw7qs=
x-served-by: cache-yyz4582-YYZ
last-modified: Wed, 15 May 2024 19:01:09 GMT
server: AmazonS3
x-timer: S1716299339.414120,VS0,VE0
etag: "b9f45a1763d1c99fc24395e9b4ac70b0"
vary: Accept-Encoding
content-type: application/x-javascript
x-amz-meta-codebuild-content-sha256: 494c53bdfc6a638427e32491a1690c92cca065c9bb894b76062fab0e7bb622b5
access-control-allow-origin: *
accept-ranges: bytes
x-cache-hits: 15

GET
H2 200 spm.v1.min.js Show response
ak.sail-horizon.com/spm/ 103 KB
34 KB 171ms
48ms Script
application/javascript 52.85.151.80
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ak.sail-horizon.com/spm/spm.v1.min.js?ver=6.4.4
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 52.85.151.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-52-85-151-80.iad89.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 4ce1f595ea044b955619f6839a22ac34a22d80efde699f84f044976baa4831e3

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:47:47 GMT
content-encoding: gzip
via: 1.1 9c90b41a9e5ac2856624d29ed4da4234.cloudfront.net (CloudFront)
last-modified: Tue, 20 Feb 2024 06:45:39 GMT
server: AmazonS3
x-amz-cf-pop: IAD89-C3
age: 73
x-amz-server-side-encryption: AES256
etag: W/"6a90e37d3f128291a2aab5a6b31ac0a6"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
cache-control: max-age=600; must-revalidate
x-amz-cf-id: VUJgD9Jn6O3iHtjt5tY5dSfpvaljayeDXsM71-KEcZTGSvUFvM_-YQ==

GET
H2 200 tag.js Show response
www.fox44news.com/wp-content/plugins/sailthru-widget/js/ 603 B
365 B 131ms
128ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/sailthru-widget/js/tag.js?ver=6.4.4
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: e7efcd6d780141149d6cfa70470b4518d2e4cbb421bc21d76df611f6b2969587

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Tue, 31 Jan 2023 16:42:07 GMT
server: nginx
x-timer: S1716299339.358514,VS0,VE4
etag: W/"63d944df-25b"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 error-logger.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 3 KB
1 KB 125ms
122ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/error-logger.bundle.min.js?ver=75b532c75e319d2ea679
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 123e5e1266e40e70c8569aff4e0115d6709bdfb5c22f7ee3c5f98e6e9a9af9a1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299339.358505,VS0,VE4
etag: W/"6632791b-a73"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 liveblog-iframe.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 2 KB
1 KB 124ms
122ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/liveblog-iframe.bundle.min.js?ver=3f4198a82a00dca82d80
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 51a5b817878c28012d651b62894d26551a3a8600e71b16a22f6345ec1f57a601

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299339.358517,VS0,VE4
etag: W/"6632791b-751"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 widget.subscribe.js Show response
www.fox44news.com/wp-content/plugins/sailthru-widget/js/ 2 KB
950 B 124ms
121ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/sailthru-widget/js/widget.subscribe.js?ver=1.1.5
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 418b99c787eb135b4690cb932bb552c2d35493637e8c5eb9c25a6c234e7bb16d

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Thu, 18 May 2023 20:07:38 GMT
server: nginx
x-timer: S1716299339.358458,VS0,VE4
etag: W/"6466858a-7b1"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 display.js Show response
www.fox44news.com/wp-content/plugins/sailthru-widget/js/ 2 KB
645 B 123ms
121ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/sailthru-widget/js/display.js?ver=1.1.2
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 77a8092d74310d763213a46d056cf0262bc3edb00579b9ad9bbc6da830212573

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Fri, 21 Jul 2023 18:10:23 GMT
server: nginx
x-timer: S1716299339.358446,VS0,VE4
etag: W/"64baca0f-6b6"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 prn_cision_logo_desktop.png
www.nxsttv.com/wp-content/uploads/2021/11/ 3 KB
3 KB 120ms
36ms Image
image/webp 192.0.66.120
AUTOMATTIC

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.nxsttv.com/wp-content/uploads/2021/11/prn_cision_logo_desktop.png
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 192.0.66.120 San Francisco, United States, ASN2635 (AUTOMATTIC, US),
Reverse DNS
Software: nginx /
Resource Hash: 459ba77cc5933099fb924c1f8d9c6ff99d76a8fcb1381385cdb05eb7d57dabbf

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
x-rq: jfk1 98 228 443
last-modified: Sat, 20 Apr 2024 10:31:33 GMT
server: nginx
etag: "df7e6a4b7d2bf1e5"
vary: Accept
x-cache: HIT
content-type: image/webp
cache-control: max-age=31536000
accept-ranges: bytes
content-length: 2868

GET
H2 200 Theranica_Logo.jpg
mma.prnewswire.com/media/2011113/ 73 KB
74 KB 164ms
80ms Image
image/jpeg 2606:4700:4400::ac40:9b8d
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://mma.prnewswire.com/media/2011113/Theranica_Logo.jpg?p=publish
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server: 2606:4700:4400::ac40:9b8d , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare / ASP.NET
Resource Hash: 6b14ec36602afb198e7084af279f647df030b5fa364aa28b9c892d2992229f89

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
cf-cache-status: HIT
x-powered-by: ASP.NET
server-timing: intid;desc=ace81da8057627cb
content-length: 74880
cf-bgj: h2pri
last-modified: Tue, 21 May 2024 12:26:45 GMT
server: cloudflare
vary: *, Accept-Encoding
access-control-allow-methods: GET, POST, OPTIONS
content-type: image/jpeg
access-control-allow-origin: *
cache-control: public, max-age=0
accept-ranges: bytes
cf-ray: 887506f7590a4bbd-BUF
access-control-allow-headers: Content-Type
expires: Tue, 21 May 2024 12:26:46 GMT

GET
H2 200 Theranica_Nerivio.jpg
mma.prnewswire.com/media/2417234/ 26 KB
26 KB 73ms
72ms Image
image/jpeg 2606:4700:4400::ac40:9b8d
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://mma.prnewswire.com/media/2417234/Theranica_Nerivio.jpg
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server: 2606:4700:4400::ac40:9b8d , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare / ASP.NET
Resource Hash: e339ed1c996364416dbfc510225485c2c7c55c85a8b1fdcf993032390eb4c8f5

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
cf-cache-status: HIT
x-powered-by: ASP.NET
server-timing: intid;desc=ca591abb41ceff13
content-length: 26613
cf-bgj: h2pri
last-modified: Tue, 21 May 2024 12:15:20 GMT
server: cloudflare
vary: *, Accept-Encoding
access-control-allow-methods: GET, POST, OPTIONS
content-type: image/jpeg
access-control-allow-origin: *
cache-control: public, max-age=1
accept-ranges: bytes
cf-ray: 887506f799334bbd-BUF
access-control-allow-headers: Content-Type
expires: Tue, 21 May 2024 12:15:21 GMT

GET
H2 200 Theranica_Logo.jpg
mma.prnewswire.com/media/2011113/ 9 KB
9 KB 82ms
82ms Image
image/jpeg 2606:4700:4400::ac40:9b8d
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://mma.prnewswire.com/media/2011113/Theranica_Logo.jpg
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server: 2606:4700:4400::ac40:9b8d , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare / ASP.NET
Resource Hash: 769335caa9987d8e062ef9149709351eed0ff21287c77e97a8d471020ceef580

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
cf-cache-status: HIT
x-powered-by: ASP.NET
content-length: 9479
cf-bgj: h2pri
last-modified: Tue, 21 May 2024 12:15:05 GMT
server: cloudflare
vary: *, Accept-Encoding
access-control-allow-methods: GET, POST, OPTIONS
content-type: image/jpeg
access-control-allow-origin: *
cache-control: public, max-age=0
accept-ranges: bytes
cf-ray: 887506f819624bbd-BUF
access-control-allow-headers: Content-Type
expires: Tue, 21 May 2024 12:15:06 GMT

GET
H2

200

favicon_image.png
c212.net/c/img/
Redirect Chain

https://c212.net/c/img/favicon.png?sn=LA18851&sd=2024-05-21
https://pixel.mathtag.com/sync/img?redir=https%3A%2F%2Fc212.net%2Fc%2Fsync%3Fu%3DL2MvaW1nL2Zhdmljb25faW1hZ2UucG5n%26c%3DUS%26dmpId%3D1%26pid%3D%5BMM_UUID%5D
https://c212.net/c/sync?u=L2MvaW1nL2Zhdmljb25faW1hZ2UucG5n&c=US&dmpId=1&pid=865d664c-a64c-4000-b856-6472404e23e6
https://c212.net/c/img/favicon_image.png

320 B
618 B

48ms
47ms

Image
image/png

3.162.103.38
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c212.net/c/img/favicon_image.png
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Server: 3.162.103.38 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-3-162-103-38.iad61.r.cloudfront.net
Software: Jetty(9.4.31.v20200723) /
Resource Hash: 7b6d03531ab9128ec3e671c66a4815f23601d844b0f6624e9922a0678e58254b

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 6946167499a4b8f515865d62f0b0b284.cloudfront.net (CloudFront)
last-modified: Fri, 22 Jan 2021 20:10:50 GMT
server: Jetty(9.4.31.v20200723)
x-amz-cf-pop: IAD61-P1
x-cache: Miss from cloudfront
content-type: image/png
accept-ranges: bytes
content-length: 320
x-amz-cf-id: 47dybFLkmcZepbKK7zsP6klm6X0UCKDF9IK3aCyO8OiNvn5f6MfWbQ==

Redirect headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 6946167499a4b8f515865d62f0b0b284.cloudfront.net (CloudFront)
server: Jetty(9.4.31.v20200723)
x-amz-cf-pop: IAD61-P1
x-cache: Miss from cloudfront
location: /c/img/favicon_image.png
content-length: 0
x-amz-cf-id: lvSHCUIOuF4grf1bBQPzxHx46Ca39ePl2kdX98ffKdbV9H3ytCaKZw==

GET
H2

200

1x1.gif
c212.net/c/img/
Redirect Chain

https://rt.prnewswire.com/rt.gif?NewsItemId=LA18851&Transmission_Id=202405210815PR_NEWS_USPR_____LA18851&DateId=20240521
https://c212.net/c/pix/?t=0&h=1142403200&ej=eyJzbiI6IkxBMTg4NTEiLCJzZCI6IjIwMjQwNTIxIiwidCI6InJ0IiwiciI6Imh0dHBzOlwvXC93d3cuZm94NDRuZXdzLmNvbVwvIn0=
https://pixel.mathtag.com/sync/img?redir=https%3A%2F%2Fc212.net%2Fc%2Fsync%3Fu%3DL2MvaW1nLzF4MS5naWY%2Fc2V0PTE%3D%26c%3DUS%26dmpId%3D1%26pid%3D%5BMM_UUID%5D
https://c212.net/c/sync?u=L2MvaW1nLzF4MS5naWY/c2V0PTE=&c=US&dmpId=1&pid=36ee664c-a64b-4200-87c5-b9a623130cad
https://c212.net/c/img/1x1.gif?set=1

49 B
346 B

50ms
50ms

Image
image/gif

3.162.103.38
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c212.net/c/img/1x1.gif?set=1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Server: 3.162.103.38 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-3-162-103-38.iad61.r.cloudfront.net
Software: Jetty(9.4.31.v20200723) /
Resource Hash: 1cd58a827318c4a29b32a0db15c8c39d5651b42d8cad227519ad81bce4adb944

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 6946167499a4b8f515865d62f0b0b284.cloudfront.net (CloudFront)
last-modified: Fri, 22 Jan 2021 20:10:50 GMT
server: Jetty(9.4.31.v20200723)
x-amz-cf-pop: IAD61-P1
x-cache: Miss from cloudfront
content-type: image/gif
accept-ranges: bytes
content-length: 49
x-amz-cf-id: qdivfuOvPiFnLU9Q1Yc96BDE5lrahOgQQ9X2B3DAlVMP7dJUoKe_-Q==

Redirect headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 6946167499a4b8f515865d62f0b0b284.cloudfront.net (CloudFront)
server: Jetty(9.4.31.v20200723)
x-amz-cf-pop: IAD61-P1
x-cache: Miss from cloudfront
location: /c/img/1x1.gif?set=1
content-length: 0
x-amz-cf-id: 3pmhYMIxeO_RMhYGPqMfIqL8_yM4pMwe8luCymxL56hA9ad8dWEsdA==

GET
H2

200

csw-polyfills.js Show response
d2zqfs55y95cft.cloudfront.net/jspoll/5/
Redirect Chain

https://get.civicscience.com/jspoll/5/csw-polyfills.js?ver=1.1
https://d2zqfs55y95cft.cloudfront.net/jspoll/5/csw-polyfills.js?ver=1.1

124 KB
40 KB

155ms
49ms

Script
application/javascript

2600:9000:24f4:5200:f:c7b3:ce40:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://d2zqfs55y95cft.cloudfront.net/jspoll/5/csw-polyfills.js?ver=1.1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Server: 2600:9000:24f4:5200:f:c7b3:ce40:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: c68171f5e0941a6df57207ec04851514e9fef3c5111f9ee8b9e29e750e34da26

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 06:22:41 GMT
content-encoding: gzip
via: 1.1 4e2b60a8131e436f5ac38dc8a953edf4.cloudfront.net (CloudFront)
last-modified: Mon, 29 Apr 2024 15:39:51 GMT
server: AmazonS3
x-amz-cf-pop: IAD55-P3
age: 26780
etag: W/"8787dfbc459533f59a6d317f823b7a10"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
x-amz-cf-id: GSA5gmAJ8y1m_ijhH8k2E27coNn7UxogFoTvqsZT1z2KHO5_Ol9mrQ==

Redirect headers

location: https://d2zqfs55y95cft.cloudfront.net:443/jspoll/5/csw-polyfills.js?ver=1.1
date: Tue, 21 May 2024 13:48:59 GMT
server: awselb/2.0
content-length: 110
content-type: text/html

GET
H2 200 pixel.js Show response
www.fox44news.com/wp-content/plugins/civic-science/js/ 495 B
652 B 87ms
83ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/civic-science/js/pixel.js?ver=1.1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: cf912d98227ff449c83070ee7bbd7b84d7fc9115014fecad1af2e01e9134dc79

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 varnish
last-modified: Mon, 30 Jan 2023 19:11:07 GMT
server: nginx
x-timer: S1716299340.584209,VS0,VE1
etag: "63d8164b-1ef"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
content-length: 495
x-cache-hits: 0

GET
H2 200 virtual-page-scripts.js Show response
www.fox44news.com/wp-content/plugins/content-syndication/scripts/ 843 B
646 B 41ms
28ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/content-syndication/scripts/virtual-page-scripts.js?ver=1.0.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 478b8b01ba77038b021866ff928dcf561f7f6f8c86b4d50605a29aa08c0f34e4

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Mon, 30 Jan 2023 19:11:07 GMT
server: nginx
x-timer: S1716299340.581240,VS0,VE1
etag: W/"63d8164b-34b"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 search-scripts.js Show response
www.fox44news.com/wp-content/plugins/content-syndication/scripts/ 929 B
539 B 46ms
33ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/content-syndication/scripts/search-scripts.js?ver=1.0.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: eef48236396dcea36eb75e7000464cf3219273946c4eb575e7017951e46f544a

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Mon, 30 Jan 2023 19:11:07 GMT
server: nginx
x-timer: S1716299340.581928,VS0,VE1
etag: W/"63d8164b-3a1"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 cookie.min.js Show response
www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/ 2 KB
1 KB 45ms
33ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/cookie.min.js?ver=3.14.1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 3b1384ff918d4b7f95f9ee5c8fc388203dedff7344d3d96598c9562162788612

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
last-modified: Wed, 15 May 2024 16:26:56 GMT
server: nginx
x-timer: S1716299340.581907,VS0,VE1
etag: W/"6644e250-72a"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 jquery.countdown.min.js Show response
www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/ 5 KB
2 KB 46ms
34ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/jquery.countdown.min.js?ver=2.2.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 2249399b2268c260d0698542503d16afebc80e437c846239f12196744ebbd40f

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Mon, 30 Jan 2023 19:11:07 GMT
server: nginx
x-timer: S1716299340.581907,VS0,VE1
etag: W/"63d8164b-14db"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 hurrytimer.js Show response
www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/ 30 KB
7 KB 45ms
34ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/hurrytimer.js?ver=%202.10.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 85facd48007af4a1b19617d15bdf545883dc30951814340c9f622123e4982f7e

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Wed, 15 May 2024 16:26:56 GMT
server: nginx
x-timer: S1716299340.581946,VS0,VE1
etag: W/"6644e250-77a5"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 hurrytimer-wv.js Show response
www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/ 708 B
441 B 45ms
34ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/hurrytimer/assets/js/hurrytimer-wv.js?ver=%202.10.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: f1b4c521f8a43a177becb026510b7541c5ff98f7166e16e681001a66fe2ccfba

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Wed, 15 May 2024 16:26:56 GMT
server: nginx
x-timer: S1716299340.581861,VS0,VE1
etag: W/"6644e250-2c4"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 common.chunk.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 486 KB
144 KB 43ms
33ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/common.chunk.min.js?ver=6e0a8493367cb9cc19f6
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 1fffffba44ec62c41ef5f1688f210f16515c7d6840e7963a37353e400859c1d3

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.581853,VS0,VE1
etag: W/"6632791b-7991e"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 api-request.min.js Show response
www.fox44news.com/wp-includes/js/ 1023 B
680 B 43ms
32ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-includes/js/api-request.min.js?ver=6.4.4
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 1a234275545ba883616ac6b4151a0f06d9bb097146e806e40317a263bbf1c51e

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
last-modified: Tue, 07 May 2024 21:39:07 GMT
server: nginx
x-timer: S1716299340.581838,VS0,VE1
etag: W/"663a9f7b-3ff"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 global.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 261 KB
81 KB 70ms
60ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/global.bundle.min.js?ver=917c7bff809c3c4424f5
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: f9abc3de35b77e7ca68557063741f4f253ff9ade44b030538b8d4d7edeadc3af

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 188 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.582969,VS0,VE1
etag: W/"6632791b-41576"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 article.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 12 KB
4 KB 75ms
65ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/article.bundle.min.js?ver=af202aba4c829764e77f
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 28d7d204022a8bb2b7ca022dba069c4080ce989d50468fc3a5ccd35a469b3777

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.583586,VS0,VE1
etag: W/"6632791b-2f05"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 weatherIcons.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 1 KB
661 B 90ms
80ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/weatherIcons.bundle.min.js?ver=8a495bdd731fcab7aa6a
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: bd5b9ff7ff355bd98d4c33a34d6bd801913bb1a0014cd6b09c0615d3f47ce489

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.583570,VS0,VE1
etag: W/"6632791b-45f"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 video-playlist.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 27 KB
8 KB 83ms
73ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/video-playlist.bundle.min.js?ver=0b72abdbb972971245f1
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 36a0054ce8d0774e4a22b49bccf3dab0c86c44cbafdc1d614b0af1342efb1ac7

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.583560,VS0,VE1
etag: W/"6632791b-6c5a"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 closings.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 5 KB
2 KB 92ms
82ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/closings.bundle.min.js?ver=e34212aeee838cb6921f
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: aed309990a56bebb35c9f547e0e3b09a80e51e38f4ebc0c39fbbf564178008ce

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.583548,VS0,VE2
etag: W/"6632791b-13c6"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 weather.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 10 KB
3 KB 84ms
74ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/weather.bundle.min.js?ver=c9c4d8a93c6a8d8d20ee
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 2adc9a837d7335f463e3194ad1dc331b0c1a366f0173fd1f55cf79e3ff0f2d7e

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.583529,VS0,VE1
etag: W/"6632791b-2985"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 limited-view.bundle.min.js Show response
www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/ 2 KB
1 KB 90ms
80ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/js/limited-view.bundle.min.js?ver=295820e2584543b62560
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: c4159fc54a350077b3556557484e0e46b67faba39b2e71acdfb774debe1184f2

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
via: 1.1 varnish
x-cache: HIT, MISS
x-served-by: cache-yyz4527-YYZ
x-rq: yyz4 85 187 443
last-modified: Wed, 01 May 2024 17:17:15 GMT
server: nginx
x-timer: S1716299340.583549,VS0,VE1
etag: W/"6632791b-80b"
vary: Accept-Encoding
state: PASS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 live-now.js Show response
www.fox44news.com/wp-content/plugins/lakana/inc/alert-banners/js/ 2 KB
724 B 75ms
65ms Script
application/javascript 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/plugins/lakana/inc/alert-banners/js/live-now.js?ver=1.0.0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 750f4c56e8b1f97a201446b3d94d6b3c5912dc5df8b06ec6f543de2270405f78

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 187 443
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
last-modified: Mon, 30 Jan 2023 19:11:07 GMT
server: nginx
x-timer: S1716299340.583505,VS0,VE1
etag: W/"63d8164b-64f"
state: PASS
x-cache: HIT, MISS
content-type: application/javascript
cache-control: max-age=31536000
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 e-202421.js Show response
stats.wp.com/ 7 KB
3 KB 117ms
36ms Script
application/javascript 192.0.76.3
AUTOMATTIC

General

Check archive.org

Show headers Download Go to

Full URL: https://stats.wp.com/e-202421.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 192.0.76.3 San Francisco, United States, ASN2635 (AUTOMATTIC, US),
Reverse DNS
Software: nginx /
Resource Hash: 4f9f4e2e225088f9cf3b6b54aa421e0f776d1802255505d2f752e1f83f441641

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-minify-cache: hit
x-nc: HIT jfk
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: br
server: nginx
x-minify: t
etag: W/14377-1704402356443.5398
vary: Accept-Encoding
access-control-allow-methods: GET, HEAD
content-type: application/javascript
access-control-allow-origin: *
cache-control: max-age=31536000
alt-svc: h3=":443"; ma=86400
expires: Thu, 08 May 2025 14:16:29 GMT

GET
H2 200 fd137de5-c96c-424c-afa7-f92a90556e38.json Show response
cdn.cookielaw.org/consent/fd137de5-c96c-424c-afa7-f92a90556e38/ 6 KB
2 KB 130ms
56ms XHR
application/x-javascript 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/consent/fd137de5-c96c-424c-afa7-f92a90556e38/fd137de5-c96c-424c-afa7-f92a90556e38.json

Requested by

Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

502d7bb5eda0a12cd5a831eadf8020b45500787adef98ffc9db687891b52754c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
strict-transport-security: max-age=31536000; includeSubDomains; preload
age: 34449
content-md5: 4dFkqoRGfNHu8UPlCDBk+g==
content-length: 1784
x-ms-lease-status: unlocked
last-modified: Wed, 27 Mar 2024 18:36:13 GMT
server: cloudflare
etag: 0x8DC4E8CC7AE1DD9
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
x-ms-request-id: b126fa57-901e-0094-7e75-808eea000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: public, max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 887506f7f9094bc6-BUF
expires: Wed, 22 May 2024 13:48:59 GMT

GET
H2 200 dnsfeed Show response
geolocation.onetrust.com/cookieconsentpub/v1/geo/location/ 78 B
245 B 128ms
51ms Script
text/javascript 2606:4700:4400::ac40:9b77
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://geolocation.onetrust.com/cookieconsentpub/v1/geo/location/dnsfeed

Requested by

Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/opt-out/otCCPAiab.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:4400::ac40:9b77 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6ed37e392b16dc80c3fe4470e3e48eb831b86dc84531de828b734190073d8062

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
server: cloudflare
cf-ray: 887506f9e8c94bcf-BUF
vary: Accept-Encoding
content-type: text/javascript

GET
H2 200 bob_001.js Show response
bob.dmpxs.com/static/ 1 KB
973 B 213ms
47ms Script
application/javascript 52.21.84.14
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://bob.dmpxs.com/static/bob_001.js?bob_cb=1716299339423406&cats=&bob_kw=&bob_desc=&story_author=&page_url=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.21.84.14 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-21-84-14.compute-1.amazonaws.com
Software: / Express
Resource Hash: 92f46c7cba4d17f6919a27bc712bcfa2ae726743ba22c8e208014990f7661268

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
last-modified: Wed, 06 Apr 2022 03:35:13 GMT
x-powered-by: Express
etag: W/"44a-17ffcf0ccc5"
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
cache-control: public, max-age=0
accept-ranges: bytes

GET
H2

200

apstag.js Show response
d3div1mtym39ic.cloudfront.net/aax2/
Redirect Chain

https://c.amazon-adsystem.com/aax2/apstag.js
https://d3div1mtym39ic.cloudfront.net/aax2/apstag.js

303 KB
67 KB

149ms
49ms

Script
application/javascript

2600:9000:2305:1600:11:1ed0:3900:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://d3div1mtym39ic.cloudfront.net/aax2/apstag.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Server: 2600:9000:2305:1600:11:1ed0:3900:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 0513a2230781b12f01a52aa25169cb9d09be5968f5f0afa4d69a818b239f34dd

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 13:18:43 GMT
content-encoding: br
via: 1.1 4b0dd366e44414a4e7e6ed6970080d58.cloudfront.net (CloudFront)
last-modified: Tue, 07 May 2024 20:29:13 GMT
server: AmazonS3
x-amz-cf-pop: IAD89-P2
age: 1818
x-amz-server-side-encryption: AES256
etag: W/"3b8ede3ac6facca086f5ab97663513eb"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
cache-control: max-age=3600
alt-svc: h3=":443"; ma=86400
x-amz-cf-id: 6WhNaI134LsWaTwf9dULaBhSOMMp_02cpnaigzlC4CbslaJdI2oOSg==

Redirect headers

date: Mon, 20 May 2024 21:57:53 GMT
via: 1.1 2c0478fce3b7f4f5348678901d1bf60a.cloudfront.net (CloudFront), 1.1 b72ec90bfb3598795e1ec469cc868742.cloudfront.net (CloudFront)
server: CloudFront
x-amz-cf-pop: IAD89-P2, IAD55-P4
age: 57066
x-cache: Hit from cloudfront
content-type: text/html
location: https://d3div1mtym39ic.cloudfront.net/aax2/apstag.js
content-length: 167
x-amz-cf-id: iTRTXRpJq86yJE-iDVBOF-iyEUa12ku0xdrIyrmyqAgGqr2hhXLUFw==

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 366 KB
103 KB 154ms
57ms Script
application/javascript 2607:f8b0:4004:c19::61
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-KJJZHXD

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c19::61 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

376d63fa1c610e17f6cc65f4aba7fec4e64deec5c0f290ba3db0436fb17eac68

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 104562
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Tue, 21 May 2024 13:48:59 GMT

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 176 KB
63 KB 208ms
123ms Script
application/javascript 2607:f8b0:4004:c19::61
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-PWTJZW

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c19::61 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

9c88c4c3cdb4016354fc20b22f571bad373a55370c78e2f10ce23a182557fa5b

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 64905
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Tue, 21 May 2024 13:48:59 GMT

GET
H2 200 loader.js Show response
cdn.taboola.com/libtrc/nexstar-network/ 839 KB
214 KB 98ms
30ms Script
application/javascript 151.101.129.44
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.taboola.com/libtrc/nexstar-network/loader.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.129.44 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: d6a583818a5147dce555cedcaa3f5f6d2cd436d24731c4f5f946e742518203b9

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: A2UJA1vjtGemP.xcOjIyPNmtzTh0us41
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:48:59 GMT
x-amz-request-id: HQ9GFRKVHJQEZ4F1
age: 16396
x-amz-server-side-encryption: AES256
x-cache: HIT
x-amz-replication-status: FAILED
content-length: 218435
x-amz-id-2: wBNQq5KMsqWA1midwYfpg9DrOiBX/bPX7LUXECPLQsvFhH7lWVS7g6wUvGpqtGPdcEtSiHNES2c=
x-served-by: cache-yyz4523-YYZ
last-modified: Tue, 21 May 2024 09:15:22 GMT
server: AmazonS3
x-timer: S1716299340.886190,VS0,VE2
etag: "4b2023665eecaf19bf3cc83970ddca64"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
abp: 91
access-control-allow-origin: *
cache-control: private,max-age=14401
accept-ranges: bytes
x-cache-hits: 1

GET
H2 200 css2
fonts.googleapis.com/ 3 KB
725 B 65ms
62ms Stylesheet
text/css 2607:f8b0:4004:c08::5f
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css2?family=Roboto+Condensed:wght@700&display=swap

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/wp-content/plugins/hurrytimer/assets/css/main.css?ver=%202.10.0

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c08::5f Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

42e28faecbd583a937b8480ba3bacb276eb243609f4f1e8c92c804879efa2e29

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Tue, 21 May 2024 13:10:00 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Tue, 21 May 2024 13:48:59 GMT

GET
H2 200 css2
fonts.googleapis.com/ 14 KB
1 KB 63ms
63ms Stylesheet
text/css 2607:f8b0:4004:c08::5f
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css2?family=Nunito+Sans:wght@600;800&family=Fira+Sans:wght@800&family=Fira+Sans+Condensed:wght@400;600;800&display=swap

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/wp-content/themes/nexstar-wv/client/build/css/global.min.css?ver=d2f04c4e99525672bbdb

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c08::5f Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

39bb5d4fbd16cd97613cc2bc227135a2ca7543482945496cb5e1aced6b554c87

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Tue, 21 May 2024 12:39:01 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Tue, 21 May 2024 13:48:59 GMT

GET
H3 200 adsbygoogle.js Show response
pagead2.googlesyndication.com/pagead/js/ 150 KB
51 KB 223ms
121ms Fetch
text/javascript 142.250.31.156
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.31.156 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bj-in-f156.1e100.net

Software

cafe /

Resource Hash

5ff8946f84894ae4cccb62ea3dc6908a81bed0c19d62602e92c8d0fa942aa174

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: br
x-content-type-options: nosniff
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 51887
x-xss-protection: 0
server: cafe
etag: 2430529397363405907
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin: *
link: <https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires: Tue, 21 May 2024 13:48:59 GMT

OPTIONS
H2 200 domaingroupcheck
cookies-data.onetrust.io/bannersdk/v1/ Frame 0
0 159ms
56ms Preflight
application/json 2606:4700:4400::ac40:9b3f
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cookies-data.onetrust.io/bannersdk/v1/domaingroupcheck
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:4400::ac40:9b3f , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Headers: domainid,location,url
Access-Control-Request-Method: GET
Origin: https://www.fox44news.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

access-control-allow-headers: domainId, url, location, Content-Type, Access-Control-Allow-Headers, Authorization, X-Requested-With
access-control-allow-methods: GET, HEAD, OPTIONS
access-control-allow-origin: *
cf-ray: 887506f919c64bbd-BUF
content-length: 0
content-type: application/json
date: Tue, 21 May 2024 13:48:59 GMT
server: cloudflare
vary: Accept-Encoding

GET
H2 200 domaingroupcheck Show response
cookies-data.onetrust.io/bannersdk/v1/ 16 B
85 B 74ms
71ms XHR
application/json 2606:4700:4400::ac40:9b3f
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cookies-data.onetrust.io/bannersdk/v1/domaingroupcheck
Requested by: Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:4400::ac40:9b3f , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 469ab758cfe6a8ac93cda5872ca28655f6f874a2f6cceafa710fc01f52fc787d

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
location: cdn.cookielaw.org
Referer: https://www.fox44news.com/
url: www.fox44news.com
domainId: fd137de5-c96c-424c-afa7-f92a90556e38
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
server: cloudflare
vary: Accept-Encoding
access-control-allow-methods: GET, HEAD, OPTIONS
content-type: application/json
access-control-allow-origin: *
cf-ray: 887506f979eb4bbd-BUF
access-control-allow-headers: Content-Type
content-length: 16

GET
H2 200 location Show response
geolocation.onetrust.com/cookieconsentpub/v1/geo/ 69 B
305 B 130ms
53ms XHR
application/json 2606:4700:4400::ac40:9b77
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://geolocation.onetrust.com/cookieconsentpub/v1/geo/location

Requested by

Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:4400::ac40:9b77 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

59e58524340cd7ad353be010374b124c242fdde10a0ed41047fe2fd4bb9e5a2e

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
accept: application/json
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
server: cloudflare
vary: Accept-Encoding
access-control-allow-methods: GET, OPTIONS
content-type: application/json
access-control-allow-origin: *
cf-ray: 887506f8e95e4bd3-BUF
access-control-allow-headers: Content-Type

GET
H2 200 chartbeat.js Show response
static.chartbeat.com/js/ 38 KB
15 KB 51ms
50ms Script
application/x-javascript 2600:9000:24f3:fe00:18:1fcd:354:4b41
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://static.chartbeat.com/js/chartbeat.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:24f3:fe00:18:1fcd:354:4b41 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: nginx /
Resource Hash: 3d107b341b2356549974efad9aa65c0d321c5627a0e9bc8681223e8f69688d80

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 18:42:39 GMT
content-encoding: gzip
via: 1.1 9b00405a1ff669043791884b75822050.cloudfront.net (CloudFront)
last-modified: Thu, 11 Apr 2024 00:12:34 GMT
server: nginx
x-amz-cf-pop: IAD55-P2
age: 68780
etag: W/"66172af2-9889"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/x-javascript
cache-control: max-age=86400
cross-origin-resource-policy: cross-origin
x-amz-cf-id: eXJ6-jd3THZWyMW3-ZqO1M6sn7wxVO2qer02iZTLhKkN6VrXIQURJw==
expires: Tue, 21 May 2024 18:42:39 GMT

GET
H2 200 P1AA93ABC-DED6-4EE2-8CE5-8F5729E1D264.js Show response
cdn-gl.imrworldwide.com/conf/ 32 KB
7 KB 180ms
48ms Script
application/javascript 2600:9000:24f4:4a00:2:42d9:3100:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn-gl.imrworldwide.com/conf/P1AA93ABC-DED6-4EE2-8CE5-8F5729E1D264.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:24f4:4a00:2:42d9:3100:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 221c5bc1b46107e81e7928ef4033bf122b0a793324bc1c5fc705841e8936864f

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: lfYd21gIBa7ZJQM0rAMC6V7p8s2Le0L.
content-encoding: gzip
via: 1.1 e030eb9e2523dd8af200ce39f28ca642.cloudfront.net (CloudFront)
date: Tue, 21 May 2024 13:18:03 GMT
last-modified: Tue, 21 May 2024 07:15:36 GMT
server: AmazonS3
x-amz-cf-pop: IAD55-P3
age: 1858
x-amz-server-side-encryption: AES256
etag: W/"20f33b22b86a6271864dabd918cbe352"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
cache-control: max-age=86400,s-maxage=86400
x-amz-cf-id: MF8DwOSTApj-oOKXOqc6V6UfFvzKqbuVJhaBfQ5xt83gD5HVrCOf_A==

GET
H2 200 KWKT-FOX44news_com-smaller-1.png
www.fox44news.com/wp-content/uploads/sites/82/2019/07/ 407 KB
408 KB 46ms
45ms Image
image/webp 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.fox44news.com/wp-content/uploads/sites/82/2019/07/KWKT-FOX44news_com-smaller-1.png
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: c7c7ba025ffde45151c6e27aff4899eae22209eff2dd1fe42d43ea4f86837d14

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 varnish
x-cache: HIT, MISS
content-length: 417040
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 80 130 443
last-modified: Thu, 09 May 2024 05:41:23 GMT
server: nginx
x-timer: S1716299340.622729,VS0,VE1
etag: "9ee6f30e22a44f51"
vary: Accept
state: PASS
content-type: image/webp
cache-control: max-age=31536000
accept-ranges: bytes, bytes
x-cache-hits: 0

GET
DATA 200
OK truncated
/ 978 B
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 55cde4226c6e9479f3df692b31b7d29e8b63bf206c8344c17e120addc3d41db2

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/svg+xml;charset=utf-8

GET
DATA 200
OK truncated
/ 571 B
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: e09145c131ed93c39e3a4a39a905a407f610dd677df80c06ac299dd5c24f5501

Request headers

Referer
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/svg+xml;charset=utf-8

GET
DATA 200
OK truncated
/ 99 B
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: d0740758bb8504c6d866f785ef823f062d89835faca1a7eebac02aa1db4f011c

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/svg+xml;charset=utf-8

GET
DATA 200
OK truncated
/ 324 B
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 631ec8e14516218cc8aa3cf460abae09bfc37616b6026abf6b903bb1f168853f

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/svg+xml;charset=utf-8

GET
H2 200 6xK3dSBYKcSV-LCoeQqfX1RYOo3qOK7l.woff2
fonts.gstatic.com/s/sourcesanspro/v22/ 15 KB
15 KB 158ms
59ms Font
font/woff2 2607:f8b0:4004:c1b::5e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/sourcesanspro/v22/6xK3dSBYKcSV-LCoeQqfX1RYOo3qOK7l.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Source+Sans+Pro%3A400%2C400i%2C600%2C600i%2C700%2C700i%2C900%2C900i%7CSource+Serif+Pro%3A400%2C600%2C700%2C900%7CRoboto+Condensed%3A400%2C700%7CLora%3A400%2C700&display=swap&ver=1.0

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7b348b30ea1fe43857e68fc462c29e5c6e63c97666af75135c4396a272e54762

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://fonts.googleapis.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 13:33:28 GMT
x-content-type-options: nosniff
age: 87331
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 14892
x-xss-protection: 0
last-modified: Thu, 01 Jun 2023 22:52:56 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 20 May 2025 13:33:28 GMT

GET
H2 200 6xKydSBYKcSV-LCoeQqfX1RYOo3ig4vwlxdu.woff2
fonts.gstatic.com/s/sourcesanspro/v22/ 14 KB
14 KB 208ms
110ms Font
font/woff2 2607:f8b0:4004:c1b::5e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/sourcesanspro/v22/6xKydSBYKcSV-LCoeQqfX1RYOo3ig4vwlxdu.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

0d0a6262c545e8bbc895116e5afb22579c468d7abb77e378f377d6fed57c1dce

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://fonts.googleapis.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 13:48:31 GMT
x-content-type-options: nosniff
age: 86428
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 14712
x-xss-protection: 0
last-modified: Thu, 01 Jun 2023 22:52:57 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 20 May 2025 13:48:31 GMT

GET
H2 200 6xKydSBYKcSV-LCoeQqfX1RYOo3iu4nwlxdu.woff2
fonts.gstatic.com/s/sourcesanspro/v22/ 14 KB
14 KB 222ms
124ms Font
font/woff2 2607:f8b0:4004:c1b::5e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/sourcesanspro/v22/6xKydSBYKcSV-LCoeQqfX1RYOo3iu4nwlxdu.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

aee584e3d58344a41b190bb7b6e550f98ad3bb8e28fbc7ea6ddca22f0ef97183

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://fonts.googleapis.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 12:06:34 GMT
x-content-type-options: nosniff
age: 92545
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 14188
x-xss-protection: 0
last-modified: Thu, 01 Jun 2023 22:53:03 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 20 May 2025 12:06:34 GMT

GET
H2 200 neIXzD-0qpwxpaWvjeD0X88SAOeasc8btSyqxA.woff2
fonts.gstatic.com/s/sourceserifpro/v17/ 21 KB
21 KB 236ms
137ms Font
font/woff2 2607:f8b0:4004:c1b::5e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/sourceserifpro/v17/neIXzD-0qpwxpaWvjeD0X88SAOeasc8btSyqxA.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

190c3fdc18618a4473729faa65a7dfd810fef1d70ce2c3fe71cb1ed843cf08cb

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://fonts.googleapis.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 10:51:53 GMT
x-content-type-options: nosniff
age: 97026
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 21432
x-xss-protection: 0
last-modified: Thu, 01 Jun 2023 23:32:52 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 20 May 2025 10:51:53 GMT

GET
H2 200 6xKydSBYKcSV-LCoeQqfX1RYOo3i54rwlxdu.woff2
fonts.gstatic.com/s/sourcesanspro/v22/ 14 KB
15 KB 144ms
46ms Font
font/woff2 2607:f8b0:4004:c1b::5e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/sourcesanspro/v22/6xKydSBYKcSV-LCoeQqfX1RYOo3i54rwlxdu.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

ca57b79a870bbf54700730858603a70d79743779c1b059922ec401bfddc5adc9

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://fonts.googleapis.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 10:35:50 GMT
x-content-type-options: nosniff
age: 97989
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 14824
x-xss-protection: 0
last-modified: Thu, 01 Jun 2023 22:52:55 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 20 May 2025 10:35:50 GMT

GET
H2 200 6xK1dSBYKcSV-LCoeQqfX1RYOo3qPZ7nsDI.woff2
fonts.gstatic.com/s/sourcesanspro/v22/ 14 KB
14 KB 195ms
97ms Font
font/woff2 2607:f8b0:4004:c1b::5e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/sourcesanspro/v22/6xK1dSBYKcSV-LCoeQqfX1RYOo3qPZ7nsDI.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1b::5e Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

500f8aaf69ddcf71a16ceae58c927f03371b33665185e16df347b67f7f11bdb9

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://fonts.googleapis.com/
Origin: https://www.fox44news.com
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 14:38:29 GMT
x-content-type-options: nosniff
age: 83430
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 14160
x-xss-protection: 0
last-modified: Thu, 01 Jun 2023 22:52:57 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 20 May 2025 14:38:29 GMT

GET
H2 200 otBannerSdk.js Show response
cdn.cookielaw.org/scripttemplates/202403.1.0/ 442 KB
107 KB 56ms
56ms Script
application/javascript 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202403.1.0/otBannerSdk.js

Requested by

Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

15de250a16ce58a10f84bebab59b9005ce36df4ec8e87c3bb1acc92726cfa971

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: s7qm2vbmUNglr6Jt5k9KHA==
age: 60573
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 109676
x-ms-lease-status: unlocked
last-modified: Thu, 21 Mar 2024 07:04:35 GMT
server: cloudflare
etag: 0x8DC49752A75EB01
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: f463857b-001e-005d-3a08-7c3307000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 887506f99f0e4bc0-BUF

GET
H3 200 OneSignalPageSDKES6.js Show response
cdn.onesignal.com/sdks/ 284 KB
68 KB 47ms
46ms Script
application/javascript 104.16.160.145
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.onesignal.com/sdks/OneSignalPageSDKES6.js?v=151605

Requested by

Host: cdn.onesignal.com
URL: https://cdn.onesignal.com/sdks/OneSignalSDK.js

Protocol

Security

QUIC, , AES_128_GCM

Server

104.16.160.145 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ebe0f94ca53bc5f7d865f89aec5b0315bca03ace6942d6c1c76d94d5b59d419a

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
via: 1.1 google
content-encoding: br
cf-cache-status: HIT
server: cloudflare
strict-transport-security: max-age=15552000; includeSubDomains
age: 2280
etag: W/"e3be409ac3c100e2a5d3f264ec260551"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=259200
cf-ray: 887506f9bf5bac30-YYZ
access-control-allow-headers: OneSignal-Subscription-Id
alt-svc: h3=":443"; ma=86400
expires: Fri, 24 May 2024 13:48:59 GMT

GET
H2 200 / Show response
www.fox44news.com/wp-json/lakana/v1/template-variables/ 370 KB
38 KB 1064ms
1064ms Fetch
application/json 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fox44news.com/wp-json/lakana/v1/template-variables/

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),

Reverse DNS

Software

nginx /

Resource Hash

b363c034f23e7b83669b107c0443ef48d96232b7b555474c02a8fdaaae3b8008

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 varnish
x-cache: EXPIRED, MISS
fastly-restarts: 1
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
server: nginx
x-timer: S1716299340.859021,VS0,VE1035
allow: GET
vary: Accept-Encoding, Origin
content-type: application/json; charset=UTF-8
api-call-time-millis: 873
access-control-expose-headers: X-WP-Total, X-WP-TotalPages, Link
cache-control: max-age=120
state: PASS
accept-ranges: bytes
x-robots-tag: noindex
link: <https://www.fox44news.com/wp-json/>; rel="https://api.w.org/"
access-control-allow-headers: Authorization, X-WP-Nonce, Content-Disposition, Content-MD5, Content-Type
x-cache-hits: 0

GET
H3 200 wrap.js Show response
cdn.confiant-integrations.net/gptprebidnative/202403121239/ 284 KB
101 KB 38ms
38ms Script
application/javascript 172.64.144.166
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.confiant-integrations.net/gptprebidnative/202403121239/wrap.js
Requested by: Host: cdn.confiant-integrations.net
URL: https://cdn.confiant-integrations.net/Y2Nn8JmiAY8HpnF4sl5n7J71jaI/gpt_and_prebid/config.js
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 172.64.144.166 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 70b914de15dd75628895223bfe09012e3687598bca4dbaa34a97234f6a8826e9

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: gzip
cf-cache-status: HIT
x-amz-request-id: Z6Y9YF5QJ6S25CRH
age: 1896443
x-amz-server-side-encryption: AES256
alt-svc: h3=":443"; ma=86400
content-length: 103213
x-amz-id-2: d60ac1C5zQ21U6epb8DPwARqggivlw5mh7SLF3yApxbEvx59uO5mWAZUAjWvdkQFhjv0r+SFehkRKvfhyYDYFw==
last-modified: Tue, 12 Mar 2024 16:41:24 GMT
server: cloudflare
etag: "c1e08625d829bb0007d3c12ed83ad1cb"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
cache-control: public, max-age=31536000
accept-ranges: bytes
cf-ray: 887506fa38c1a21d-YYZ

GET
H2 200 cs Show response
nexstar.blueconic.net/DG/DEFAULT/ 16 B
702 B 148ms
47ms Script
text/javascript 34.194.130.13
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL

https://nexstar.blueconic.net/DG/DEFAULT/cs?&callback=bc_json970

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

34.194.130.13 Ashburn, United States, ASN14618 (AMAZON-AES, US),

Reverse DNS

ec2-34-194-130-13.compute-1.amazonaws.com

Software

- /

Resource Hash

891b51a10704213ba4c6860cac1515974d72c06e02d99192bb485009f5ea2d54

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: -
x-permitted-cross-domain-policies: master-only
content-type: text/javascript; charset=utf-8
p3p: policyref="", CP="DSP"
cache-control: no-cache, no-store, no-transform, must-revalidate, private
x-robots-tag: noindex, nofollow
content-length: 36
x-xss-protection: 1; mode=block
expires: Thu, 01 Jan 1970 00:00:00 GMT

GET
H2 200 / Show response
www.fox44news.com/wp-json/lakana/v1/template-variables/ 370 KB
0 955ms
954ms XHR
application/json 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fox44news.com/wp-json/lakana/v1/template-variables/

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/wp-content/plugins/lakana/inc/alert-banners/js/live-now.js?ver=1.0.0

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),

Reverse DNS

Software

nginx /

Resource Hash

b363c034f23e7b83669b107c0443ef48d96232b7b555474c02a8fdaaae3b8008

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 varnish
x-cache: EXPIRED, MISS
fastly-restarts: 1
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 85 188 443
server: nginx
x-timer: S1716299340.859021,VS0,VE1035
allow: GET
vary: Accept-Encoding, Origin
content-type: application/json; charset=UTF-8
api-call-time-millis: 873
access-control-expose-headers: X-WP-Total, X-WP-TotalPages, Link
cache-control: max-age=120
state: PASS
accept-ranges: bytes
x-robots-tag: noindex
link: <https://www.fox44news.com/wp-json/>; rel="https://api.w.org/"
access-control-allow-headers: Authorization, X-WP-Nonce, Content-Disposition, Content-MD5, Content-Type
x-cache-hits: 0

GET
H2 200 / Show response
mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/ 319 B
597 B 153ms
54ms XHR
application/json 2a04:4e42:600::714
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/?host=mycentx.com&domain=fox44news.com&path=%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F
Requested by: Host: static.chartbeat.com
URL: https://static.chartbeat.com/js/chartbeat_mab.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2a04:4e42:600::714 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash: adde7f67d897091118d27be67145c705d166d72f6de4cfdfeb49a20140214d68

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-cache-hits: 0
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
via: 1.1 varnish (Varnish/6.0), 1.1 varnish
age: 0
x-cache: MISS
cross-origin-resource-policy: cross-origin
content-length: 239
x-served-by: cache-nyc-kteb1890027-NYC
x-timer: S1716299340.073004,VS0,VE17
vary: Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
content-type: application/json
access-control-allow-origin: *
cache-control: no-store, no-cache, must-revalidate, max-age=0, s-maxage=0
accept-ranges: bytes
expires: Sun, 19 May 2024 13:49:00 GMT

GET
H2 200 en.json Show response
cdn.cookielaw.org/consent/fd137de5-c96c-424c-afa7-f92a90556e38/73094c91-e124-478b-8ebf-4c7ef0d7e8b5/ 274 KB
50 KB 57ms
56ms Fetch
application/x-javascript 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/consent/fd137de5-c96c-424c-afa7-f92a90556e38/73094c91-e124-478b-8ebf-4c7ef0d7e8b5/en.json

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1262ec885139b80a18633cf61f3fb476752d225223300f10c1f117602183caea

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
strict-transport-security: max-age=31536000; includeSubDomains; preload
age: 54252
content-md5: lzjFi2MokGgFBZxr4s+HLQ==
content-length: 51032
x-ms-lease-status: unlocked
last-modified: Wed, 27 Mar 2024 18:36:36 GMT
server: cloudflare
etag: 0x8DC4E8CD55FD276
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
x-ms-request-id: 95443595-201e-0075-4d75-8052af000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: public, max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 887506fb5ae14bc6-BUF
expires: Wed, 22 May 2024 13:49:00 GMT

GET
H3 202 31b9b552-f32e-4036-8364-726eb992b71d
analyticssystems.net/api/v2/client/impression/ 0
495 B 99ms
61ms Image
text/plain 172.67.203.105
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://analyticssystems.net/api/v2/client/impression/31b9b552-f32e-4036-8364-726eb992b71d?rand=905842
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 172.67.203.105 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
cf-cache-status: DYNAMIC
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=AZPFADdn5EcweetVerZ%2BcCQ1Z1A8mjM%2FMpaTSPZMBcUI%2FO%2FixHgzTwA7mz9vDxRZxD1JGNi2OQJfnuNrbSuvmI%2FUfTiQPZhk%2FgXhNya4DaGWTqgaCGh3YwahqDrgINUUanQxIMa9WQ%3D%3D"}],"group":"cf-nel","max_age":604800}
access-control-allow-origin: *
access-control-expose-headers
cache-control: max-age=0, private, must-revalidate
access-control-allow-credentials: true
cf-ray: 887506fbb8244bc0-BUF
alt-svc: h3=":443"; ma=86400
content-length: 0
x-request-id: F9GFKBEMPTleRYxOg7-B

GET
H3 200 adsbygoogle.js Show response
pagead2.googlesyndication.com/pagead/js/ 150 KB
0 0ms
0ms Fetch
text/javascript 142.250.31.156
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.31.156 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bj-in-f156.1e100.net

Software

cafe /

Resource Hash

5ff8946f84894ae4cccb62ea3dc6908a81bed0c19d62602e92c8d0fa942aa174

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
content-encoding: br
x-content-type-options: nosniff
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 51887
x-xss-protection: 0
server: cafe
etag: 2430529397363405907
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin: *
link: <https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires: Tue, 21 May 2024 13:48:59 GMT

GET
H2 404 settings Show response
cdn.segment.com/v1/projects// 49 B
525 B 416ms
308ms Fetch
text/plain 99.86.191.237
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.segment.com/v1/projects//settings
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.86.191.237 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-86-191-237.iad79.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 54537283a414fe6543bc0efacd9397c3ba993e787ee28d3a004eccc8b5a06fda

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: null
date: Tue, 21 May 2024 13:44:02 GMT
via: 1.1 72b77c557ac4c265c32d99bdef4e9d6a.cloudfront.net (CloudFront)
x-amz-cf-pop: IAD79-C3
age: 298
x-cache: Error from cloudfront
content-length: 49
last-modified: Mon, 25 Jun 2018 17:54:06 GMT
server: AmazonS3
etag: "328257380186d550f96adf638ff85092"
access-control-max-age: 3000
access-control-allow-methods: GET, HEAD
content-type: text/plain; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=300
vary: Accept-Encoding
accept-ranges: bytes
x-amz-cf-id: LoR-kgQv-UTKXzH8GoWv1EZZFYuhoC8C2kwFdcXUvaJ-ZSB1cOZYEA==

GET
H2 200 g.gif
pixel.wp.com/ 50 B
177 B 42ms
36ms Image
image/gif 192.0.76.3
AUTOMATTIC

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://pixel.wp.com/g.gif?v=ext&blog=162794820&post=0&tz=-5&srv=www.fox44news.com&hp=vip&j=1%3A12.4&host=www.fox44news.com&ref=&fcp=1782&rand=0.9724803371968596
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 192.0.76.3 San Francisco, United States, ASN2635 (AUTOMATTIC, US),
Reverse DNS
Software: nginx /
Resource Hash: f3a8992acb9ab911e0fa4ae12f4b85ef8e61008619f13ee51c7a121ff87f63b1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

access-control-allow-origin: *
date: Tue, 21 May 2024 13:49:00 GMT
cache-control: no-cache
server: nginx
alt-svc: h3=":443"; ma=86400
content-length: 50
content-type: image/gif

GET
H2 200 RC92007626d7c54ac1b1c436077290d2d5-source.min.js Show response
assets.adobedtm.com/3f27c430a962/d33d8acd711c/e7a613ecf7a8/ 2 KB
898 B 66ms
66ms Script
application/x-javascript 2600:1408:c400:e87::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/3f27c430a962/d33d8acd711c/e7a613ecf7a8/RC92007626d7c54ac1b1c436077290d2d5-source.min.js
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2600:1408:c400:e87::1e80 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 37b19198f79bbd7bcd63e20fb04678eb869709a229a2df4a7eec460fb3035488

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
last-modified: Fri, 17 May 2024 18:27:58 GMT
server: AkamaiNetStorage
etag: "c1da2c546c80a62f66a2f9ea1dba7e41:1715970478.514538"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.fox44news.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 640
expires: Tue, 21 May 2024 14:49:00 GMT

GET
H2 204 3
www.civicscience.com/idsync/ 0
51 B 63ms
47ms Image
text/plain 34.238.186.72
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.civicscience.com/idsync/3?p=nxs1&uid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.238.186.72 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-34-238-186-72.compute-1.amazonaws.com
Software: nginx/1.14.2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
server: nginx/1.14.2

GET
H2 200 ping
ping.chartbeat.net/ 43 B
201 B 146ms
46ms Image
image/gif 34.199.54.80
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ping.chartbeat.net/ping?h=mycentx.com&p=%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&u=Ck07s6BgBgcsD27Gm8&d=fox44news.com&g=23192&g0=No%20Section&g1=No%20Author&g4=press%20release&n=1&f=00001&c=0&x=0&m=0&y=4519&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&PA=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&b=2189&t=DH7KYzBh10PDCMcZQMDCcpy-Dr6LJ4&V=145&i=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable%2C%20a%20Non-Drug%20Treatment%20for%20Migraine&tz=600&sn=1&sv=C8XCphzTEHoBrxAAvDC__GEDdB8Ym&sr=external&sd=1&im=06132c4f&_
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.199.54.80 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-34-199-54-80.compute-1.amazonaws.com
Software: /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

content-type: image/gif
pragma: no-cache
date: Tue, 21 May 2024 13:49:00 GMT
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
content-length: 43
expires: 0

GET
H3 200 gpt.js Show response
securepubads.g.doubleclick.net/tag/js/ 93 KB
29 KB 206ms
113ms Script
text/javascript 172.253.62.154
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/tag/js/gpt.js

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.253.62.154 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bc-in-f154.1e100.net

Software

cafe /

Resource Hash

af301a4edc1e0f96cf07ff06fc39715809a8904f8c08f3969a81670d20dfb4a5

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: br
x-content-type-options: nosniff
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 29887
x-xss-protection: 0
server: cafe
etag: 949 / 19864 / m202405090101 / config-hash: 2178188746714871077
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900, stale-while-revalidate=3600
timing-allow-origin: *
expires: Tue, 21 May 2024 13:49:00 GMT

GET
H2 200 launchpad-liveramp.js Show response
launchpad-wrapper.privacymanager.io/68713bba-01e6-43ff-b1b6-da374170dd37/ 20 KB
3 KB 175ms
81ms Script
text/javascript 52.85.151.43
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://launchpad-wrapper.privacymanager.io/68713bba-01e6-43ff-b1b6-da374170dd37/launchpad-liveramp.js
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 52.85.151.43 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-52-85-151-43.iad89.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 0682e207831f1b478ce6972a5b0feb7b38721947a83f7ee607e170e55715062b

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: 8RJoWWC64EACAcVDaxTEGtIwueh5n.GO
content-encoding: gzip
via: 1.1 368146333bf1a1071e8432a7d4e41e1a.cloudfront.net (CloudFront)
date: Tue, 21 May 2024 08:10:34 GMT
x-amz-cf-pop: IAD89-C3
age: 20499
x-amz-server-side-encryption: AES256
x-cache: Hit from cloudfront
x-amz-replication-status: COMPLETED
content-disposition: attachment; filename="launchpad-liveramp.js"
last-modified: Wed, 16 Aug 2023 12:35:54 GMT
server: AmazonS3
etag: W/"36836895e356fb0d4ae300c65670cee6"
vary: Accept-Encoding
content-type: text/javascript
x-amz-cf-id: kvQnArTVcpCn3Nurzc8yez-B0-ou53tIdyie1RidsgojhoiBp1F-JA==

GET
H3 200 web Show response
onesignal.com/api/v1/sync/70760225-ef4d-4c60-a595-d2d89bc14aad/ 5 KB
2 KB 188ms
181ms Script
text/javascript 104.16.160.145
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://onesignal.com/api/v1/sync/70760225-ef4d-4c60-a595-d2d89bc14aad/web?callback=__jp0

Requested by

Host: cdn.onesignal.com
URL: https://cdn.onesignal.com/sdks/OneSignalPageSDKES6.js?v=151605

Protocol

Security

QUIC, , AES_128_GCM

Server

104.16.160.145 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

23a056f6ae5529dd22fd975c9c9e93d90ea2bf4d98ede0fc1de0dc57ccb630ce

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 google
x-content-type-options: nosniff
cf-cache-status: EXPIRED
content-encoding: br
x-permitted-cross-domain-policies: none
strict-transport-security: max-age=15552000; includeSubDomains
alt-svc: h3=":443"; ma=86400
x-xss-protection: 1; mode=block
x-request-id: 37f577b6-901f-48e7-a020-a22a7f24aafb
x-runtime: 0.031865
referrer-policy: strict-origin-when-cross-origin
server: cloudflare
etag: W/"23a056f6ae5529dd22fd975c9c9e93d9"
x-download-options: noopen
vary: Origin, Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=3600
cf-ray: 887506fc6a16ac30-YYZ
access-control-allow-headers: SDK-Version
expires: Tue, 21 May 2024 14:49:00 GMT

GET
BLOB 200
OK 74b8c488-4a0f-48c9-957d-a1c7a3ba6cd0
https://www.fox44news.com/ 487 KB
0 Other
text/plain

General

Check archive.org

Show headers Download Go to

Full URL: blob:https://www.fox44news.com/74b8c488-4a0f-48c9-957d-a1c7a3ba6cd0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: BLOB
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 5dc1ee100f3fb6ee7cbe620ec37efc411177b6f62cd80510c7daf38c3c8c2a64

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Length: 498840
Content-Type

GET
H2 200 sync Show response
gum.criteo.com/ 46 B
431 B 133ms
44ms Script
text/javascript 2620:100:a00b::12
AS-CRITEO

General

Check archive.org

Show headers Download Go to

Full URL

https://gum.criteo.com/sync?c=72&r=2&j=TRC.getRTUS&us_privacy=1---&gdpr=0&gdpr_consent=&gdpr_pd=

Requested by

Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/nexstar-network/loader.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2620:100:a00b::12 , United States, ASN19750 (AS-CRITEO, US),

Reverse DNS

Software

Kestrel /

Resource Hash

189b8ed64093b12937354b2ef71ccf1df59690d90432241a10fe1cb25000acba

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:48:59 GMT
strict-transport-security: max-age=31536000; preload;
content-encoding: gzip
server: Kestrel
vary: Accept-Encoding
content-type: text/javascript; charset=utf-8
cache-control: private, max-age=3600
server-processing-duration-in-ticks: 283091
expires: 60

GET
H2 200 impl.20240521-6-RELEASE.js Show response
cdn.taboola.com/libtrc/ 896 KB
182 KB 29ms
28ms Script
application/javascript 151.101.129.44
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.taboola.com/libtrc/impl.20240521-6-RELEASE.js
Requested by: Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/nexstar-network/loader.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.129.44 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: AmazonS3-br /
Resource Hash: 489ff5eaed368b34fe65e3a3bcf34c357d93a1656ca1e268f8f81093e47f9e79

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: X5aSR16PmzB4wLms12C4pGhS7gKKrKa4
content-encoding: br
via: 1.1 varnish
date: Tue, 21 May 2024 13:49:00 GMT
x-amz-request-id: 2Q9SFPJX4XY90EB4
age: 17227
x-amz-server-side-encryption: AES256
x-cache: HIT
content-length: 186133
x-amz-id-2: 5oEkpY1mJgK87qI8JqI2sEHymmSRPo0CyGGf3XcqLm5aJzBa5o5EaUT7UHOYeeeBd9lfvYHe1J0=
x-served-by: cache-yyz4523-YYZ
last-modified: Tue, 21 May 2024 09:01:19 GMT
server: AmazonS3-br
x-timer: S1716299340.359260,VS0,VE0
etag: "f3b9a25eeab6c1a31f11e2ad11496b61"
vary: Accept-Encoding
content-type: application/javascript
abp: 97
access-control-allow-origin: *
cache-control: private,max-age=31536000
accept-ranges: bytes
x-cache-hits: 13040

GET
H/1.1 200
OK load.js Show response
s.ntv.io/serve/ 571 KB
180 KB 138ms
50ms Script
application/x-javascript 104.70.185.205
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://s.ntv.io/serve/load.js
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 104.70.185.205 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a104-70-185-205.deploy.static.akamaitechnologies.com
Software: AmazonS3 /
Resource Hash: e6d16748291f37c9b341e0f628bbcb5a01e7d4c5d844c1053361df425221c516

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Date: Tue, 21 May 2024 13:49:00 GMT
Content-Encoding: gzip
x-amz-request-id: 8RW3MGPQFCRYE1M9
x-amz-server-side-encryption: AES256
Transfer-Encoding: chunked
Connection: keep-alive, Transfer-Encoding
x-amz-id-2: XMtsRdoqRcJRnaBhClnmvYg/Mpa+CT1jRKjexdnivsAkjl79f5FZ6CcLFIzL7OKBkrQy0ozHJxo=
Last-Modified: Mon, 20 May 2024 20:44:41 GMT
Server: AmazonS3
ETag: "ff882f521d6174435c9ce808d49e7365"
Vary: Accept-Encoding
Access-Control-Allow-Methods: GET
Content-Type: application/x-javascript
Access-Control-Allow-Origin: *
Cache-Control: public, max-age=3600
Accept-Ranges: bytes
Access-Control-Allow-Headers: *

GET
H2 200 beacon.js Show response
sb.scorecardresearch.com/ 4 KB
2 KB 150ms
44ms Script
text/javascript 18.160.10.44
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://sb.scorecardresearch.com/beacon.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.160.10.44 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-160-10-44.iad12.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 1aee66e2e24e851039801c0dace90f3efb7a1a17b033f7d5bbc12ca7c1d19432

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 23:29:57 GMT
content-encoding: gzip
via: 1.1 66b6cd04ec22251498906e833eb08668.cloudfront.net (CloudFront)
last-modified: Fri, 03 May 2024 13:20:45 GMT
server: AmazonS3
x-amz-cf-pop: IAD12-P3
age: 51544
etag: W/"a06e7a176f40dc26aa5e9567ac9d2d5e"
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/javascript
cache-control: max-age=86400
x-amz-cf-id: lIimzmV3-gxH-mphd4qSeGzl4732QRoTG5ch3Vo1EIgE65bpW-oN4g==

GET
H2 200 tag.js Show response
a.teads.tv/analytics/ 11 KB
4 KB 187ms
46ms Script
text/javascript 23.55.205.47
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://a.teads.tv/analytics/tag.js
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KJJZHXD
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 23.55.205.47 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a23-55-205-47.deploy.static.akamaitechnologies.com
Software: /
Resource Hash: 06ed0d809178333c4cc4e1442b50e1f2e076b947466c4a204202fc90df34f833

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: IwRCxZF1T4gMT4TMeNkDrOCkruVfKfAe
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: br
last-modified: Wed, 28 Feb 2024 14:26:38 GMT
x-amz-request-id: 6KRFMQPRH9GYWCRT
etag: "d86492df4bad2a485597bfa437c78ad2"
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
content-type: text/javascript;charset=utf-8
cache-control: private, max-age=3600
accept-ranges: bytes
content-length: 3393
x-amz-id-2: JKeR+t0utAryyRMSUlPIdQYf5qMTi0SU8VdI0eCLq1AqdyWySDP+n3S0r+UXFM+T6ryUAySLaUjJUpnlp1RN6Q==

GET
H2

200

endsync
cm.lotlinx.com/live/141000/
Redirect Chain

https://cm2.lotlinx.com/live/141000/sync?hms
https://cm.g.doubleclick.net/pixel?google_sc=&google_nid=lemonfree&google_hm=ZDIzNWNlMmYxZDc2ZTYwYzQzN2ZiOTk4&google_ula=500446778&google_redir=https%3A%2F%2Fcm.lotlinx.com%2Flive%2F141000%2Fendsync
https://cm.g.doubleclick.net/pixel?google_sc=&google_nid=lemonfree&google_hm=ZDIzNWNlMmYxZDc2ZTYwYzQzN2ZiOTk4&google_ula=500446778&google_redir=https%3A%2F%2Fcm.lotlinx.com%2Flive%2F141000%2Fendsyn...
https://cm.lotlinx.com/live/141000/endsync?google_ula=500446778,0

43 B
224 B

77ms
47ms

Image
image/gif

3.223.52.218
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://cm.lotlinx.com/live/141000/endsync?google_ula=500446778,0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Server: 3.223.52.218 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-223-52-218.compute-1.amazonaws.com
Software: /
Resource Hash: b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-length: 43
content-type: image/gif

Redirect headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:00 GMT
server: HTTP server (unknown)
content-type: text/html; charset=UTF-8
location: https://cm.lotlinx.com/live/141000/endsync?google_ula=500446778,0
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 262
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 nlsSDK600.bundle.min.js Show response
cdn-gl.imrworldwide.com/novms/js/2/ 199 KB
56 KB 51ms
51ms Script
application/javascript 2600:9000:24f4:4a00:2:42d9:3100:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn-gl.imrworldwide.com/novms/js/2/nlsSDK600.bundle.min.js
Requested by: Host: cdn-gl.imrworldwide.com
URL: https://cdn-gl.imrworldwide.com/conf/P1AA93ABC-DED6-4EE2-8CE5-8F5729E1D264.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:24f4:4a00:2:42d9:3100:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: d98cc6e770bf9c71b8758a040222960e918adb20cc1f71f2296ae4f70256d510

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:26:47 GMT
x-amz-version-id: Aabpvbg3ktgBmwIqp1b4kZ3V88L5QhMx
content-encoding: gzip
via: 1.1 e030eb9e2523dd8af200ce39f28ca642.cloudfront.net (CloudFront)
x-amz-cf-pop: IAD55-P3
age: 1334
x-amz-server-side-encryption: AES256
x-cache: Hit from cloudfront
x-amz-storage-class: INTELLIGENT_TIERING
last-modified: Wed, 06 Sep 2023 13:04:53 GMT
server: AmazonS3
etag: W/"2be1fe7a43ef5ba626afab2ceddfc177"
vary: Accept-Encoding
content-type: application/javascript
cache-control: max-age=86400
x-amz-cf-id: NUv9VJw4nGEvwASSCFRX5iRaI4QKPM9wz2JgknGFlwGTkBZRYHWEVA==

POST
H2 200 969 Show response
blue.fox44news.com/DG/DEFAULT/rest/rpc/ 96 KB
15 KB 64ms
63ms XHR
application/json 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/DG/DEFAULT/rest/rpc/969?referer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bcsessionid=&bctempid=&overruleReferrer=&time=2024-05-21T03%3A49%3A00-10%3A00&ts=1716299340455

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

ddfa2cec054506cff6bad2862fcd8bf61f0b8ddb30ef1724800c9db1af049152

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
x-cache: Miss from cloudfront
p3p: policyref="", CP="DSP"
content-length: 13927
x-xss-protection: 1; mode=block
pragma: no-cache
server: -
accept-ch: sec-ch-ua-platform-version
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, no-transform, must-revalidate, private
access-control-allow-credentials: true
x-robots-tag: noindex, nofollow
x-amz-cf-id: NztzrJZVK08Zo6cWak-hMSj_O3PLpf2PEtA0aFXFI1WApQLNImjgSQ==
expires: Thu, 01 Jan 1970 00:00:00 GMT

GET
H2 200 aps_csm.js Show response
c.amazon-adsystem.com/bao-csm/aps-comm/ 6 KB
3 KB 134ms
45ms XHR
application/javascript 18.165.100.155
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c.amazon-adsystem.com/bao-csm/aps-comm/aps_csm.js
Requested by: Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.165.100.155 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-165-100-155.iad55.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 06b99248a163333e36980a6cfb756f1a7de60fa49517162b87b1a44d5d48f844

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 16:47:16 GMT
x-amz-version-id: r5.lR.LJ66XEXzxUUVo7iMemjL_F_GoE
content-encoding: gzip
via: 1.1 5e85a7e9f75a591c64db206ef2e2a17c.cloudfront.net (CloudFront)
x-amz-cf-pop: IAD55-P4
age: 75705
x-amz-server-side-encryption: AES256
x-cache: Hit from cloudfront
last-modified: Thu, 29 Feb 2024 02:13:08 GMT
server: AmazonS3
etag: W/"a4d296427fc806b21335359e398c025c"
access-control-max-age: 3000
access-control-allow-methods: GET
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=86400
vary: Accept-Encoding,Origin
x-amz-cf-id: iByARVXN8y8gesG_tloDprb5-pIjdTpr-la3Wxjs5P5SlcFyvPBc7A==

GET
H2 200 otGPP.js Show response
cdn.cookielaw.org/scripttemplates/202403.1.0/ 81 KB
17 KB 57ms
57ms Script
application/javascript 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202403.1.0/otGPP.js

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8126da8bb4af8f970a2acb8640a3c3d7a38bafc2dcbc41fde93fd55473a5de66

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:00 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: zMjDHhMNQgqbyypFtxjSzA==
age: 76393
x-ms-lease-status: unlocked
last-modified: Thu, 21 Mar 2024 07:04:39 GMT
server: cloudflare
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: 8d4fc33d-001e-0010-7608-7cfceb000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 887506fe49864bc0-BUF

POST
H2 200 interact Show response
axp.fox44news.com/ee/v1/ 943 B
1 KB 172ms
53ms Fetch
application/json 63.140.38.112
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL

https://axp.fox44news.com/ee/v1/interact?configId=2d3a9df0-344f-464e-8b3c-79141641d86e&requestId=5299831d-bc26-42d6-bac0-9196bcc054be

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

63.140.38.112 , United States, ASN14618 (AMAZON-AES, US),

Reverse DNS

ip-63-140-38-112.data.adobedc.net

Software

jag /

Resource Hash

dcd9d9230cc3e6674aedcc299081dec8b239966fd9096d0cd18f6d96fb8835a9

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain; charset=UTF-8

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=31536000; includeSubDomains
server: jag
vary: Origin
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fox44news.com
access-control-expose-headers: Retry-After, X-Adobe-Edge, X-Request-ID
x-adobe-edge: VA6;7
access-control-allow-credentials: true
x-konductor: N/A
cache-control: no-cache, no-store, max-age=0, no-transform, private
x-xss-protection: 1; mode=block
x-request-id: 5299831d-bc26-42d6-bac0-9196bcc054be

GET
H2 200 dc81743d452bd64ea295851cb1cc09a4 Show response
blue.fox44news.com/plugin/plugin/ 167 KB
38 KB 49ms
48ms Script
text/javascript 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/plugin/plugin/dc81743d452bd64ea295851cb1cc09a4

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

3ff77173faa08e27210d18fcec1f06df48ff19ce8d5411a40a35bb2563096eca

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 15 May 2024 07:03:22 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
age: 542738
x-cache: Hit from cloudfront
p3p: policyref="", CP="DSP"
content-length: 38599
x-xss-protection: 1; mode=block
last-modified: Tue, 14 May 2024 07:03:22 GMT
server: -
etag: dc81743d452bd64ea295851cb1cc09a4
content-type: text/javascript; charset=utf-8
cache-control: public, no-cache="Set-Cookie", max-age=31536000
x-robots-tag: noindex, nofollow
x-amz-cf-id: lhEqdvRUACYN5vKaf_GSRgUQp2d81k0eVMd55DgiMzHok5WzNsC4ew==
expires: Thu, 15 May 2025 07:03:22 GMT

GET
H2 200 launchpad.bundle.js Show response
launchpad.privacymanager.io/latest/ 205 KB
43 KB 159ms
49ms Script
application/x-javascript 18.160.18.69
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://launchpad.privacymanager.io/latest/launchpad.bundle.js
Requested by: Host: launchpad-wrapper.privacymanager.io
URL: https://launchpad-wrapper.privacymanager.io/68713bba-01e6-43ff-b1b6-da374170dd37/launchpad-liveramp.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.160.18.69 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-160-18-69.iad12.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 6c892a3b81f32ff562d0c8f44e909e65c8366453aa55cc88c8d136bb51578375

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: G5ps5XkVrakniD._EiRoY_pU9_2jf8nx
content-encoding: br
via: 1.1 c022ca80d7b946eb138dfd2e55c98980.cloudfront.net (CloudFront)
date: Tue, 21 May 2024 12:50:28 GMT
last-modified: Fri, 17 May 2024 13:05:55 GMT
server: AmazonS3
x-amz-cf-pop: IAD12-P4
age: 3513
x-amz-server-side-encryption: AES256
etag: W/"e71ebe4c8fcf58b53c9a099a76c2af39"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/x-javascript
cache-control: must-revalidate,public,max-age=3600
x-amz-cf-id: OmhH92mvAb3nOWyhxuREL9ouXSXTcQky_pf087IX8xwupaCUmJ3YKQ==

GET
H3 200 pubads_impl.js Show response
securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405090101/ 454 KB
142 KB 43ms
43ms Script
text/javascript 172.253.62.154
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405090101/pubads_impl.js

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.253.62.154 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bc-in-f154.1e100.net

Software

cafe /

Resource Hash

aba3b1e74a53993ab198f8376eaf3bc0c9d841b9bc6d95f47ab839bbdb502d47

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 20 May 2024 17:15:56 GMT
content-encoding: br
x-content-type-options: nosniff
age: 73984
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 145002
x-xss-protection: 0
server: cafe
etag: 8410536799634492291
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: public, immutable, max-age=31536000
timing-allow-origin: *
expires: Tue, 20 May 2025 17:15:56 GMT

GET
H2 200 card-interference-detector.20240521-6-RELEASE.es6.js Show response
cdn.taboola.com/libtrc/ 5 KB
3 KB 29ms
29ms Script
application/javascript 151.101.129.44
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.taboola.com/libtrc/card-interference-detector.20240521-6-RELEASE.es6.js
Requested by: Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/nexstar-network/loader.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.129.44 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 8c4751023785e791aa1df7ab3b86782af670a13bbcb22280ffff8fed4ec22a59

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: YLv6jG7NPCivbTpwDBk5wibcUMiibxBn
content-encoding: gzip
via: 1.1 varnish
date: Tue, 21 May 2024 13:49:00 GMT
x-amz-request-id: S5KR6WX6XDEMRY6S
age: 17144
x-amz-server-side-encryption: AES256
x-cache: HIT
x-amz-replication-status: COMPLETED
content-length: 2180
x-amz-id-2: KHAJ4p2mO/PkHo8CzL2fHAX9QNLJL6uj8TCxSquXfHCN2WVOogorroRWzUGfkz0k5WIzjcnG3SY=
x-served-by: cache-yyz4523-YYZ
last-modified: Tue, 21 May 2024 09:02:31 GMT
server: AmazonS3
x-timer: S1716299341.609626,VS0,VE0
etag: "56edb692e3462c50192e6fd26e6790ee"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
abp: 99
access-control-allow-origin: *
cache-control: private,max-age=2629743
accept-ranges: bytes
x-cache-hits: 3110

GET
H2 200 ls.html
cdn-gl.imrworldwide.com/novms/html/ Frame 01DB 0
0 129ms
43ms Document
text/html 2600:9000:24f4:b200:2:42d9:3100:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn-gl.imrworldwide.com/novms/html/ls.html
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:24f4:b200:2:42d9:3100:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

age: 1456
cache-control: max-age=86400
content-encoding: gzip
content-type: text/html
date: Tue, 21 May 2024 13:24:45 GMT
etag: W/"7fa83dfc7b78314b137e2eb13834daa7"
last-modified: Wed, 06 Sep 2023 13:04:52 GMT
server: AmazonS3
vary: Accept-Encoding
via: 1.1 181a665d1a0b3047b4fa647eeabfb330.cloudfront.net (CloudFront)
x-amz-cf-id: 2dHlaWej58cfF_dts1Oxim3G0OJn1xo8PCEXXHOaV37RFzGtB-RLmw==
x-amz-cf-pop: IAD55-P3
x-amz-server-side-encryption: AES256
x-amz-version-id: CTbRZ.5UlARhD4XceMUpZU1V6DSHtB37
x-cache: Hit from cloudfront

GET
H2 200 3410 Show response
config.aps.amazon-adsystem.com/configs/ 531 B
799 B 141ms
42ms Script
application/javascript 18.160.10.20
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://config.aps.amazon-adsystem.com/configs/3410
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.160.10.20 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-160-10-20.iad12.r.cloudfront.net
Software: CloudFront /
Resource Hash: 08c344ced1c211edca3c4bd90ae828e40f23cf24c034df96c0f0f1103e9d54a3

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:11:31 GMT
via: 1.1 1f1067e4f193aaabd2c24b99bcdc4e88.cloudfront.net (CloudFront)
server: CloudFront
x-amz-cf-pop: IAD12-P3
age: 2249
x-cache: Hit from cloudfront
content-type: application/javascript
cache-control: max-age=3600
content-length: 531
x-amz-cf-id: 6DIKPwT-c-mfPv_qZKrVJfPoOqqkXjhs_0tREwCGdBrcJCzoCXN4QA==

GET
H2 200 config Show response
c.amazon-adsystem.com/cdn/prod/ 483 B
843 B 44ms
44ms XHR
application/json 18.165.100.155
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c.amazon-adsystem.com/cdn/prod/config?src=3410&u=https%3A%2F%2Fwww.fox44news.com
Requested by: Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.165.100.155 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-165-100-155.iad55.r.cloudfront.net
Software: Server /
Resource Hash: 418820aa1a9ce49a1e6bc019081a7f7a6a0543b792a24c9c45fb5dda1c6675ff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 09:21:47 GMT
via: 1.1 b72ec90bfb3598795e1ec469cc868742.cloudfront.net (CloudFront)
server: Server
x-amz-cf-pop: IAD55-P4
age: 16032
x-cache: Hit from cloudfront
content-type: application/json;charset=UTF-8
access-control-allow-origin: https://www.fox44news.com
cache-control: max-age=21550, s-maxage=21600
access-control-allow-credentials: true
content-length: 483
x-amz-cf-id: 2AVmLJfuNbR_rfD8kCzAsIZPj0jim2pPE10cthJZtyA6BUjOb4UgqQ==

GET
H2 200 otFlat.json Show response
cdn.cookielaw.org/scripttemplates/202403.1.0/assets/ 13 KB
3 KB 47ms
46ms Fetch
application/json 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202403.1.0/assets/otFlat.json

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f4aaa18c55c90588c5e828e56dcc6b2cb0acf9a4280494c7d1a53fc5e3669112

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: KLWFssuowJEtDumTaVZD/A==
age: 81081
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 3041
x-ms-lease-status: unlocked
last-modified: Thu, 21 Mar 2024 07:04:28 GMT
server: cloudflare
etag: 0x8DC497526A04834
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
x-ms-request-id: 7db0fa4f-b01e-0091-7fd3-9bd5d8000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 887506ff6d054bc6-BUF

GET
H2 200 otPcTab.json Show response
cdn.cookielaw.org/scripttemplates/202403.1.0/assets/v2/ 63 KB
13 KB 48ms
47ms Fetch
application/json 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202403.1.0/assets/v2/otPcTab.json

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

51dfbad7e1a227d3935016e5c4190e5e46e03daa4b249e5ded55f54235efbd7a

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: JqD83lHxEjWNdmDqKd9lzA==
age: 69094
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 13599
x-ms-lease-status: unlocked
last-modified: Thu, 21 Mar 2024 07:04:31 GMT
server: cloudflare
etag: 0x8DC4975281E71C8
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
x-ms-request-id: 4166af92-901e-0002-01d3-7e873b000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 887506ff6d064bc6-BUF

GET
H2 200 otCommonStyles.css Show response
cdn.cookielaw.org/scripttemplates/202403.1.0/assets/ 24 KB
4 KB 50ms
49ms Fetch
text/css 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202403.1.0/assets/otCommonStyles.css

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

06c0edbfc1b871fb45195265f5faad3e23191305f6ff2125557a9fbc287c8992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:00 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: 4ErYmXXFNbMLrnc9DrDTsg==
age: 39637
x-ms-lease-status: unlocked
last-modified: Thu, 21 Mar 2024 07:04:40 GMT
server: cloudflare
vary: Accept-Encoding
content-type: text/css
access-control-allow-origin: *
x-ms-request-id: 9b4b4dda-a01e-006b-20d3-7ebe77000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 887506ff6d074bc6-BUF

GET
H2

204

b2
sb.scorecardresearch.com/
Redirect Chain

https://sb.scorecardresearch.com/b?c1=2&c2=6036439&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1716299340703&ns_c=UTF-8&cs_ucfr=&cs_fpid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&cs_fpit=c&cs_fpd...
https://sb.scorecardresearch.com/b2?c1=2&c2=6036439&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1716299340703&ns_c=UTF-8&cs_ucfr=&cs_fpid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&cs_fpit=c&cs_fp...

0
226 B

44ms
44ms

Image
text/plain

18.160.10.44
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://sb.scorecardresearch.com/b2?c1=2&c2=6036439&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1716299340703&ns_c=UTF-8&cs_ucfr=&cs_fpid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&cs_fpit=c&cs_fpdm=*null&cs_fpdt=*null&c7=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&c8=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable%2C%20a%20Non-Drug%20Treatment%20for%20Migraine&c9=
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Server: 18.160.10.44 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-160-10-44.iad12.r.cloudfront.net
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 66b6cd04ec22251498906e833eb08668.cloudfront.net (CloudFront)
accept-ch: UA, Platform, Arch, Model, Mobile
x-amz-cf-pop: IAD12-P3
x-amz-cf-id: djuKORMbWgAGBw6pzYrfFjF1BcL4qAgld3GAbr3UIEQnhX6uk1k-Ww==
x-cache: Miss from cloudfront

Redirect headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 66b6cd04ec22251498906e833eb08668.cloudfront.net (CloudFront)
accept-ch: UA, Platform, Arch, Model, Mobile
x-amz-cf-pop: IAD12-P3
x-cache: Miss from cloudfront
location: /b2?c1=2&c2=6036439&cs_it=b9&cv=4.0.0%2B2301240627&ns__t=1716299340703&ns_c=UTF-8&cs_ucfr=&cs_fpid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&cs_fpit=c&cs_fpdm=*null&cs_fpdt=*null&c7=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&c8=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable%2C%20a%20Non-Drug%20Treatment%20for%20Migraine&c9=
content-length: 0
x-amz-cf-id: W-TAaSyMx497NajVqFsSJ_vlPsGbfGvs63ZlSDrIukSvqUArIzHKHA==

GET
H2 200 76b9e8efcb571f19aa63cde7f3c8d1a4 Show response
blue.fox44news.com/plugin/library/ 337 KB
104 KB 50ms
48ms Script
text/javascript 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/plugin/library/76b9e8efcb571f19aa63cde7f3c8d1a4

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

bc3f35e661ad741e510b4b24181e0b2c773607ba5b85de2173f3b78993525be7

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Wed, 15 May 2024 07:03:22 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
age: 542738
x-cache: Hit from cloudfront
p3p: policyref="", CP="DSP"
content-length: 106140
x-xss-protection: 1; mode=block
last-modified: Tue, 14 May 2024 07:03:22 GMT
server: -
etag: 76b9e8efcb571f19aa63cde7f3c8d1a4
content-type: text/javascript; charset=utf-8
cache-control: public, no-cache="Set-Cookie", max-age=31536000
x-robots-tag: noindex, nofollow
x-amz-cf-id: T6Bfyfs06U5psjvg6MDaymwHvpy-IHlCXTNNbVVwvxVa5jX0PMoMKQ==
expires: Thu, 15 May 2025 07:03:22 GMT

POST
H2 200 LB-Zone-1 Show response
blue.fox44news.com/DG/DEFAULT/rest/rpc/969/ 4 KB
2 KB 80ms
79ms XHR
application/json 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/DG/DEFAULT/rest/rpc/969/LB-Zone-1?referer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bcsessionid=&bctempid=027d3beb-efbb-43a7-9c81-5c77593b79b7&overruleReferrer=&time=2024-05-21T03%3A49%3A00-10%3A00&ts=1716299340714

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

409e5521fa38a90d06bcd1f643faa032446c5cb0bb52b2df92a859d29375fc4f

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
x-cache: Miss from cloudfront
p3p: policyref="", CP="DSP"
content-length: 1169
x-xss-protection: 1; mode=block
pragma: no-cache
server: -
accept-ch: sec-ch-ua-platform-version
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, no-transform, must-revalidate, private
access-control-allow-credentials: true
x-robots-tag: noindex, nofollow
x-amz-cf-id: 2hXJRV7OC42mRO48tzbdReRGjgHYgmjGMrqoNdXGsDyIMm6l6j8-tA==
expires: Thu, 01 Jan 1970 00:00:00 GMT

GET
H/1.1 200
OK fpc Show response
at.teads.tv/ 56 B
397 B 213ms
51ms Fetch
text/plain 23.62.165.62
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://at.teads.tv/fpc?analytics_tag_id=PUB_21595&tfpvi=&gdpr_status=22&gdpr_reason=220&gdpr_consent=&ccpa_consent=1---&shared_ids=&sv=90769f5&
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 23.62.165.62 Ashburn, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a23-62-165-62.deploy.static.akamaitechnologies.com
Software: /
Resource Hash: fa3ce259d2120f06f23889c837f97ca81d7f5224dc4565c55e659d25dd4f6e7e

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Pragma: no-cache
Date: Tue, 21 May 2024 13:49:00 GMT
Content-Type: text/plain; charset=UTF-8
Access-Control-Allow-Origin: https://www.fox44news.com
Cache-Control: max-age=0, no-cache, no-store
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 56
Expires: Tue, 21 May 2024 13:49:00 GMT

GET
H2 200 RCe2ff322010d74a98a55983a2ab0b1393-source.min.js Show response
assets.adobedtm.com/3f27c430a962/d33d8acd711c/e7a613ecf7a8/ 340 B
476 B 45ms
44ms Script
application/x-javascript 2600:1408:c400:e87::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/3f27c430a962/d33d8acd711c/e7a613ecf7a8/RCe2ff322010d74a98a55983a2ab0b1393-source.min.js
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2600:1408:c400:e87::1e80 Ashburn, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: f3a54aa493a8b5f51a07114aeb989b70bb7e6f0491e70adda194b812031de276

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
last-modified: Fri, 17 May 2024 18:27:58 GMT
server: AkamaiNetStorage
etag: "c1da2c546c80a62f66a2f9ea1dba7e41:1715970478.514538"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.fox44news.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 219
expires: Tue, 21 May 2024 14:49:00 GMT

GET
H2 200 t Show response
jadserve.postrelease.com/ 2 KB
1 KB 207ms
56ms Script
text/javascript 52.202.142.82
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://jadserve.postrelease.com/t?ntv_url=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&ntv_mvi&us_privacy=1---
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.202.142.82 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-202-142-82.compute-1.amazonaws.com
Software: nginx /
Resource Hash: ceaefa2415c6623df0858b7e7fba758c0b83390aba0115ce0f6f531bc00a1255

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
server: nginx
content-type: text/javascript;charset=UTF-8
access-control-allow-origin: *
p3p: CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
content-length: 998
expires: Mon, 1 Jan 1990 12:00:00 GMT

OPTIONS
H2 200 recordVendorsLoaded
prod.us-east-1.cxm-bcn.publisher-services.amazon.dev/v1/ Frame 0
0 147ms
46ms Preflight 44.214.246.0
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://prod.us-east-1.cxm-bcn.publisher-services.amazon.dev/v1/recordVendorsLoaded
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 44.214.246.0 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-44-214-246-0.compute-1.amazonaws.com
Software: /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Headers: content-type
Access-Control-Request-Method: POST
Origin: https://www.fox44news.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

access-control-allow-headers: content-type
access-control-allow-methods: POST
access-control-allow-origin: *
access-control-max-age: 1800
allow: GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length: 0
date: Tue, 21 May 2024 13:49:00 GMT
vary: Origin Access-Control-Request-Method Access-Control-Request-Headers

POST
H2 200 recordVendorsLoaded Show response
prod.us-east-1.cxm-bcn.publisher-services.amazon.dev/v1/ 0
128 B 48ms
47ms XHR
text/plain 44.214.246.0
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://prod.us-east-1.cxm-bcn.publisher-services.amazon.dev/v1/recordVendorsLoaded
Requested by: Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 44.214.246.0 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-44-214-246-0.compute-1.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: application/json

Response headers

access-control-allow-origin: *
date: Tue, 21 May 2024 13:49:00 GMT
content-length: 0
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers

GET
H2 200 bid Show response
aax.amazon-adsystem.com/e/dtb/ 798 B
1 KB 552ms
397ms XHR
text/javascript 18.160.20.121
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://aax.amazon-adsystem.com/e/dtb/bid?src=3410&u=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&pid=bVODJqe0vpQsT&cb=0&ws=1600x1200&v=24.506.1519&t=2000&slots=%5B%7B%22sd%22%3A%22acm-ad-tag-billboard1-billboard1%22%2C%22s%22%3A%5B%22728x90%22%2C%22970x90%22%2C%22970x250%22%5D%2C%22sn%22%3A%22%2F5678%2Fnx.kwkt%2F%22%7D%2C%7B%22sd%22%3A%22acm-ad-tag-adhesion-adhesion%22%2C%22s%22%3A%5B%22728x90%22%5D%2C%22sn%22%3A%22%2F5678%2Fnx.kwkt%2F%22%7D%5D&pj=%7B%22us_privacy%22%3A%221---%22%2C%22si_section%22%3A%22%22%2C%22device%22%3A%7B%22sua%22%3A%7B%22architecture%22%3A%22x86%22%2C%22bitness%22%3A%2264%22%2C%22mobile%22%3A0%2C%22model%22%3A%22%22%2C%22source%22%3A2%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%2C%22version%22%3A%5B%2210%22%2C%220%22%2C%220%22%5D%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22124%22%2C%220%22%2C%226367%22%2C%22207%22%5D%7D%2C%7B%22brand%22%3A%22Google+Chrome%22%2C%22version%22%3A%5B%22124%22%2C%220%22%2C%226367%22%2C%22207%22%5D%7D%2C%7B%22brand%22%3A%22Not-A.Brand%22%2C%22version%22%3A%5B%2299%22%2C%220%22%2C%220%22%2C%220%22%5D%7D%5D%7D%7D%7D&gpp=DBABBg%7EBUoAAAKA.QA&gpp_sid=%5B8%5D&sm=77092e26-4f81-42de-bac5-46b2de9c15a8&gdprl=%7B%22status%22%3A%22no-cmp%22%7D&_c=1
Requested by: Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.160.20.121 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-160-20-121.iad12.r.cloudfront.net
Software: Server /
Resource Hash: 649603a20c6cec1e5cd00f33bc60b8b54024c572a50f867d965d448d598972ee

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
via: 1.1 bd5ab138e49a090fd3089313c9c8105c.cloudfront.net (CloudFront)
server: Server
x-amz-cf-pop: IAD12-P4
x-cache: Miss from cloudfront
content-type: text/javascript;charset=UTF-8
access-control-allow-origin: https://www.fox44news.com
access-control-allow-credentials: true
timing-allow-origin: *
content-length: 798
x-amz-cf-id: Is1cvM0u079wordeWWnPxrEW0sYcGd9nNFDiYZOYJk2Cgu6O_pcarw==

GET
H2 403 .js Show response
dyv1bugovvq1g.cloudfront.net/67/www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-f... 243 B
655 B 168ms
57ms Fetch
application/xml 2600:9000:20aa:a600:5:82fd:2500:21
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://dyv1bugovvq1g.cloudfront.net/67/www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/.js
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:20aa:a600:5:82fd:2500:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 6069603f4ad8af1951a3c434c4d6fc1072c64d532914e9872bb48e899011e092

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 a97d638d4e395a6f27b927572cf3bfda.cloudfront.net (CloudFront)
server: AmazonS3
x-amz-cf-pop: IAD89-C2
vary: Origin,Access-Control-Request-Headers,Access-Control-Request-Method
access-control-max-age: 3000
access-control-allow-methods: GET
access-control-allow-origin: https://www.fox44news.com
x-cache: Error from cloudfront
content-type: application/xml
access-control-allow-credentials: true
x-amz-cf-id: ZasD3ySXGFHDKHhKmi7oij06R0Vpnfm2N_kh4CaDXysR2d0TIIB_hg==

POST
H2 204 cdb Show response
bidder.criteo.com/ 0
196 B 286ms
201ms Fetch 74.119.117.6
AS-CRITEO

General

Check archive.org

Show headers Download Go to

Full URL

https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.42.0&cb=62495553127&lsavail=1

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),

Reverse DNS

Software

Kestrel /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

access-control-allow-origin: https://www.fox44news.com
date: Tue, 21 May 2024 13:49:00 GMT
strict-transport-security: max-age=31536000; preload;
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
server: Kestrel
vary: Origin

POST
H2 200 auction Show response
tlx.3lift.com/header/ 19 B
691 B 210ms
90ms Fetch
application/json 3.233.167.98
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL

https://tlx.3lift.com/header/auction?lib=prebid&v=8.42.0&referrer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&tmax=2000&us_privacy=1---

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

3.233.167.98 Ashburn, United States, ASN14618 (AMAZON-AES, US),

Reverse DNS

ec2-3-233-167-98.compute-1.amazonaws.com

Software

Resource Hash

0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

pragma: no-cache
content-encoding: gzip
x-auction-status: 5
vary: Accept-Encoding
content-type: application/json; charset=utf-8
p3p: policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
x-xss-protection: 0
expires: Thu, 15 Oct 1992 20:10:00 GMT

POST
H2 200 pbjs Show response
htlb.casalemedia.com/openrtb/ 36 B
670 B 126ms
60ms Fetch
application/json 172.64.151.101
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://htlb.casalemedia.com/openrtb/pbjs?s=515369
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: ae162c1803e62d7eca63538e2ac5c6a8c1e7e4c2f256c09b8cedc4c5e943ff03

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:00 GMT
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server: cloudflare
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=FVaE8LfReLWAz3flfLpF0%2F2VYUzzZmWN2xwVvnZJH4OOr7tdctLS9qCDYq7JvB8xa8sCejaYdl0pv2qQ4%2FImw1WNAIFjDglRnylkCOOCUJQSgRKowTtMoyZiJa%2F9%2B3VqPQ2pNFi0"}],"group":"cf-nel","max_age":604800}
content-type: application/json
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache
access-control-allow-credentials: true
cf-ray: 88750700d8a6a23a-YYZ
alt-svc: h3=":443"; ma=86400
content-length: 36
expires: 0

POST
H2 200 prebid Show response
prebid.media.net/rtb/ 1 KB
1 KB 391ms
304ms Fetch
application/json 34.120.63.153
GOOGLE-CLOUD-PLAT...

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid.media.net/rtb/prebid?cid=8CUG5MNEO
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS: 153.63.120.34.bc.googleusercontent.com
Software: envoy /
Resource Hash: b6c34240766bca2696b23f78deb66a2f40b253295dbff38739b8d9b479849e6d

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:00 GMT
content-encoding: gzip
via: 1.1 google
accept-ch: Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server: envoy
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials: true
x-envoy-upstream-service-time: 245
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Tue, 21 May 2024 13:49:00 GMT

GET
H2 204 prebid Show response
ads.yieldmo.com/exchange/ 0
373 B 310ms
145ms Fetch 3.208.91.57
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://ads.yieldmo.com/exchange/prebid?pbav=8.42.0&p=%5B%7B%22placement_id%22%3A%22acm-ad-tag-adhesion-adhesion%22%2C%22callback_id%22%3A%2216a38d1a6f57cef%22%2C%22sizes%22%3A%5B%5B728%2C90%5D%5D%2C%22ym_placement_id%22%3A%222498831624305582325%22%2C%22gpid%22%3A%22%2F5678%2Fnx.kwkt%2F%232%22%2C%22tid%22%3A%227a66b728-2e00-41c8-b222-5a0eafbe180f%22%2C%22auctionId%22%3A%221791d40b-3da9-425d-aa67-1fe2c5d1ece9%22%7D%5D&page_url=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bust=1716299340861&dnt=false&description=&tmax=2000&userConsent=%7B%22gdprApplies%22%3A%22%22%2C%22cmp%22%3A%22%22%2C%22gpp%22%3A%22%22%2C%22gpp_sid%22%3A%5B%5D%7D&us_privacy=1---&pr=&scrd=1&title=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable%2C%20a%20Non-Drug%20Treatment%20for%20Migraine&w=1600&h=1200
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.208.91.57 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-208-91-57.compute-1.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

access-control-allow-origin: https://www.fox44news.com
pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
access-control-allow-credentials: true
x-robots-tag: none,NOINDEX,NOFOLLOW
access-control-allow-methods: POST, GET, OPTIONS
access-control-request-headers: Cache-Control, Pragma

GET
H2 200 imp Show response
g2.gumgum.com/hbid/ 2 B
331 B 154ms
45ms Fetch
application/json 34.198.96.69
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://g2.gumgum.com/hbid/imp?lt=1716299340862&to=600&aun=acm-ad-tag-adhesion-adhesion&gpid=%2F5678%2Fnx.kwkt%2F%232&t=c3nffkxg&pi=2&uspConsent=1---&vw=1600&vh=1200&sw=1600&sh=1200&pu=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&ce=true&dpr=1&jcsi=%7B%22t%22%3A0%2C%22rq%22%3A8%2C%22pbv%22%3A%228.42.0%22%7D&ogu=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&ns=10240
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.198.96.69 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-34-198-96-69.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
server: nginx
content-type: application/json;charset=UTF-8
access-control-allow-origin: https://www.fox44news.com
cache-control: private, no-store, must-revalidate, max-age=0
access-control-allow-credentials: true
timing-allow-origin: *
content-length: 2
expires: 0

GET
H2 200 fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 538 B
890 B 235ms
127ms Fetch
application/json 2602:803:c002:200::32
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=10043&site_id=330576&zone_id=1727124&size_id=2&alt_size_ids=55%2C57&us_privacy=1---&rf=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&tg_i.domain=fox44news.com&tg_i.page=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&tg_i.d_code=1&tg_i.pbadslot=%2F5678%2Fnx.kwkt%2F%231&tk_flint=pbjs_lite_v8.42.0&x_source.tid=1791d40b-3da9-425d-aa67-1fe2c5d1ece9&l_pb_bid_id=202665a79bee7f9&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=5428dd49-dc23-4ee8-83d3-3fbb36dc07b3&rp_maxbids=1&p_gpid=%2F5678%2Fnx.kwkt%2F%231&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22124%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22124%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22124%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22124%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.9401332031679266
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.21.4 /
Resource Hash: f59860dfab094f392314e9c4bbaaf81e9098e3c6874cabca6c59932a16868a3e

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
server: nginx/1.21.4
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials: true
content-length: 538
expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H2 200 fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 518 B
1 KB 230ms
122ms Fetch
application/json 2602:803:c002:200::32
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=10043&site_id=330576&zone_id=1727120&size_id=2&us_privacy=1---&rf=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&tg_i.domain=fox44news.com&tg_i.page=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&tg_i.d_code=1&tg_i.pbadslot=%2F5678%2Fnx.kwkt%2F%232&tk_flint=pbjs_lite_v8.42.0&x_source.tid=1791d40b-3da9-425d-aa67-1fe2c5d1ece9&l_pb_bid_id=21348d44e528763&p_screen_res=1600x1200&rp_secure=1&x_imp.ext.tid=7a66b728-2e00-41c8-b222-5a0eafbe180f&rp_maxbids=1&p_gpid=%2F5678%2Fnx.kwkt%2F%232&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22124%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22124%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22124%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22124%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.09534304925515857
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.21.4 /
Resource Hash: 75dbe28b171f93c4b889977b9edbc20015c0504460ff85f76a1e16d5f5a88dbf

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
server: nginx/1.21.4
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials: true
content-length: 518
expires: Wed, 17 Sep 1975 21:32:10 GMT

POST
H2 200 prebid Show response
ib.adnxs.com/ut/v3/ 255 B
1 KB 267ms
191ms Fetch
application/json 68.67.179.87
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

68.67.179.87 North Bergen, United States, ASN29990 (ASN-APPNEX, US),

Reverse DNS

585.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net

Software

nginx/1.23.4 /

Resource Hash

2197057aff6d99fc69869d7d0841eb406a3f7dabe37985033470542ffa0bdab4

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
an-x-request-uuid: ab7424bb-fd31-4efb-8985-218a9f055887
server: nginx/1.23.4
accept-ch: Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-store, no-cache, private
access-control-allow-credentials: true
x-proxy-origin: 96.9.249.44; 96.9.249.44; 585.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length: 255
x-xss-protection: 0
expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H2 200 / Show response
geo.privacymanager.io/ 30 B
626 B 43ms
43ms Fetch
application/json 13.32.151.21
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://geo.privacymanager.io/
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 13.32.151.21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-13-32-151-21.iad66.r.cloudfront.net
Software: /
Resource Hash: 8f8ba42d03a7c5a04626835a48b8212f61a3440e51d66b4b866a8d20acf32f57

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: application/json
Accept: application/json
Referer: https://www.fox44news.com/
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 06:25:57 GMT
via: 1.1 999e0c944d96e4c2945aab8389961e9c.cloudfront.net (CloudFront), 1.1 53c349fc522efbb2ef351788548039c0.cloudfront.net (CloudFront)
x-amz-cf-pop: IAD61-P2, IAD66-C2
age: 26584
x-amzn-requestid: 2e2d1204-eb16-4f0c-ab61-f4f83b05bc97
x-amzn-trace-id: Root=1-664c3e75-3ccf4df213eb661058fee528;Parent=12b68750289118a3;Sampled=0;lineage=06620786:0
access-control-allow-methods: DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
content-type: application/json
access-control-allow-origin: *
x-cache: Hit from cloudfront
x-amz-apigw-id: YG6yWHDCjoEET0w=
content-length: 30
x-amz-cf-id: Ua3ws3vVL9jZhhhLYSevKGIHwP2hhAA7XZ1NsnloqBrABkJxhT8a2g==
access-control-allow-headers: Content-Type,Authorization,X-Amz-Date,X-Api-Key,X-Amz-Security-Token

OPTIONS
H2 200 /
geo.privacymanager.io/ Frame 0
0 351ms
251ms Preflight
application/json 13.32.151.21
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://geo.privacymanager.io/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 13.32.151.21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-13-32-151-21.iad66.r.cloudfront.net
Software: /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Headers: content-type
Access-Control-Request-Method: GET
Origin: https://www.fox44news.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

access-control-allow-headers: Content-Type,Authorization,X-Amz-Date,X-Api-Key,X-Amz-Security-Token
access-control-allow-methods: DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin: *
content-length: 0
content-type: application/json
date: Tue, 21 May 2024 13:49:01 GMT
via: 1.1 359b6b96f5bc39c3c18c245a5430d31c.cloudfront.net (CloudFront), 1.1 53c349fc522efbb2ef351788548039c0.cloudfront.net (CloudFront)
x-amz-apigw-id: YH7sGG8sDoEEiaA=
x-amz-cf-id: ZPl_H_-KMNSAtSZ0wD03DL4XRVwaugWMquJML5UzGW6ISwFypcMxpA==
x-amz-cf-pop: IAD61-P2 IAD66-C2
x-amzn-requestid: bd082df3-bde2-4a5b-9390-f8259a3caf28
x-cache: Miss from cloudfront

GET
H2 200 ot_guard_logo.svg Show response
cdn.cookielaw.org/logos/static/ 497 B
494 B 49ms
48ms Fetch
image/svg+xml 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/logos/static/ot_guard_logo.svg

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

691dcdb24853a0f5ce4e6597e5713dea66799b57ffe2c2a10f28f98e0b569b19

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:00 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: tXyZydHjxQshFMbbBT1/8A==
age: 63290
x-ms-lease-status: unlocked
last-modified: Mon, 20 May 2024 16:31:16 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
access-control-allow-origin: *
x-ms-request-id: dffcd514-501e-003a-24e5-aa02ca000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 887507011da34bc6-BUF

GET
H2 200 nexstarMG_logo.png
cdn.cookielaw.org/logos/60ba8bee-28bd-45b9-bfaf-0bc25767ba53/0ac87efb-2e61-4c6a-adb8-c3c201bbcf92/be3863dd-e753-4963-bcc1-0113e4f85d60/ 13 KB
13 KB 60ms
57ms Image
image/png 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://cdn.cookielaw.org/logos/60ba8bee-28bd-45b9-bfaf-0bc25767ba53/0ac87efb-2e61-4c6a-adb8-c3c201bbcf92/be3863dd-e753-4963-bcc1-0113e4f85d60/nexstarMG_logo.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6d37f3708268f1179d38dea04c1fdff2743856af859e98ed7d356f00027fcb96

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:01 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: cVUFs+yweIvnNtM1VwclWQ==
age: 64374
content-length: 12809
x-ms-lease-status: unlocked
last-modified: Wed, 03 Aug 2022 19:56:03 GMT
server: cloudflare
etag: 0x8DA758A321596D6
vary: Accept-Encoding
content-type: image/png
access-control-allow-origin: *
x-ms-request-id: 4843b083-d01e-0061-5711-241ac0000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 887507012b1c4bc0-BUF

GET
H2 200 powered_by_logo.svg
cdn.cookielaw.org/logos/static/ 5 KB
2 KB 59ms
56ms Image
image/svg+xml 2606:4700::6813:b134
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://cdn.cookielaw.org/logos/static/powered_by_logo.svg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:b134 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5fa00d047acd959697b9d7772c31dcd37bec33c70c6fbf80ab8316205d1d286d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-ms-blob-type: BlockBlob
date: Tue, 21 May 2024 13:49:01 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: Y+c301RBZNK39PvKQWrIBw==
age: 81835
x-ms-lease-status: unlocked
last-modified: Thu, 16 May 2024 19:34:08 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
access-control-allow-origin: *
x-ms-request-id: b59d8306-901e-0005-0c8d-a8b516000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 887507012b1e4bc0-BUF

GET
H2 200 cs Show response
nexstar.blueconic.net/DG/DEFAULT/ 66 B
856 B 46ms
46ms Script
text/javascript 34.194.130.13
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL

https://nexstar.blueconic.net/DG/DEFAULT/cs?bcsessionid=027d3beb-efbb-43a7-9c81-5c77593b79b7&&callback=bc_json971

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

34.194.130.13 Ashburn, United States, ASN14618 (AMAZON-AES, US),

Reverse DNS

ec2-34-194-130-13.compute-1.amazonaws.com

Software

- /

Resource Hash

b1a667359bee273f7c54bf3ecbc10a379d829071211009e4c63eeabe2e3052ae

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: -
x-permitted-cross-domain-policies: master-only
content-type: text/javascript; charset=utf-8
p3p: policyref="", CP="DSP"
cache-control: no-cache, no-store, no-transform, must-revalidate, private
x-robots-tag: noindex, nofollow
content-length: 86
x-xss-protection: 1; mode=block
expires: Thu, 01 Jan 1970 00:00:00 GMT

POST
H2 200 969 Show response
blue.fox44news.com/DG/DEFAULT/rest/rpc/ 8 KB
4 KB 54ms
53ms XHR
application/json 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/DG/DEFAULT/rest/rpc/969?referer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bcsessionid=027d3beb-efbb-43a7-9c81-5c77593b79b7&bctempid=&overruleReferrer=&time=2024-05-21T03%3A49%3A01-10%3A00&ts=1716299341061

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

b71d258af5149d6447df92e9d4451983ddaf484711943ce5f5c4cd461b6aafaa

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
x-cache: Miss from cloudfront
p3p: policyref="", CP="DSP"
content-length: 2943
x-xss-protection: 1; mode=block
pragma: no-cache
server: -
accept-ch: sec-ch-ua-platform-version
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, no-transform, must-revalidate, private
access-control-allow-credentials: true
x-robots-tag: noindex, nofollow
x-amz-cf-id: JOocGmVw8Z43PaNfVx7eb80tdTFCsz7bV1Bdd4X6uBcd1SfHot4bhA==
expires: Thu, 01 Jan 1970 00:00:00 GMT

POST
H2 200 969 Show response
blue.fox44news.com/DG/DEFAULT/rest/rpc/ 559 B
1 KB 52ms
51ms XHR
application/json 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/DG/DEFAULT/rest/rpc/969?referer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bcsessionid=027d3beb-efbb-43a7-9c81-5c77593b79b7&bctempid=&overruleReferrer=&time=2024-05-21T03%3A49%3A01-10%3A00&ts=1716299341080

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

1ec13bd664a9dcf452255819c2ff9458f3965916d959a46c17d55372d033461c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
x-cache: Miss from cloudfront
p3p: policyref="", CP="DSP"
content-length: 181
x-xss-protection: 1; mode=block
pragma: no-cache
server: -
accept-ch: sec-ch-ua-platform-version
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, no-transform, must-revalidate, private
access-control-allow-credentials: true
x-robots-tag: noindex, nofollow
x-amz-cf-id: S771oz5Us8hGWVUO5XHeZrHd70_1q2ie9cXPGgIRDYgX70b0s080NA==
expires: Thu, 01 Jan 1970 00:00:00 GMT

POST
H2 200 969 Show response
blue.fox44news.com/DG/DEFAULT/rest/rpc/ 187 B
1 KB 50ms
49ms XHR
application/json 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/DG/DEFAULT/rest/rpc/969?referer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bcsessionid=027d3beb-efbb-43a7-9c81-5c77593b79b7&bctempid=&overruleReferrer=&time=2024-05-21T03%3A49%3A01-10%3A00&ts=1716299341083

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

d964e49fc98b65bfbbbbdb6d93ea3b9c7873298e2f1fe4d7344dc67b4912b059

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
x-cache: Miss from cloudfront
p3p: policyref="", CP="DSP"
content-length: 167
x-xss-protection: 1; mode=block
pragma: no-cache
server: -
accept-ch: sec-ch-ua-platform-version
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, no-transform, must-revalidate, private
access-control-allow-credentials: true
x-robots-tag: noindex, nofollow
x-amz-cf-id: SmAUJNDH8-XDWn8CDO_ipm1avW4MO6qd1HVgAuxkbafkfosNyQ-IiQ==
expires: Thu, 01 Jan 1970 00:00:00 GMT

POST
H2 200 969 Show response
blue.fox44news.com/DG/DEFAULT/rest/rpc/ 187 B
1 KB 60ms
59ms XHR
application/json 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/DG/DEFAULT/rest/rpc/969?referer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bcsessionid=027d3beb-efbb-43a7-9c81-5c77593b79b7&bctempid=&overruleReferrer=&time=2024-05-21T03%3A49%3A01-10%3A00&ts=1716299341088

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

25c3387f1df2971c2789bdb43d85c3d59ca92673ecb86450b2b95d33c028c5e9

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
x-cache: Miss from cloudfront
p3p: policyref="", CP="DSP"
content-length: 168
x-xss-protection: 1; mode=block
pragma: no-cache
server: -
accept-ch: sec-ch-ua-platform-version
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, no-transform, must-revalidate, private
access-control-allow-credentials: true
x-robots-tag: noindex, nofollow
x-amz-cf-id: naXwhXbOdFDX0JimU_1msOUUlTbqYTnkaYFNnHtT6kPl24Q1VT9JVg==
expires: Thu, 01 Jan 1970 00:00:00 GMT

POST
H2 200 collector Show response
collector-pxcvbtpurj.px-cloud.net/api/v2/ 420 B
484 B 160ms
160ms XHR
application/json 35.190.10.96
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://collector-pxcvbtpurj.px-cloud.net/api/v2/collector
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.190.10.96 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS: 96.10.190.35.bc.googleusercontent.com
Software: /
Resource Hash: 730cb72acdd6d1a908e3902ea83e872934d228779a84b6486ca67a83736bcfc7

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-type: application/x-www-form-urlencoded

Response headers

date: Tue, 21 May 2024 13:49:00 GMT
via: 1.1 google
access-control-allow-methods: GET,HEAD,PUT,PATCH,POST,DELETE
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
access-control-allow-credentials: true
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 420

POST
H2 200 969 Show response
blue.fox44news.com/DG/DEFAULT/rest/rpc/ 187 B
1 KB 48ms
47ms XHR
application/json 99.84.208.28
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://blue.fox44news.com/DG/DEFAULT/rest/rpc/969?referer=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&bcsessionid=027d3beb-efbb-43a7-9c81-5c77593b79b7&bctempid=&overruleReferrer=&time=2024-05-21T03%3A49%3A01-10%3A00&ts=1716299341120

Requested by

Host: blue.fox44news.com
URL: https://blue.fox44news.com/script.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

99.84.208.28 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-99-84-208-28.iad79.r.cloudfront.net

Software

- /

Resource Hash

1412e9492f65ae9422a39cbd4566e31ac1dbc6203a7d3f4dadf0c42316ae7a79

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
via: 1.1 f8558580f66929e19ed69bba2e85da74.cloudfront.net (CloudFront)
x-permitted-cross-domain-policies: master-only
x-amz-cf-pop: IAD79-C1
x-cache: Miss from cloudfront
p3p: policyref="", CP="DSP"
content-length: 167
x-xss-protection: 1; mode=block
pragma: no-cache
server: -
accept-ch: sec-ch-ua-platform-version
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store, no-transform, must-revalidate, private
access-control-allow-credentials: true
x-robots-tag: noindex, nofollow
x-amz-cf-id: JMNQqXtjtVDXl1fjEPXxvnzU4sI-QN_nRaNeiaINADfVsXd8hw-e_A==
expires: Thu, 01 Jan 1970 00:00:00 GMT

GET
H2 404 getLiveAlertsByCounties Show response
weather.psg.nexstardigital.net/service/api/v3/alerts/ 3 B
323 B 226ms
203ms Fetch
application/json 151.101.66.133
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL

https://weather.psg.nexstardigital.net/service/api/v3/alerts/getLiveAlertsByCounties?counties=48309,48041,48099,48333,48411,48281,48145,48331,48395,48293,48289,48051,48313,48027,48035,48217

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

151.101.66.133 San Francisco, United States, ASN54113 (FASTLY, US),

Reverse DNS

Software

Resource Hash

5984eac0c5c6d947241e29dd5671b81a1546cedf77e08d38438ac47029969afa

Security Headers

Name	Value
Strict-Transport-Security	max-age=300
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=300
via: 1.1 varnish
age: 0
x-cache: MISS
content-length: 23
x-xss-protection: 1; mode=block
x-served-by: cache-yyz4582-YYZ
x-timer: S1716299341.169043,VS0,VE174
x-frame-options: DENY
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Accept-Encoding
content-type: application/json
access-control-allow-origin: *
cache-control: public
accept-ranges: bytes
x-cache-hits: 0

GET
H2 200 trk.gif
jadserve.postrelease.com/ 43 B
618 B 48ms
48ms Image
image/gif 52.202.142.82
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://jadserve.postrelease.com/trk.gif?ntv_at=394&ntv_usid=1999074&ntv_pl=1144945
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.202.142.82 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-202-142-82.compute-1.amazonaws.com
Software: nginx /
Resource Hash: a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
server: nginx
content-type: image/gif
access-control-allow-origin: *
p3p: CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
content-length: 43
expires: Mon, 1 Jan 1990 12:00:00 GMT

GET
H3 200 OneSignalSDKStyles.css
onesignal.com/sdks/ 82 KB
9 KB 46ms
46ms Stylesheet
text/css 104.16.160.145
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://onesignal.com/sdks/OneSignalSDKStyles.css?v=2

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

QUIC, , AES_128_GCM

Server

104.16.160.145 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

db7e0b393e175f19922fefbdcaa2866fca209c521d01cc834ae06cbf8d0f91b7

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
via: 1.1 google
content-encoding: br
cf-cache-status: HIT
server: cloudflare
strict-transport-security: max-age=15552000; includeSubDomains
age: 2283
etag: W/"4e9aaefffd5f8ae7dc83361aa2294190"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=2592000
cf-ray: 887507028f9bac30-YYZ
access-control-allow-headers: OneSignal-Subscription-Id
alt-svc: h3=":443"; ma=86400
expires: Thu, 20 Jun 2024 13:49:01 GMT

GET
H2 200 oPS.js Show response
d15kdpgjg3unno.cloudfront.net/ 116 KB
26 KB 143ms
48ms Script
application/javascript 2600:9000:2199:f400:11:b309:9100:21
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://d15kdpgjg3unno.cloudfront.net/oPS.js?cid=67
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:2199:f400:11:b309:9100:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: f5441ece0e7fd76d08bc8dc8d50c06353bd6b67634787f399e996df2e5ae842a

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: xUg1Ol0Oo66bugiURL58YfBvYWWdx3Pj
content-encoding: gzip
via: 1.1 03a399d73bdcccc9e7ad44d059b07ef4.cloudfront.net (CloudFront)
date: Tue, 21 May 2024 06:38:04 GMT
x-amz-cf-pop: IAD79-C1
age: 25858
x-amz-server-side-encryption: AES256
x-cache: Hit from cloudfront
content-length: 25702
x-amz-meta-etag: fHkyrit3WrjPNO/LFB53nw==
last-modified: Fri, 17 May 2024 02:44:23 GMT
server: AmazonS3
etag: "14239dc76c08eb5568660816a25fc583"
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
cache-control: max-age=84600
accept-ranges: bytes
x-amz-cf-id: JE7zarhUpKzmeT-tOx2X5MPbONN-6WNKGNhCA2Lpit3J5S2chEuw3A==

GET
H/1.1 200
OK 1x1-pixel.png
ams-pageview-public.s3.amazonaws.com/ 68 B
480 B 155ms
51ms Image
image/png 3.5.27.142
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ams-pageview-public.s3.amazonaws.com/1x1-pixel.png?id=2c3e2cad9f8d
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 3.5.27.142 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 63ef318d96b5d0d0ceba6e04a4e622b1158335cdc67c49e27839132c6f655058

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Date: Tue, 21 May 2024 13:49:02 GMT
Last-Modified: Mon, 26 Oct 2020 16:52:19 GMT
Server: AmazonS3
x-amz-request-id: FQ7X2S0FBGNX88KD
ETag: "91e42db1c66c0b276abf6234dc50b2eb"
Content-Type: image/png
Cache-Control: no-store
Accept-Ranges: bytes
Content-Length: 68
x-amz-id-2: B16fGHqu1g0kNqjEn7TKgNa9u9RzCIiRDCKRCxfw+KYJC0xVJbtQxxg3C3VdbbjyOVEo5ZJTOzRoSmj4g5u2UZoe/9eBRDzUBRG53YH5ZWw=

OPTIONS
H2 200 simple
api.sail-personalize.com/v1/personalize/ Frame 0
0 179ms
53ms Preflight
text/plain 99.83.154.140
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://api.sail-personalize.com/v1/personalize/simple?pageviews=1&isMobile=0
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 99.83.154.140 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: aa7557bb34ea5624b.awsglobalaccelerator.com
Software: /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Headers: authorization,content-type,x-lib-version,x-referring-url
Access-Control-Request-Method: GET
Origin: https://www.fox44news.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials: true
access-control-allow-headers: Content-Type,Authorization,X-Requested-With,Content-Length,Accept,Origin,X-Lib-Version,X-Referring-URL
access-control-allow-methods: OPTIONS,GET,POST,PUT,DELETE
access-control-allow-origin: https://www.fox44news.com
access-control-max-age: 1800
allow: HEAD,GET,OPTIONS
content-length: 18
content-type: text/plain
date: Tue, 21 May 2024 13:49:01 GMT

GET
H2 200 simple Show response
api.sail-personalize.com/v1/personalize/ 288 B
498 B 60ms
60ms Fetch
application/json 99.83.154.140
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://api.sail-personalize.com/v1/personalize/simple?pageviews=1&isMobile=0
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 99.83.154.140 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: aa7557bb34ea5624b.awsglobalaccelerator.com
Software: /
Resource Hash: 0123f4f1835b2114c181e9a8ef0687982e0458b1394e0da30537c50b0ce2813a

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
x-lib-version: v1.0.1
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
authorization: Bearer 900965f1a717be422edee3f11b3ddb12
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: application/json
accept: application/json
Referer: https://www.fox44news.com/
x-referring-url: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
allowedorigins: *
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
allowedmethods: GET,OPTIONS
cache-control: no-store
access-control-allow-credentials: true
allowedheaders: Content-Type,Authorization,X-Requested-With,Content-Length,Accept,Origin
content-length: 197
expires: -1

GET
H3 200 sodar Show response
pagead2.googlesyndication.com/getconfig/ 16 KB
12 KB 114ms
114ms XHR
application/json 142.250.31.156
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=m202405090101&st=env

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405090101/pubads_impl.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.31.156 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bj-in-f156.1e100.net

Software

cafe /

Resource Hash

fcead4f926d6e552b591a90a1e6aeb796f6f4b206c3d77d786ace66c1cc90465

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: br
x-content-type-options: nosniff
server: cafe
content-type: application/json; charset=UTF-8
access-control-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 12578
x-xss-protection: 0

GET
H3 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 101 KB
33 KB 590ms
589ms XHR
text/plain 172.253.62.154
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?pvsid=3168434896657255&correlator=887905164432183&hxva=1&scor=772466745543419&eid=44809527%2C31083556%2C95332897%2C95327819%2C31079527&output=ldjh&gdfp_req=1&vrg=202405090101&ptt=17&impl=fifs&us_privacy=1---&gpp=DBABBg~BUoAAAKA.QA&gpp_sid=8&iu_parts=5678%2Cnx.kwkt&enc_prev_ius=%2F0%2F1%2F%2C%2F0%2F1%2F%2C%2F0%2F1%2F%2C%2F0%2F1%2F&prev_iu_szs=88x31%2C728x90%7C970x250%7C970x90%7C970x30%2C2x2%2C728x90&ifi=1&sfv=1-0-40&ists=2&eri=33&sc=1&cookie_enabled=1&abxe=1&dt=1716299341415&lmt=1716299341&adxs=1482%2C436%2C799%2C-12245933&adys=43%2C195%2C3523%2C-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0%7C0%7C1%7C-1&ucis=1%7C2%7C3%7C4&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNC4wLjYzNjcuMjA3IixudWxsLDAsbnVsbCwiNjQiLFtbIkNocm9taXVtIiwiMTI0LjAuNjM2Ny4yMDciXSxbIkdvb2dsZSBDaHJvbWUiLCIxMjQuMC42MzY3LjIwNyJdLFsiTm90LUEuQnJhbmQiLCI5OS4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&vis=1&psz=113x-1%7C728x0%7C1600x0%7C0x-1&msz=88x-1%7C728x0%7C1600x0%7C0x-1&fws=0%2C0%2C0%2C640&ohw=0%2C0%2C0%2C0&ga_vid=1040319147.1716299341&ga_sid=1716299341&ga_hid=78350817&ga_fc=false&dlt=1716299338931&idt=1856&ppid=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&prev_scp=kw%3D%252Fbusiness%252Fpress-releases%252Fcision%252F20240521LA18851%252Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%252F%26pos%3Dheader-microbar%26fold%3Datf%26ad_rendercount%3D1%7Ckw%3D%252Fbusiness%252Fpress-releases%252Fcision%252F20240521LA18851%252Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%252F%26pos%3Dbillboard1%26fold%3Datf%26ad_rendercount%3D1%26amzniid%3DJMYv93iOhdAHIqI5FUaKoGsAAAGPm2meLAEAAA1SAQBhcHNfdHhuX2JpZDEgICBhcHNfdHhuX2ltcDEgICCl0h75%26amznp%3D1tjtmv4%26amznsz%3D970x90%26amznbid%3D1sddczk%26amznactt%3DOPEN%7Ckw%3D%252Fbusiness%252Fpress-releases%252Fcision%252F20240521LA18851%252Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%252F%26pos%3Dexit%26fold%3Datf%26ad_rendercount%3D1%7Ckw%3D%252Fbusiness%252Fpress-releases%252Fcision%252F20240521LA18851%252Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%252F%26pos%3Dadhesion%26fold%3Datf%26ad_rendercount%3D1&cust_params=permutive%3D%26htlbid%3Dapplied%26pagetype%3Dnone%26pagetest%3D43%26sessiontest%3D43%26pers_cid%3Dcsp-999-virtualpage-cision.20240521LA18851%26d_code%3D1%26upid%3D9ba7fdc9-d53e-4eff-9fe9-e784b41da712%26refid%3DDirect%26htlbidid%3D36035%26imp_hash%3D1716299340401-249784%26amznbid%3D0%26amznp%3D0&adks=1937646057%2C3021812148%2C1714449613%2C2816212572&frm=20&eoidce=1

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405090101/pubads_impl.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.253.62.154 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bc-in-f154.1e100.net

Software

cafe /

Resource Hash

3ba0a8e9aead34749787656fe8f57dffba98bfb91cb56888843488ea8bfd60cd

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: br
x-content-type-options: nosniff
observe-browsing-topics: ?1
google-mediationgroup-id: -2,-2,-2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 33892
x-xss-protection: 0
google-lineitem-id: -2,6720215423,-2,-1
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2,138475903476,-2,-1
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 container.html
530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 3860 0
0 156ms
48ms Document
text/html 2607:f8b0:4004:c1d::84
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405090101/pubads_impl.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1d::84 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

accept-ranges: bytes
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: public, immutable, max-age=31536000
content-encoding: br
content-length: 2653
content-type: text/html
cross-origin-opener-policy-report-only: same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy: cross-origin
date: Tue, 21 May 2024 13:49:01 GMT
expires: Wed, 21 May 2025 13:49:01 GMT
last-modified: Thu, 03 Nov 2022 19:10:08 GMT
report-to: {"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server: sffe
timing-allow-origin: *
vary: Accept-Encoding
x-content-type-options: nosniff
x-xss-protection: 0

GET
H/1.1

200
OK

iu3
s.amazon-adsystem.com/ Frame 1355
Redirect Chain

https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=gg_n-index_n-MediaNet_ox-db5_n-cadent_n-undertone_n-sharethrough_n-simpli.fi_ym_rbd_n-vmg_n-nativo_an-db5_sovrn_3lift
https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=gg_n-index_n-MediaNet_ox-db5_n-cadent_n-undertone_n-sharethrough_n-simpli.fi_ym_rbd_n-vmg_n-nativo_an-db5_sovrn_3lift&dcc=t

0
0

75ms
75ms

Document
text/html

52.46.143.56
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=gg_n-index_n-MediaNet_ox-db5_n-cadent_n-undertone_n-sharethrough_n-simpli.fi_ym_rbd_n-vmg_n-nativo_an-db5_sovrn_3lift&dcc=t

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_128_GCM

Server

52.46.143.56 Ashburn, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

Software

Server /

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=47474747; includeSubDomains; preload

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

Cache-Control: max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection: keep-alive
Content-Length: 382
Content-Type: text/html;charset=ISO-8859-1
Date: Tue, 21 May 2024 13:49:01 GMT
Expires: Thu, 01 Jan 1970 00:00:00 GMT
Pragma: no-cache
Server: Server
Strict-Transport-Security: max-age=47474747; includeSubDomains; preload
Vary: Content-Type,Accept-Encoding,User-Agent
p3p: policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
x-amz-rid: 1CZAQ6ZSS2XR7KHSRFE1

Redirect headers

Cache-Control: max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection: keep-alive
Content-Length: 0
Date: Tue, 21 May 2024 13:49:01 GMT
Expires: Thu, 01 Jan 1970 00:00:00 GMT
Location: https://s.amazon-adsystem.com/iu3?cm3ppd=1&d=dtb-pub&csif=t&dl=gg_n-index_n-MediaNet_ox-db5_n-cadent_n-undertone_n-sharethrough_n-simpli.fi_ym_rbd_n-vmg_n-nativo_an-db5_sovrn_3lift&dcc=t
Pragma: no-cache
Server: Server
Strict-Transport-Security: max-age=47474747; includeSubDomains; preload
Vary: Content-Type,Accept-Encoding,User-Agent
p3p: policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
x-amz-rid: S1GQ7HCSDD221PM00KXR

POST
H/1.1 200
OK Test_oPS_Script_Loads Show response
sqs.us-east-1.amazonaws.com/397719490216/ 378 B
682 B 197ms
48ms XHR
text/xml 3.236.169.12
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://sqs.us-east-1.amazonaws.com/397719490216/Test_oPS_Script_Loads?Action=SendMessage&MessageBody=cid%3D67%26bt%3Dnull
Requested by: Host: d15kdpgjg3unno.cloudfront.net
URL: https://d15kdpgjg3unno.cloudfront.net/oPS.js?cid=67
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 3.236.169.12 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-236-169-12.compute-1.amazonaws.com
Software: /
Resource Hash: aa688213a0cd3c5b84f1011dd76e53ba45347d54f66d503203ae7ff0ffc38a37

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin: *
Access-Control-Expose-Headers: x-amzn-RequestId,x-amzn-ErrorType,x-amzn-ErrorMessage,Date
Date: Tue, 21 May 2024 13:49:01 GMT
connection: keep-alive
x-amzn-RequestId: f753c534-1c25-58a4-a77b-9bf2b4a83e23
Content-Length: 378
Content-Type: text/xml

GET
H2 200 cropped-Favicon-2-1-1.png
www.fox44news.com/wp-content/uploads/sites/82/2019/07/ 888 B
1 KB 30ms
30ms Other
image/webp 151.101.65.91
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://www.fox44news.com/wp-content/uploads/sites/82/2019/07/cropped-Favicon-2-1-1.png?w=32
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: c6ddfc08a19ccb22cd36985291791038bb3d6da52d221600b02ef3475aca3354

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
via: 1.1 varnish
x-cache: HIT, MISS
content-length: 888
x-served-by: cache-yyz4527-YYZ
x-rq: yyz3 80 130 443
last-modified: Thu, 09 May 2024 12:31:36 GMT
server: nginx
x-timer: S1716299341.492858,VS0,VE1
etag: "f5a1638d22a364a3"
vary: Accept
state: PASS
content-type: image/webp
cache-control: max-age=31536000
accept-ranges: bytes, bytes
x-cache-hits: 0

GET
H2 200 sodar2.js Show response
tpc.googlesyndication.com/sodar/ 17 KB
7 KB 154ms
54ms Script
text/javascript 2607:f8b0:4004:c09::84
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/sodar/sodar2.js

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c09::84 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 6386
x-xss-protection: 0
server: sffe
cross-origin-opener-policy: same-origin; report-to="adspam-signals-scs"
etag: "1637097310169751"
vary: Accept-Encoding
report-to: {"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type: text/javascript
cache-control: private, max-age=3000
accept-ranges: bytes
expires: Tue, 21 May 2024 13:49:01 GMT

GET
H2 200 ats.js Show response
ats-wrapper.privacymanager.io/ats-modules/6aa9a9af-97d4-4c9b-8654-8476fecec395/ 159 KB
52 KB 189ms
60ms Script
application/javascript 99.84.191.89
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ats-wrapper.privacymanager.io/ats-modules/6aa9a9af-97d4-4c9b-8654-8476fecec395/ats.js
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.84.191.89 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-84-191-89.iad89.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: fff9570bd5f4f30df87430e2d15463786c17a5084c6dbe91ea5f08fd2a9547ff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: VOvMLeDhPT741xIkNRTWieBnC2_9gQfL
content-encoding: gzip
via: 1.1 427271f19372c1be0d143a1d4c76a128.cloudfront.net (CloudFront)
date: Tue, 21 May 2024 13:09:12 GMT
last-modified: Tue, 14 May 2024 12:56:14 GMT
server: AmazonS3
x-amz-cf-pop: IAD89-C2
age: 2390
x-amz-server-side-encryption: AES256
etag: W/"0ea1c48e0bdd2f936bbf0c13df4d8dd1"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
cache-control: must-revalidate,public,max-age=3600
x-amz-cf-id: Hs0E9nMXfYKgkDhu3b9gxUpiiQAZp71s2T6INWTLENNZbNM3gpoXFQ==

GET
H2 200 runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame 9627 0
0 145ms
49ms Document
text/html 2607:f8b0:4004:c09::84
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c09::84 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

accept-ranges: bytes
age: 334106
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: public, max-age=31536000
content-encoding: gzip
content-length: 5046
content-type: text/html
cross-origin-opener-policy: same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy: cross-origin
date: Fri, 17 May 2024 17:00:35 GMT
expires: Sat, 17 May 2025 17:00:35 GMT
last-modified: Mon, 21 Jun 2021 20:47:05 GMT
report-to: {"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server: sffe
vary: Accept-Encoding
x-content-type-options: nosniff
x-xss-protection: 0

GET
H3 200 aframe
www.google.com/recaptcha/api2/ Frame AF5B 0
0 169ms
61ms Document
text/html 172.253.63.99
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/aframe

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.253.63.99 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bi-in-f99.1e100.net

Software

GSE /

Resource Hash

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-fiWfR11lIz98wFpvuSXz9w' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: private, max-age=300
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-fiWfR11lIz98wFpvuSXz9w' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Tue, 21 May 2024 13:49:01 GMT
expires: Tue, 21 May 2024 13:49:01 GMT
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H2 200 / Show response
geo.privacymanager.io/ 30 B
625 B 43ms
43ms Fetch
application/json 13.32.151.21
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://geo.privacymanager.io/
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 13.32.151.21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-13-32-151-21.iad66.r.cloudfront.net
Software: /
Resource Hash: 8f8ba42d03a7c5a04626835a48b8212f61a3440e51d66b4b866a8d20acf32f57

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 06:25:57 GMT
via: 1.1 999e0c944d96e4c2945aab8389961e9c.cloudfront.net (CloudFront), 1.1 53c349fc522efbb2ef351788548039c0.cloudfront.net (CloudFront)
x-amz-cf-pop: IAD61-P2, IAD66-C2
age: 26584
x-amzn-requestid: 2e2d1204-eb16-4f0c-ab61-f4f83b05bc97
x-amzn-trace-id: Root=1-664c3e75-3ccf4df213eb661058fee528;Parent=12b68750289118a3;Sampled=0;lineage=06620786:0
access-control-allow-methods: DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
content-type: application/json
access-control-allow-origin: *
x-cache: Hit from cloudfront
x-amz-apigw-id: YG6yWHDCjoEET0w=
content-length: 30
x-amz-cf-id: PQztW1fjIa9ww_ii6yNlu3rNzD59qxHYxAKnY15gs5xmAjg23QMpag==
access-control-allow-headers: Content-Type,Authorization,X-Amz-Date,X-Api-Key,X-Amz-Security-Token

GET
H2 200 bob_zero_zero_one.js Show response
bob.dmpxs.com/static/ 4 KB
2 KB 47ms
46ms Script
application/javascript 52.21.84.14
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://bob.dmpxs.com/static/bob_zero_zero_one.js
Requested by: Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.21.84.14 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-21-84-14.compute-1.amazonaws.com
Software: / Express
Resource Hash: fa852bc86d8cf44647c08d2428f4b6e7bced846930e419b34629fe177f44bee7

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
content-encoding: gzip
last-modified: Fri, 09 Dec 2022 20:45:04 GMT
x-powered-by: Express
etag: W/"10af-184f8a26941"
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
cache-control: public, max-age=0
accept-ranges: bytes

GET
H3 200 view
securepubads.g.doubleclick.net/pcs/ Frame 3C60 0
0 108ms
102ms Fetch
image/gif 172.253.62.154
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvbTRE-Ocnz8C66G67uT-IJdCkh9fbteN653LjDPjtURDtkhLT29E5JEqqQdosthnJWVsjQmqpx5cTPCqEeeZsr6mOxrjMF6SeGf7f8NpHQzuDvwoYYBJ0Zfw_VT-1DYTWp8f7EB5Y0JgEHtc7eSnfDnfmz3oSe8oLfpaETdOF3uiQ-VFhQ5HgV2nz3LdAfJ8elcT41iRWgxS1mEzguBcCxK26RDtDNV5K7ynRCuGnOts6tYYiINpuSCz2kmX5KtDt0lG4Oiw8QFMc6XBVO-ndYZ5OrTm9GFFcwzve-zdwrEek0zSrN0PwxQAC4uYE_Dz17bhOo9v7USi0JL8hkORN3Zb3vc07Kyh_VtI060OZK5ze1zYZlKpaZ6-Y&sai=AMfl-YQz4YB8m9b_Oj59n03TsOe8clvksgMLd4VamZoV-VcX2PbV6RRGKfGIciMOjTk4AM95K6p7eIaU2OJW458iDvyart-l_XgVD8X50mCMA-dGWHiRkC4BJThMnUUPpvgQ_6zEfh2Koi3488QScbTOxA&sig=Cg0ArKJSzCKoRmce2UmQEAE&uach_m=%5BUACH%5D&adurl=

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

172.253.62.154 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bc-in-f154.1e100.net

Software

cafe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
x-content-type-options: nosniff
accept-ch: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server: cafe
content-type: image/gif
access-control-allow-origin: *
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: private
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
x-xss-protection: 0

GET
H2 200 window_focus_fy2021.js Show response
tpc.googlesyndication.com/pagead/js/r20240516/r20110914/client/ Frame 3C60 3 KB
1 KB 54ms
49ms Script
text/javascript 2607:f8b0:4004:c09::84
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/pagead/js/r20240516/r20110914/client/window_focus_fy2021.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c09::84 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 09:51:04 GMT
content-encoding: br
x-content-type-options: nosniff
age: 14278
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 1236
x-xss-protection: 0
server: cafe
etag: 15004572836499977866
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: public, max-age=1209600
timing-allow-origin: *
expires: Tue, 04 Jun 2024 09:51:04 GMT

GET
H3 200 ufs_web_display.js Show response
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame 3C60 214 KB
65 KB 132ms
44ms Script
text/javascript 142.250.31.156
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.31.156 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bj-in-f156.1e100.net

Software

cafe /

Resource Hash

f860805800875da202a4d22d7b42f596aa87139dcf425e96db78bdf60af687a3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:41:14 GMT
content-encoding: br
x-content-type-options: nosniff
age: 468
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 66378
x-xss-protection: 0
server: cafe
etag
vary: Accept-Encoding
content-type: text/javascript; charset=ISO-8859-1
cache-control: public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin: *
expires: Tue, 21 May 2024 14:41:14 GMT

GET
H2 200 18247150076179856511
tpc.googlesyndication.com/simgad/ Frame 3C60 88 KB
88 KB 55ms
51ms Image
image/png 2607:f8b0:4004:c09::84
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://tpc.googlesyndication.com/simgad/18247150076179856511

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c09::84 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

f5cff45bf1b55f194e156a92ac8b57e40aa79aeeb07852ac02eccb83335a56f0

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

expires: Wed, 21 May 2025 13:16:32 GMT
date: Tue, 21 May 2024 13:16:32 GMT
x-content-type-options: nosniff
age: 1950
x-dns-prefetch-control: off
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 90029
x-xss-protection: 0
last-modified: Mon, 20 May 2024 18:14:37 GMT
server: sffe
report-to: {"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type: image/png
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="content-ads-owners"
allow-fenced-frame-automatic-beacons: true

GET l
www.google.com/ads/measurement/ Frame 3C60 0
0

GET
H2 200 container.html
530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 3FD5 0
0 0ms
0ms Document
text/html 2607:f8b0:4004:c1d::84
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4004:c1d::84 Washington, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

accept-ranges: bytes
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: public, immutable, max-age=31536000
content-encoding: br
content-length: 2653
content-type: text/html
cross-origin-opener-policy-report-only: same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy: cross-origin
date: Tue, 21 May 2024 13:49:01 GMT
expires: Wed, 21 May 2025 13:49:01 GMT
last-modified: Thu, 03 Nov 2022 19:10:08 GMT
report-to: {"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server: sffe
timing-allow-origin: *
vary: Accept-Encoding
x-content-type-options: nosniff
x-xss-protection: 0

GET
DATA 200
OK truncated
/ Frame 3C60 216 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 6ed77ac607812fe6c4ac1b439a58ae8b0af33fa9976c69defd232acd69e04062

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/png

GET cs
sync.rtk.io/ Frame C20E 0
0

GET
H2

200

magnetar_attract
bob.dmpxs.com/
Redirect Chain

https://ib.adnxs.com/getuid?https%3A%2F%2Fbob.dmpxs.com%2Fmagnetar_attract%3Fbob_tag_id%3Dbob_001%26apnx_uid%3D%24UID
https://bob.dmpxs.com/magnetar_attract?bob_tag_id=bob_001&apnx_uid=7109922249490532377

35 B
196 B

47ms
46ms

Image
image/gif

52.21.84.14
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://bob.dmpxs.com/magnetar_attract?bob_tag_id=bob_001&apnx_uid=7109922249490532377
Protocol: H2
Server: 52.21.84.14 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-21-84-14.compute-1.amazonaws.com
Software: / Express
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
x-powered-by: Express

Redirect headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:02 GMT
an-x-request-uuid: 5ed5af60-e3fb-426f-89b0-974191a4620e
server: nginx/1.23.4
accept-ch: Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type: text/html; charset=utf-8
access-control-allow-origin: *
cache-control: no-store, no-cache, private
access-control-allow-credentials: true
location: https://bob.dmpxs.com/magnetar_attract?bob_tag_id=bob_001&apnx_uid=7109922249490532377
x-proxy-origin: 96.9.249.44; 96.9.249.44; 585.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length: 0
x-xss-protection: 0
expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H2

200

magnetar_attract
bob.dmpxs.com/
Redirect Chain

https://match.prod.bidr.io/cookie-sync/nextardigital
https://match.prod.bidr.io/cookie-sync/nextardigital?_bee_ppp=1
https://bob.dmpxs.com/magnetar_attract?bx_uid=AAE2RE7MmU0AABRLhY-U5A

35 B
199 B

53ms
52ms

Image
image/gif

52.21.84.14
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://bob.dmpxs.com/magnetar_attract?bx_uid=AAE2RE7MmU0AABRLhY-U5A
Protocol: H2
Server: 52.21.84.14 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-21-84-14.compute-1.amazonaws.com
Software: / Express
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
x-powered-by: Express

Redirect headers

location: https://bob.dmpxs.com/magnetar_attract?bx_uid=AAE2RE7MmU0AABRLhY-U5A
Date: Tue, 21 May 2024 13:49:02 GMT
strict-transport-security: max-age=2592000; includeSubDomains
Server: gunicorn
Connection: keep-alive
Content-Length: 0

GET
H2 200 bob_001.gif
bob.dmpxs.com/ 35 B
105 B 48ms
48ms Image
image/gif 52.21.84.14
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://bob.dmpxs.com/bob_001.gif?bob_session_id=1716299342183-494590&bob_cb=1716299339423406&bob_event=evar_checkin&dcode=1&repeat_visitor=1716299342182-397040&referrer=&page_title=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable,%20a%20Non-Drug%20Treatment%20for%20Migraine&page_url=fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/&persistentid=csp-999-virtualpage-cision.20240521LA18851&imp_hash=1716299340401-249784&ndn=7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414&bcsessionid=027d3beb-efbb-43a7-9c81-5c77593b79b7
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.21.84.14 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-21-84-14.compute-1.amazonaws.com
Software: / Express
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
x-powered-by: Express

GET
H3 200 view
securepubads.g.doubleclick.net/pcs/ Frame 3C60 0
0 191ms
103ms Fetch
image/gif 172.253.62.154
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvUWpLHBw4aj4-o6ua9_iqro8OmEEf1gOwjTueG-SkGBI48iXPo9-6CJw7C7cG5orGjJ19ZVFy5MZGD6OU9Er4j0F6vxZdXHEFEwdmGfPDlPcAlqXP9q86jhWDGcv3Q9IdednDHbUB9KJKvO1vS2e0woSihPgOoT6QaUzxrLPdqQ8c36YWDYDBfDRt4YqB7qOYrgjmMkT67F5juQBlA1Z8tmBEkMteYywG9lh4agQ8YvjmMz79nHeG3XdfP2f2wURtUBUd0y5xVgoLjJb_jmKZos7lC3o66YRnIbkjh1qfLgmIkKhf40yZ0wpRYWVE9_cEbbJk3bhSARYkNf9_YO8iRYDePHOzpeWYpRTmmbyydzRPA4ayyOyfhfscY5g&sai=AMfl-YTvFX_S4A62q_58rEwwChOnVZmVRA_zVV6dxrfNx1WQAYCmCh8g_cOtBeLB9N5YNqf0Ha0Cui28K1BnBcTu1Lh2WO1e8RpYM8hx9EsAMh16Kwc0UfF3Z6V_7u498EalYXTGhjkSIVhzKBFK2mJ_Yw&sig=Cg0ArKJSzFFA6AL8LLLfEAE&uach_m=%5BUACH%5D&adurl=

Requested by

Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.253.62.154 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bc-in-f154.1e100.net

Software

cafe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
x-content-type-options: nosniff
accept-ch: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server: cafe
content-type: image/gif
access-control-allow-origin: *
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: private
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
x-xss-protection: 0
expires: Tue, 21 May 2024 13:49:02 GMT

GET
H3 204 gen_204
pagead2.googlesyndication.com/pagead/ Frame 3C60 0
0 117ms
113ms Fetch
image/gif 142.250.31.156
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/pagead/gen_204?id=av-js&type=reach&proto=CAlgAWACaAM%3D

Requested by

Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.31.156 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bj-in-f156.1e100.net

Software

cafe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:02 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 bob_006.gif
bob.dmpxs.com/ Frame 3C60 35 B
105 B 53ms
46ms Image
image/gif 52.21.84.14
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://bob.dmpxs.com/bob_006.gif?dfpid=5678&c_orderid=3546403185&c_lineid=6720215423&c_adunit=121969302&c_adunithigh=121969302&c_bannerid=138475903476&c_adsize=728x90&dcode=1&imp_hash=1716299340401-249784&persistent_id=csp-999-virtualpage-cision.20240521LA18851&page_url=https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/&cb_hash=1716299342353-6836461207
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.21.84.14 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-21-84-14.compute-1.amazonaws.com
Software: / Express
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
x-powered-by: Express

GET
H2 200 gn
secure-dcr.imrworldwide.com/cgi-bin/ 44 B
425 B 168ms
56ms Image
image/gif 3.20.52.199
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://secure-dcr.imrworldwide.com/cgi-bin/gn?prd=dcr&ci=us-400338&ch=us-400338_c97_defChnAsset_S&asn=defChnAsset&fp_id=uyh0fbgzkpbvsddmgzkmlofpry9pu1716299340&fp_cr_tm=1716299340606&fp_acc_tm=1716299340606&fp_emm_tm=1716299340606&ve_id=&sessionId=stjbayqajkabgie3ebtqxxoevgveu1716299340&prv=1&c6=vc,c97&ca=NA&c13=asid,P1AA93ABC-DED6-4EE2-8CE5-8F5729E1D264&c32=segA,NA&c33=segB,NA&c34=segC,NA&c15=apn,&sup=1&segment2=&segment1=&forward=0&plugv=&playerv=&ad=0&cr=V&c9=devid,&enc=true&c1=nuid,e58x4zigekkchnvfhvikjbmrc1cic1716299340&at=view&rt=text&c16=sdkv,bj.6.0.0&c27=cln,0&crs=&lat=&lon=&c29=plid,17162993406022701&c30=bldv,6.0.0.673&st=dcr&c7=osgrp,&c8=devgrp,&c10=plt,&c40=adbid,&c14=osver,NA&c26=dmap,1&dd=&hrd=&wkd=&c35=adrsid,&c36=cref1,&c37=cref2,&c11=agg,1&c12=apv,&c51=adl,0&c52=noad,0&pc=NA&c53=fef,n&c54=oad,&c55=cref3,&c57=adldf,2&ai=0&c3=st,c&c64=starttm,1716299342&adid=0&c58=isLive,false&c59=sesid,&c61=createtm,1716299341&c63=pipMode,&uoo=&c68=bndlid,&nodeTM=&logTM=&c73=phtype,&c74=dvcnm,&c76=adbsnid,&c44=progen,&davty=0&si=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&c66=mediaurl,&sdd=&c62=sendTime,1716299341&rnd=97858
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.20.52.199 Columbus, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-3-20-52-199.us-east-2.compute.amazonaws.com
Software: nginx /
Resource Hash: 5ecb58845a9ac30e4eb4b18eb0e7431ba1fb195ce035309735efaee67421c7a3

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:02 GMT
server: nginx
accept-ch: Sec-Ch-Ua-Model, Sec-Ch-Ua-Platform, Sec-Ch-Ua-Platform-Version
access-control-allow-methods: POST, OPTIONS
p3p: P3P policyref="http://secure-dcr.imrworldwide.com/w3c/p3p.xml", CP="NOI DSP COR NID PSA ADM OUR IND UNI NAV COM"
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache
cross-origin-resource-policy: cross-origin
content-length: 44
expires: Thu, 01 Dec 1994 16:00:00 GMT

GET
H2 200 gn
global.imrworldwide.com/cgi-bin/ 35 B
426 B 322ms
100ms Image
image/gif 52.35.121.22
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://global.imrworldwide.com/cgi-bin/gn?prd=metadata&c9=devid,&c13=asid,P1AA93ABC-DED6-4EE2-8CE5-8F5729E1D264&sessionId=stjbayqajkabgie3ebtqxxoevgveu1716299340&c30=bldv,6.0.0.673&pgUrl=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&pgTitle=DC%20Medicaid%20Becomes%20the%20First%20Medicaid%20Plan%20to%20Cover%20the%20Nerivio%C2%AE%20REN%20Wearable%2C%20a%20Non-Drug%20Treatment%20for%20Migraine&uoo=

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.35.121.22 Boardman, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-52-35-121-22.us-west-2.compute.amazonaws.com

Software

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:02 GMT
strict-transport-security: max-age=31536000
max-age: 0
accept-ch: Sec-Ch-Ua-Model, Sec-Ch-Ua-Platform, Sec-Ch-Ua-Platform-Version
content-type: image/gif
p3p: P3P policyref="http://global.imrworldwide.com/w3c/p3p.xml", CP="NOI DSP COR NID PSA ADM OUR IND UNI NAV COM"
access-control-allow-origin: *
cache-control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
cross-origin-resource-policy: cross-origin
content-length: 35
expires: 0

GET sodar
pagead2.googlesyndication.com/pagead/ 0
0

GET
H2 200 publishertag.prebid.144.js Show response
static.criteo.net/js/ld/ 96 KB
31 KB 178ms
87ms Script
text/javascript 2620:100:a00b::4
AS-CRITEO

General

Check archive.org

Show headers Download Go to

Full URL

https://static.criteo.net/js/ld/publishertag.prebid.144.js

Requested by

Host: htlbid.com
URL: https://htlbid.com/v3/fox44news.com/htlbid.js?ver=1.0.0

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2620:100:a00b::4 , United States, ASN19750 (AS-CRITEO, US),

Reverse DNS

Software

nginx /

Resource Hash

66776998b10e583a72f8fd29391a50e2c80eb3bc9a65b0dafe97e576d7d88507

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
content-encoding: gzip
strict-transport-security: max-age=31536000; preload;
last-modified: Fri, 27 Oct 2023 06:43:26 GMT
server: nginx
etag: W/"653b5c0e-1811e"
content-type: text/javascript
access-control-allow-origin: *
cache-control: max-age=86400, public
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
expires: Wed, 22 May 2024 13:49:02 GMT

GET
H3 200 activeview Show response
pagead2.googlesyndication.com/pcs/ Frame 3C60 42 B
65 B 102ms
101ms Fetch
image/gif 142.250.31.156
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsu3VXIAnnkF7840_ZsmzMHOVVjogKox5dQ1zryYdHJm0m1inh8WIsUj0yQXye4PdKYJ6LBCzeXUcoFFR1WXhkBzr3Hh2fbWeuR37cJSIt9lEcecvybghMT7jDunPlzzrvqPYDfnA9E6FuVStB1QyJq4u4l6Im5MNx65dMq6Lg&sig=Cg0ArKJSzLc3jYkZF4MyEAE&id=lidar2&mcvt=1000&p=150,436,240,1164&mtos=1000,1000,1000,1000,1000&tos=1000,0,0,0,0&v=20240520&bin=7&avms=nio&bs=1600,1200&mc=1&vu=1&app=0&itpl=3&adk=3021812148&rs=4&la=0&cr=0&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNC4wLjYzNjcuMjA3IixudWxsLDAsbnVsbCwiNjQiLFtbIkNocm9taXVtIiwiMTI0LjAuNjM2Ny4yMDciXSxbIkdvb2dsZSBDaHJvbWUiLCIxMjQuMC42MzY3LjIwNyJdLFsiTm90LUEuQnJhbmQiLCI5OS4wLjAuMCJdXSwwXQ%3D%3D&vs=4&r=v&co=1223214200&rst=1716299342082&rpt=262&isd=0&lsd=0&met=mue&wmsd=0&pbe=0&fle=0&vae=0&spb=0&sfl=0&ffslot=0&reach=8&io2=0

Requested by

Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.31.156 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

bj-in-f156.1e100.net

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Tue, 21 May 2024 13:49:03 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
access-control-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 1262 Show response
check.analytics.rlcdn.com/check/ 25 B
383 B 362ms
253ms Fetch
application/json 99.84.208.120
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://check.analytics.rlcdn.com/check/1262
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.84.208.120 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-84-208-120.iad79.r.cloudfront.net
Software: /
Resource Hash: 8a9ba7bbc88ec23d81a2d63845638a3b6603de473261872f301803cef84ef335

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:03 GMT
via: 1.1 e811c1e9e6ed756b98bfcf15c74f6bea.cloudfront.net (CloudFront)
x-amz-cf-pop: IAD79-C1
x-amzn-trace-id: Root=1-664ca64f-6116141c7b376691211d8a42
x-amzn-requestid: be02eb8a-be61-4843-9688-5db34e3d9570
x-cache: Miss from cloudfront
content-type: application/json
access-control-allow-origin: *
x-amz-apigw-id: YH7sgEfXDoEEFLA=
content-length: 25
x-amz-cf-id: u3xEjjt8ALedp2wGtKvirVedeHFDH-dNtBvuSYv5S23eCln3944ajA==

GET
H2 200 syncframe
gum.criteo.com/ Frame 6E9B 0
0 129ms
44ms Document
text/html 2620:100:a00b::12
AS-CRITEO

General

Check archive.org

Show headers Download Go to

Full URL

https://gum.criteo.com/syncframe?origin=publishertag&topUrl=www.fox44news.com&us_privacy=1---&gpp=DBABBg~BUoAAAKA.QA&gpp_sid=8

Requested by

Host: d3plfjw9uod7ab.cloudfront.net
URL: https://d3plfjw9uod7ab.cloudfront.net/31b9b552-f32e-4036-8364-726eb992b71d.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2620:100:a00b::12 , United States, ASN19750 (AS-CRITEO, US),

Reverse DNS

Software

Kestrel /

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Accept-Language: en-US,en;q=0.9;q=0.9
Referer: https://www.fox44news.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

cache-control: private, max-age=3600
content-encoding: gzip
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Tue, 21 May 2024 13:49:03 GMT
server: Kestrel
server-processing-duration-in-ticks: 514379
strict-transport-security: max-age=31536000; preload;
vary: Accept-Encoding
x-robots-tag: noindex

GET
H2 200 publishertag.prebid.144.js Show response
static.criteo.net/js/ld/ 96 KB
0 1ms
1ms XHR
text/javascript 2620:100:a00b::4
AS-CRITEO

General

Check archive.org

Show headers Download Go to

Full URL: https://static.criteo.net/js/ld/publishertag.prebid.144.js
Requested by: Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.144.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2620:100:a00b::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software: nginx /
Resource Hash: 66776998b10e583a72f8fd29391a50e2c80eb3bc9a65b0dafe97e576d7d88507

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Tue, 21 May 2024 13:49:02 GMT
content-encoding: gzip
last-modified: Fri, 27 Oct 2023 06:43:26 GMT
server: nginx
etag: W/"653b5c0e-1811e"
content-type: text/javascript
access-control-allow-origin: *
cache-control: max-age=86400, public
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
expires: Wed, 22 May 2024 13:49:02 GMT

GET
H2 200 fed Show response
ups.analytics.yahoo.com/ups/58743/ 391 B
764 B 141ms
47ms Fetch
application/json 34.200.65.202
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL

https://ups.analytics.yahoo.com/ups/58743/fed?v=1&1p=0&gdpr=0&gdpr_consent=&us_privacy=1---&url=https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/&pixelId=58743

Requested by

Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

34.200.65.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),

Reverse DNS

ec2-34-200-65-202.compute-1.amazonaws.com

Software

ATS/9.1.10.112 /

Resource Hash

b99856a0ae1022256001c1c08153c59a99505cc4290602670782ae6ad99d0039

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:04 GMT
strict-transport-security: max-age=31536000
server: ATS/9.1.10.112
age: 0
vary: Origin
p3p: CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
access-control-allow-origin: https://www.fox44news.com
content-type: application/json
access-control-allow-credentials: true

GET
H2 204 envelope Show response
api.rlcdn.com/api/identity/ 0
281 B 189ms
74ms Fetch 34.107.165.188
GOOGLE-CLOUD-PLAT...

General

Check archive.org

Show headers Download Go to

Full URL: https://api.rlcdn.com/api/identity/envelope?pid=1262
Requested by: Host: www.fox44news.com
URL: https://www.fox44news.com/CvbtpUrj/init.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 34.107.165.188 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS: 188.165.107.34.bc.googleusercontent.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.fox44news.com/
Accept-Language: en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
content-type: text/plain

Response headers

date: Tue, 21 May 2024 13:49:04 GMT
via: 1.1 google
access-control-allow-methods: GET, OPTIONS
access-control-allow-origin: https://www.fox44news.com
cache-control: no-cache, no-store
access-control-allow-credentials: true
timing-allow-origin: *
access-control-allow-headers: Accept, Authorization, Content-Type, Cookie, Origin, X-Requested-With
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain: www.google.com
URL: https://www.google.com/ads/measurement/l?ebcid=ALh7CaSHphjuewPIIS7-XBCEiqEs_ah0EWvYYLGLzXuuZKp7W-cHLcULRfV9UjFTEHhXn8gTwkoGaIgcPwdJF8o_DLP7Cmc4CA

Domain: sync.rtk.io
URL: https://sync.rtk.io/cs

Domain: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gpt_m202405090101&jk=3168434896657255&bg=!k5ClkN_NAAaTdHvKs3Q7ADQBe5WfOGHLaaPON1Irt7PcDj3aXvt1nvN9nb0BFpdJKXlJY8TxHpXLTum1abBBnB2e8JyEAgAAAD1SAAAAA2gBB34ANZI-gb3S9qs21gKY8mIlA7gQRvhlyxWFovZvbWr4RQjSDpgl2hHwHn77tWdXJGpYzs5b2-f_mQKeArinIlZ55a1FnB-KYoqWoNe-voE6JzCa1KtOP8JkskXr4tItc7BUtSFlJMk3Bp_KiZeYBVcO0F16OwU21lorNmrw34NCn48SbJHhkXujEDlvBEVgTvv7RV_bNSRZzpWiSTItNOn_mBREImD-tEZlqjS2jGD3_Mj-jrOPPErLM9d7ROlK7Bf8S0ebjlH2yqYly7PI5b-F3Pw9BW1loNCYD9TX2BUMcxjoNqpQUMSEolmajQxrtAK3efxfUxXwQv_PX_EmuiN2Hmk6ygDaQV9NzwMZUcz03MduTM-TOxnnFryxTH_T51RiZNBp0VoOVhhJJ93ULivUawifcM2L0wCFEVrTQDw6fSWzXjI41R4Su7K9Zb_T-ecIDU6mwXqvIQ1gzmiVMBiSF2bK0ZpEwQWKrEnHqDG4oTNPyubphISwvtqAt9t7p0ylwVNtswsXYKSu0UIyXXahFTnFNJ-EmJcVrp9xgQywAxOa190d2rDQF79d3jPVbJEsIjoMxGj_0-64eR3YH-xVVb38HNWqG7HdJGc5R7TDZdhQ6gK1cr5lczbU9GcPeMnd07ARiEHPZZ7lKD_rArEM23JqOboB8RM0-uWhngWLxtyDTdjZd3TvkbLHfDOCAwsNJSVze7ydCBAgyw3jrvuoFeZCLss71w-ohye0bFXOKYnOGqBT44f0ZgQ23tQD1ZcjpN9Ctljtmqb3NIynMBsYRoaZj6qblkRUAmqVmRg_R-IJwZR9kev0pIZR0qMlxP8MJMWgzxSj8iAVdaZBHgoj0o81itilaKEGanIJSpg1FDPw2IZxEDUzj9AcaWLfmZdZTmv7T9H3OSFwa8hhFLdF4EmMuvZMDD6z0M03KQWzeuKh782V2h-eXQVJT_SPY8rMaVqHEdPUew

Verdicts & Comments Add Verdict or Comment

456 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

227 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
blue.fox44news.com/DG/DEFAULT	1970-01-21 06:20:59	Name: BCSessionID Value: 027d3beb-efbb-43a7-9c81-5c77593b79b7
nexstar.blueconic.net/DG/DEFAULT	1970-01-21 05:30:35	Name: BCSessionID Value: 027d3beb-efbb-43a7-9c81-5c77593b79b7
c212.net/c	1970-01-21 01:11:23	Name: c Value: 0%3A12441e00%3A1e439eb8%3A664ca64b%3A2ffc
www.fox44news.com/	1970-01-21 05:30:35	Name: _pxhd Value: dbb00bfd2f07e737147f0eb0890d4daa80eacf64d6f4279fad18bf967be40017:df430822-1778-11ef-81b3-4014abef9fe9
.www.fox44news.com/	1970-01-21 05:30:35	Name: ndn Value: 7768e95b-0a33-4162-b180-ffc07f4170f4-1716299339414
.fox44news.com/	1969-12-31 23:59:59	Name: pxcts Value: e008be6e-1778-11ef-8bb0-80d2f1c01551
.fox44news.com/	1970-01-21 05:30:35	Name: _pxvid Value: df430822-1778-11ef-81b3-4014abef9fe9
.prnewswire.com/	1970-01-20 20:45:01	Name: __cf_bm Value: l0TZMiiPR.vOVpoq5UKvOlXrlihgnwF17FmohKT4onA-1716299339-1.0.1.1-dJ7_AzAD5kYnangWeZBeIfBIEgapU9A9fngejek8yyMwLlFGAJNiX3xgdlB4KfHnyx3gGEsXfz0vHXvZcR1rew
www.fox44news.com/	1970-01-20 20:45:02	Name: referralId Value: Direct
.onesignal.com/	1970-01-20 20:45:01	Name: __cf_bm Value: KPh0cfCdP5Zxm_xdCS5Wf9ASxV9L647oniB_e8GKaUI-1716299339-1.0.1.1-ZRjQrHoEbYFsoBEpjSlQ327y7QrT7cGMZVagNvfTRQ5g6Re6dxD8BBW.gkghMH2SLh1fZOoDx.K27FddKARGiQ
www.fox44news.com/	1970-01-21 05:30:35	Name: last_visit_bc Value: 1716299339913
bob.dmpxs.com/	1970-01-21 06:20:59	Name: bob_c_id Value: 159d393752815dc0a5cbf3702d4ad8f6baccfba401786bdbfdc95cb4beabdfdb473ef2b4
.mathtag.com/	1970-01-21 06:10:54	Name: uuid Value: 865d664c-a64c-4000-b856-6472404e23e6
.fox44news.com/	1970-01-20 20:45:01	Name: seg_sessionid Value: 71b03c43-d503-4bf7-8cd3-70a16ea92747
.fox44news.com/	1970-01-21 06:13:47	Name: _cb Value: Ck07s6BgBgcsD27Gm8
.fox44news.com/	1970-01-21 06:13:47	Name: _chartbeat2 Value: .1716299340147.1716299340147.1.C8XCphzTEHoBrxAAvDC__GEDdB8Ym.1
.fox44news.com/	1970-01-20 20:45:01	Name: _cb_svref Value: external
.criteo.com/	1970-01-21 06:06:35	Name: receive-cookie-deprecation Value: 1
.fox44news.com/	1969-12-31 23:59:59	Name: s_ips Value: 1200
.fox44news.com/	1969-12-31 23:59:59	Name: s_ppv Value: kwkt%253Adc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2C27%2C27%2C27%2C1200%2C3%2C1
.fox44news.com/	1970-01-21 01:04:11	Name: nol_fpid Value: uyh0fbgzkpbvsddmgzkmlofpry9pu1716299340\|1716299340606\|1716299340606\|1716299340606
.www.fox44news.com/	1970-01-21 05:30:35	Name: OTGPPConsent Value: DBABBg~BUoAAAKA.QA
.fox44news.com/	1970-01-20 20:45:01	Name: kndctr_19020C7354766EB60A4C98A4_AdobeOrg_cluster Value: va6
.fox44news.com/	1970-01-21 06:13:47	Name: kndctr_19020C7354766EB60A4C98A4_AdobeOrg_identity Value: CiY1MTA1MjkwMDI1NDA0NTQ4Njc1MDM2Mzg3MjA1NjE1NDU0NDU0OVISCPy2ptv5MRABGAEqA1ZBNjAA8AH8tqbb%2DTE%3D
www.fox44news.com/	1970-01-21 05:30:35	Name: usprivacy Value: 1YNN
.scorecardresearch.com/	1970-01-21 06:20:59	Name: UID Value: 1FEd521c1f41b1923e3995f1716299340
.scorecardresearch.com/	1970-01-20 22:54:35	Name: PID Value: 19Bd521c1f2681923e397ac1716299340
.scorecardresearch.com/	1970-01-21 06:20:59	Name: XID Value: 1FEd521c1f41b1923e3995f1716299340
www.fox44news.com/	1970-01-21 05:30:35	Name: ntv_as_us_privacy Value: 1---
www.fox44news.com/	1969-12-31 23:59:59	Name: BCSessionID Value: 027d3beb-efbb-43a7-9c81-5c77593b79b7
.doubleclick.net/	1970-01-21 06:20:59	Name: IDE Value: AHWqTUlAg9B0m-AvjRU1hwQGXHgsr_Wr2qIWX5Yqrcz6WuA9k28GEIyKQKeh3MtxSpc
.www.fox44news.com/	1970-01-21 05:30:35	Name: OptanonConsent Value: isGpcEnabled=0&datestamp=Tue+May+21+2024+03%3A49%3A00+GMT-1000+(Hawaii-Aleutian+Standard+Time)&version=202403.1.0&browserGpcFlag=0&isIABGlobal=false&hosts=&consentId=d3592d03-cab1-441c-adee-437f3e2b8fa6&interactionCount=0&isAnonUser=1&landingPath=https%3A%2F%2Fwww.fox44news.com%2Fbusiness%2Fpress-releases%2Fcision%2F20240521LA18851%2Fdc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine%2F&GPPCookiesCount=1&groups=SPD_BG%3A1%2CC0002%3A1%2CC0004%3A1%2CC0003%3A1
.postrelease.com/	1970-01-21 05:30:35	Name: visitor Value: 00bce5bf-4892-4b61-aadd-a55c0557586e
.postrelease.com/	1970-01-21 05:30:35	Name: status Value: 0
.casalemedia.com/	1970-01-21 05:30:35	Name: receive-cookie-deprecation Value: 1
.gumgum.com/	1970-01-21 05:30:35	Name: cs Value: true
.cm.lotlinx.com/	1970-01-21 06:20:59	Name: LX_GHM Value: 8f974d0328eae4a1a0af6a4c
.3lift.com/	1970-01-20 22:54:35	Name: receive-cookie-deprecation Value: 1
.3lift.com/	1970-01-20 22:54:35	Name: tluid Value: 4285554314701999865372
nexstar.blueconic.net/	1970-01-20 20:55:04	Name: AWSALBCORS Value: ntso/jah0lBiFHcMaWhRrlfR2aiTmm4g2nLuQrFtPllFC0z9QD6OhKzemMlU5JxHe73nDd41bpMwgg+PueE8uBPB6UdibXYEeSONlBXMMIBhQFIT3QpEN0573i92
.imrworldwide.com/	1970-01-21 06:06:35	Name: IMRID Value: e108cf20-1778-11ef-9dc9-5f9f65104eee
.rubiconproject.com/	1970-01-21 05:30:35	Name: khaos Value: LWGGBB2L-1N-5LZD
.adnxs.com/	1970-01-20 22:54:35	Name: XANDR_PANID Value: 6ZSyHDhqy598VCjEXRRdRQGNO8SWKDLkC_RVdSsWQ-dNCJYFFYEP-dhk9rQzTxlJt4fQRXj4T0bszE7GGjoD1LUBgaeJlFodmfp7Zb-nxPc.
.adnxs.com/	1970-01-20 22:54:35	Name: icu Value: ChgIsuVtEAoYASABKAEwzcyysgY4AUABSAEQzcyysgYYAA..
.adnxs.com/	1970-01-21 06:20:59	Name: receive-cookie-deprecation Value: 1
.adnxs.com/	1970-01-20 22:54:35	Name: uuid2 Value: 7109922249490532377
www.fox44news.com/	1970-01-21 05:30:35	Name: _tfpvi Value: NjE3YzVhNGUtMDY3MS00ZTZhLThlNmEtMWY4OTY1YTAxOGY5IzItMQ%3D%3D
www.fox44news.com/	1969-12-31 23:59:59	Name: ntvSession Value: {"id":1999074,"placementID":1144945,"lastInteraction":1716299341167,"sessionStart":1716299341167,"sessionEndDate":1716372000000,"experiment":""}
blue.fox44news.com/	1970-01-20 20:55:04	Name: AWSALB Value: n9Hap16h+gjd6wQK3odAA8j44CluzFN9d+HPSIaitTIS17fFEJTbH6imtmkg9t/ZMCCYboUWAKbPXZWGBOPk04ThtDmpxT3QMhzo9n8tgJytOnCU4Lz6CLWlDGmz
blue.fox44news.com/	1970-01-20 20:55:04	Name: AWSALBCORS Value: n9Hap16h+gjd6wQK3odAA8j44CluzFN9d+HPSIaitTIS17fFEJTbH6imtmkg9t/ZMCCYboUWAKbPXZWGBOPk04ThtDmpxT3QMhzo9n8tgJytOnCU4Lz6CLWlDGmz
www.fox44news.com/	1970-01-21 05:30:35	Name: _ntv_uid Value: 00bce5bf-4892-4b61-aadd-a55c0557586e
.postrelease.com/	1970-01-21 05:30:35	Name: ver Value: 1
prebid.media.net/	1970-01-21 01:04:11	Name: receive-cookie-deprecation Value: 1
.fox44news.com/	1970-01-20 20:44:59	Name: _px2 Value: eyJ1IjoiZGZjZWM4ODAtMTc3OC0xMWVmLTkwMTMtNWRlM2Q3YjdhNjkzIiwidiI6ImRmNDMwODIyLTE3NzgtMTFlZi04MWIzLTQwMTRhYmVmOWZlOSIsInQiOjE3MTYyOTk2NDEyMTMsImgiOiIyYzhjYzljMjZhN2U3NGY1MGE1MTQxMjAzYWUxYTcxMWUwNzAyZDBkMjZmM2RkMTNkMWQ2N2E5YjM3MzMyNDBkIn0=
www.fox44news.com/	1970-01-20 20:45:01	Name: sailthru_pageviews Value: 1
.fox44news.com/	1969-12-31 23:59:59	Name: s_tp Value: 4520
.fox44news.com/	1969-12-31 23:59:59	Name: s_plt Value: 3.42%2Ckwkt%3Adc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine
www.fox44news.com/	1970-01-21 05:30:35	Name: sailthru_content Value: 407eaa891dac9da6960644cc4a81ed1d
www.fox44news.com/	1970-01-21 05:30:35	Name: sailthru_visitor Value: caed7f70-f6a6-4487-b09c-0407ab815325
.amazon-adsystem.com/	1970-01-21 02:08:59	Name: ad-id Value: A7ZZMlzIE0tit88Qacg1iLI
.amazon-adsystem.com/	1970-01-21 06:20:59	Name: ad-privacy Value: 0
.casalemedia.com/	1970-01-21 05:30:35	Name: CMID Value: ZkymTdHM654AAGXfAPoLfwAA
.casalemedia.com/	1970-01-20 22:54:35	Name: CMPS Value: 1316
.casalemedia.com/	1970-01-20 22:54:35	Name: CMPRO Value: 1316
.gumgum.com/	1970-01-21 05:30:35	Name: vst Value: u_e69d0f92-c28e-4809-9d30-a8ec5befade3
.sharethrough.com/	1970-01-20 21:28:11	Name: stx_user_id Value: f68d4c6d-518f-4d62-a4ce-879f7a2d2905
.simpli.fi/	1970-01-21 05:32:01	Name: suid Value: 727B631CEB4D4EAFA5BAA438BDBDD76A
.3lift.com/	1970-01-20 22:54:35	Name: tluidp Value: 4285554314701999865372
.emxdgt.com/	1970-01-20 22:54:35	Name: uid Value: 50101716299341925952a5
www.fox44news.com/	1970-01-20 20:46:25	Name: _lr_geo_location_state Value: NY
www.fox44news.com/	1970-01-20 20:46:25	Name: _lr_geo_location Value: US
.advertising.com/	1970-01-21 05:30:56	Name: A3 Value: d=AQABBE2mTGYCEC9_RUX7cCyvh2EkQaU63Y0FEgEBAQH3TWZWZtxH0iMA_eMAAA&S=AQAAAsv4m_ctnDVcFLkzTp7CfiE
.yieldmo.com/	1970-01-21 05:30:35	Name: yieldmo_id Value: VIr5MMM665MzRdFRBLmd%7C1716249600000%7C3543694813090093069
.ads.yieldmo.com/	1970-01-21 05:30:35	Name: re_sync Value: pp%3D1192714%7Cunl%3D1192714%7Cc%3D1192714%7Ctapad%3D1192714%7Cdv360%3D1192714
.media.net/	1970-01-21 05:30:35	Name: visitor-id Value: 3593009416634827000V10
.fox44news.com/	1970-01-21 06:06:35	Name: __gads Value: ID=6e1fb47ee30f93dc:T=1716299341:RT=1716299341:S=ALNI_MbbnPA-rZMjBsXtXcw57EUdCnRNgw
.fox44news.com/	1970-01-21 06:06:35	Name: __gpi Value: UID=00000e23d3c13086:T=1716299341:RT=1716299341:S=ALNI_MZ_9cicqxKZCuxfEpSPUTCwcdSICw
.fox44news.com/	1970-01-21 01:04:11	Name: __eoi Value: ID=adb556dadac6e64d:T=1716299341:RT=1716299341:S=AA-AfjbYx8r1j5-BpBtBoQPtfeCv
.adform.net/	1970-01-20 21:29:37	Name: C Value: 1
.contextweb.com/	1970-01-21 05:23:23	Name: V Value: nVu9zyNDTcKp
.contextweb.com/	1970-01-21 05:23:23	Name: VP Value: part_nVu9zyNDTcKp
bh.contextweb.com/	1969-12-31 23:59:59	Name: INGRESSCOOKIE Value: f63bf948c3260089
.adsrvr.org/	1970-01-21 05:30:35	Name: TDID Value: 2506c257-2773-4150-836a-dcd7ee410ac2
.deepintent.com/	1970-01-21 06:20:59	Name: CDIUSER Value: di_4bce114da57e44748dc15
.smartadserver.com/	1970-01-21 06:15:13	Name: pid Value: 4243734242329525550
.sitescout.com/	1970-01-21 05:30:35	Name: ssi Value: 95cbe412-2814-47c6-9e65-966c0ef70952#1716299342058
.adform.net/	1970-01-20 22:11:23	Name: uid Value: 240628083671673788
.bttrack.com/	1970-01-20 22:54:35	Name: GLOBALID Value: 2uKlc8-sIBd984cSkD72HtjNhbXceF2afMfOU3XeEp3t4airVMZiFmYj217xPTKQDGNQKDoRsrMC4Q2
.yahoo.com/	1970-01-21 05:30:56	Name: A3 Value: d=AQABBE6mTGYCELai3SVzhtEtkZZGPfg8ATIFEgEBAQH3TWZWZgAAAAAA_eMAAA&S=AQAAAvrSVvtJw0WPhX96KqMrZvI
.lijit.com/	1970-01-21 05:30:35	Name: ljt_reader Value: IsX9APZHD2rsUE7aQZa4nVL4
.undertone.com/	1970-01-21 05:30:35	Name: UTID Value: 7053d2fdf0e64cbc8aad86473479e41e
.undertone.com/	1970-01-21 05:30:35	Name: UTID_ENC Value: 6neh0sno2lze6z31abtu5fehq
.undertone.com/	1970-01-21 05:30:56	Name: UID_EXT_56 Value: y-OsMwae5E2uHHSsIquDZqoarxFLoqrvdybS.LSeg-~A
.bidswitch.net/	1970-01-21 05:30:35	Name: tuuid Value: c83a9d81-0c14-4eb5-b205-5d6d843e90b5
.bidswitch.net/	1970-01-21 05:30:35	Name: c Value: 1716299342
.bidswitch.net/	1970-01-21 05:30:35	Name: tuuid_lu Value: 1716299342
.quantserve.com/	1970-01-21 06:15:13	Name: mc Value: 664ca64e-13be6-58daf-0ab53
.mediago.io/	1970-01-21 05:30:35	Name: __mguid_ Value: 7f23a0819f1514732nal1t00lwggbbwi
.undertone.com/	1970-01-21 05:30:56	Name: UID_EXT_39 Value: b6216458-57f2-45db-9a15-620261c68e99
.company-target.com/	1970-01-21 06:20:59	Name: tuuid Value: debe8c18-f9f2-457c-a211-1160b3dffc59
.company-target.com/	1970-01-21 06:20:59	Name: tuuid_lu Value: 1716299342\|ix:0
.lijit.com/	1970-01-21 05:30:35	Name: ljtrtbexp Value: eJyrVrIwULIyNDc0NzWwsDQx0lEysUTlWxij8U1Q%2BYYGKApqAa4GEJs%3D
.ipredictive.com/	1970-01-21 05:30:35	Name: cu Value: baf8f21a-ddcc-4ed8-a7d2-341aadd975f3\|1716299342123
.zemanta.com/	1970-01-21 05:30:35	Name: zuid Value: 50Jdir10cP-zcdrJx7Rw
sync.srv.stackadapt.com/	1970-01-21 05:30:35	Name: sa-user-id Value: s%3A0-20a81f00-d359-5f7e-4077-eaafb07c68a6.k5ykQTHCLLrjZUfBYORyyjB%2Fw7paExohKBXx0R%2FADTw
.srv.stackadapt.com/	1970-01-21 05:30:35	Name: sa-user-id Value: s%3A0-20a81f00-d359-5f7e-4077-eaafb07c68a6.k5ykQTHCLLrjZUfBYORyyjB%2Fw7paExohKBXx0R%2FADTw
sync.srv.stackadapt.com/	1970-01-21 05:30:35	Name: sa-user-id-v2 Value: s%3AIKgfANNZX35Ad-qvsHxopmAJ-Sw.%2BH0JF%2FlxWHwi0gipIsRKsrHJmDfsEgSmlSsiDP%2BQbYo
.srv.stackadapt.com/	1970-01-21 05:30:35	Name: sa-user-id-v2 Value: s%3AIKgfANNZX35Ad-qvsHxopmAJ-Sw.%2BH0JF%2FlxWHwi0gipIsRKsrHJmDfsEgSmlSsiDP%2BQbYo
sync.srv.stackadapt.com/	1970-01-21 05:30:35	Name: sa-user-id-v3 Value: s%3AAQAKIFbuZhR1SdhjUh14pEG1c4QPe-BslSSK3sWYiUoi4djGEGcYBCDOzLKyBjABOgQsIBciQgSZUhzi.tWTZL0BwGKxWvT41UFh9jYrx9njul%2Bm3YuI8zoMZcKI
.srv.stackadapt.com/	1970-01-21 05:30:35	Name: sa-user-id-v3 Value: s%3AAQAKIFbuZhR1SdhjUh14pEG1c4QPe-BslSSK3sWYiUoi4djGEGcYBCDOzLKyBjABOgQsIBciQgSZUhzi.tWTZL0BwGKxWvT41UFh9jYrx9njul%2Bm3YuI8zoMZcKI
.undertone.com/	1970-01-21 05:30:56	Name: UID_EXT_46 Value: 2506c257-2773-4150-836a-dcd7ee410ac2
.tapad.com/	1970-01-20 22:11:23	Name: TapAd_TS Value: 1716299342146
.tapad.com/	1970-01-20 22:11:23	Name: TapAd_DID Value: 06cddbd2-9a3f-494a-a5fa-6a103d2a9290
.www.fox44news.com/	1970-01-21 05:30:35	Name: repeat_visitor Value: 1716299342182-397040
.www.fox44news.com/	1970-01-20 20:45:02	Name: bob_session_id Value: 1716299342183-494590
.rubiconproject.com/	1970-01-20 22:54:35	Name: receive-cookie-deprecation Value: 1
.ads.yieldmo.com/	1970-01-21 05:30:35	Name: ptrc Value: CAESELFWUKdnt7uN8-wvEwRq9ME
.ads.yieldmo.com/	1970-01-21 05:30:35	Name: ptrpp Value: nVu9zyNDTcKp
.ads.yieldmo.com/	1970-01-21 05:30:35	Name: ptrunl Value: OPTOUT
.undertone.com/	1970-01-21 05:30:56	Name: UID_EXT_47 Value: LWGGBB2L-1N-5LZD
bob.dmpxs.com/	1970-01-21 06:20:59	Name: apnx_uid Value: 7109922249490532377
.lijit.com/	1970-01-21 05:30:35	Name: _ljtrtb_49 Value: nVu9zyNDTcKp
.creativecdn.com/	1970-01-21 05:30:35	Name: g Value: 1Y3osX8RykqIe7XbayjR_1716299342280
.creativecdn.com/	1970-01-21 05:30:35	Name: ts Value: 1716299342
.pubmatic.com/	1970-01-21 05:30:35	Name: KADUSERCOOKIE Value: 6EC0B09B-9E03-41A0-B322-AC780BB322DB
.crwdcntrl.net/	1970-01-21 03:13:44	Name: _cc_dc Value: 0
.crwdcntrl.net/	1970-01-21 03:13:44	Name: _cc_id Value: c8d6460a96cafc3190b5b8db31c91f06
.crwdcntrl.net/	1970-01-21 03:13:47	Name: _cc_cc Value: "ACZ4nGNQSLZIMTMxM0i0NEtOTEs2NrQ0SDJNskhJMjZMtjRMMzBjAII0n2V%2BDAgAAFvOCrQ%3D"
.crwdcntrl.net/	1970-01-21 03:13:47	Name: _cc_aud Value: "ABR4nGNgYGBI81nmxwAHABSkAac%3D"
.clickagy.com/	1970-01-21 06:20:59	Name: cb Value: ZkymTmpPGZyCSgbMKaRaeHi9
aorta.clickagy.com/	1970-01-21 06:20:59	Name: chs Value: [{"ch":"185","t":"2024-05-21 13:49:02"}]
.adsrvr.org/	1970-01-21 05:30:35	Name: TDCPM Value: CAESGwoMc2hhcmV0aHJvdWdoEgsIxqmj4tnp_DwQBRIUCgV0YXBhZBILCOLd4ePZ6fw8EAUSFwoIcHVibWF0aWMSCwik3_fk2en8PBAFGAEgASgCMgsI8tX6kfDp_DwQBTgBWghwdWJtYXRpY2AC
.deepintent.com/	1970-01-21 06:20:59	Name: CDIPARTNERS Value: %7B%221%22%3A%2220240521%22%2C%22141%22%3A%2220240521%22%7D
.analytics.yahoo.com/	1970-01-21 05:30:35	Name: IDSYNC Value: "18y3~2ijp:18z9~2ijp:18z8~2ijp"
.tapad.com/	1970-01-20 22:11:23	Name: TapAd_3WAY_SYNCS Value:
.lijit.com/	1970-01-21 05:30:35	Name: _ljtrtb_84 Value: ZkymTmpPGZyCSgbMKaRaeHi9
.bidr.io/	1970-01-21 06:13:32	Name: bito Value: AAE2RE7MmU0AABRLhY-U5A
.bidr.io/	1970-01-21 06:13:32	Name: bitoIsSecure Value: ok
.lijit.com/	1970-01-21 05:30:35	Name: _ljtrtb_80 Value: LWGGBB2L-1N-5LZD
.undertone.com/	1970-01-21 05:30:56	Name: UID_EXT_54 Value: 95cbe412-2814-47c6-9e65-966c0ef70952-664ca64e-5553
.bidr.io/	1970-01-20 20:44:59	Name: checkForPermission Value: ok
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_1251 Value: 23269-di_4bce114da57e44748dc15&KRTB&23571-di_4bce114da57e44748dc15
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_80 Value: 22987-CAESEIiAlWmRSvZsrWpqcTB-W_E&KRTB&23025-CAESEIiAlWmRSvZsrWpqcTB-W_E&KRTB&23386-CAESEIiAlWmRSvZsrWpqcTB-W_E
.pubmatic.com/	1970-01-20 21:28:11	Name: KRTBCOOKIE_148 Value: 19421-uid:727B631CEB4D4EAFA5BAA438BDBDD76A&KRTB&23486-uid:727B631CEB4D4EAFA5BAA438BDBDD76A&KRTB&23489-uid:727B631CEB4D4EAFA5BAA438BDBDD76A&KRTB&23539-uid:727B631CEB4D4EAFA5BAA438BDBDD76A
bob.dmpxs.com/	1970-01-21 06:20:59	Name: bx_uid Value: AAE2RE7MmU0AABRLhY-U5A
.pubmatic.com/	1970-01-20 21:28:11	Name: KRTBCOOKIE_279 Value: 22890-baf8f21a-ddcc-4ed8-a7d2-341aadd975f3&KRTB&23011-baf8f21a-ddcc-4ed8-a7d2-341aadd975f3&KRTB&23355-baf8f21a-ddcc-4ed8-a7d2-341aadd975f3
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_377 Value: 6810-2506c257-2773-4150-836a-dcd7ee410ac2&KRTB&22918-2506c257-2773-4150-836a-dcd7ee410ac2&KRTB&22926-2506c257-2773-4150-836a-dcd7ee410ac2&KRTB&23031-2506c257-2773-4150-836a-dcd7ee410ac2
.adx.opera.com/	1970-01-21 05:30:35	Name: UID Value: OPUfc8e936a0bec4115923b12a48d8d4908
.socdm.com/	1970-01-21 06:20:59	Name: SOC Value: ZkymTsCo5soAAKGTlPYAAAAA
pool.admedo.com/	1970-01-21 05:30:35	Name: tuuid Value: 16840fe0-dc14-4f1e-a283-89b1e5bde5b2
pool.admedo.com/	1970-01-21 05:30:35	Name: c Value: 1716299342
pool.admedo.com/	1970-01-21 05:30:35	Name: tuuid_lu Value: 1716299342
.lijit.com/	1970-01-21 05:30:35	Name: ljtrtb Value: eJyrVjKxVLJSygsrtayq9HMJSfYuUNJRsjAAivmEu7s7ORn56Br66Zr6RLmAxE2A4lHZlbkhuQUB7lGVzsHpSb7eiUGJqR6Zlkq1ADVSFgw%3D
.lijit.com/	1970-01-21 05:30:35	Name: _ljtrtb_103 Value: OPUfc8e936a0bec4115923b12a48d8d4908
.rubiconproject.com/	1970-01-21 05:30:35	Name: audit Value: 1\|mFVHqHkj5bF0dMDxsJLQuVYvo2XO8wv+z0QnGM0pmGRDnsFJXDqd+5Q2U9+wXQc+XR8Wqgioqji3vST627QYiMBQn6AvuCLFX0hBhcS7Zjsg1lWKl0gcYNLeItSKttXd
.lijit.com/	1970-01-21 05:30:35	Name: _ljtrtb_83 Value: LWGGBB2L-1N-5LZD
.connatix.com/	1970-01-20 21:28:11	Name: cnx_userId Value: 38b7e6121f534605b4b0d5d95a6e7989
.undertone.com/	1970-01-21 05:30:56	Name: UID_EXT_53 Value: 6EC0B09B-9E03-41A0-B322-AC780BB322DB
.linkedin.com/	1970-01-21 05:30:35	Name: bcookie Value: "v=2&a23c4469-7d3b-40a8-8c48-fd57e3332228"
.linkedin.com/	1970-01-20 20:46:25	Name: lidc Value: "b=TGST05:s=T:r=T:a=T:p=T:g=3030:u=1:x=1:i=1716299342:t=1716385742:v=2:sig=AQFjI6bq1WwyDRYe4GEYLz9eIjIh2K_z"
.owneriq.net/	1970-01-21 06:20:59	Name: si Value: Q7695857421129178900P
.owneriq.net/	1970-01-20 20:59:23	Name: p2 Value: gguuid
.owneriq.net/	1970-01-20 20:59:23	Name: gguuid Value: 1
.adingo.jp/	1970-01-20 21:28:11	Name: ID Value: fa488359c719c20887c0b40e8e53c4be
.teads.tv/	1970-01-21 05:29:08	Name: tt_viewer Value: 42978d54-ecb8-417b-8041-071e328b3b2a
.media.net/	1970-01-20 21:05:08	Name: data-g Value: CAESEBRhrEbs-yzHQSXnlbP6840~~6
www.fox44news.com/	1970-01-20 20:46:25	Name: _lr_sampling_rate Value: 100
.criteo.com/	1970-01-21 06:06:35	Name: uid Value: 3bf95595-e7b5-4375-8b9b-5021e11fb67f
www.fox44news.com/	1970-01-20 20:45:02	Name: _lr_retry_request Value: true
www.fox44news.com/	1970-01-20 21:28:11	Name: _lr_env_src_ats Value: false
.pubmatic.com/	1970-01-20 21:28:11	Name: SPugT Value: 1716299343
.fox44news.com/	1970-01-21 05:30:35	Name: connectId Value: %7B%22puid%22%3A%22b32c0c7d32a59606cb21cf540a0a0b80faa87e2a0dc65122e724be80c3d608fa%22%2C%22vmuid%22%3A%220ezw5emz8TpjZLkFG-Q3SndaEUyU13YRaXvzXRXXH8lV4q6EUhblAL2AfYBgCl_ImW-xH5_pPtbGTNNA65rOcQ%22%2C%22connectid%22%3A%220ezw5emz8TpjZLkFG-Q3SndaEUyU13YRaXvzXRXXH8lV4q6EUhblAL2AfYBgCl_ImW-xH5_pPtbGTNNA65rOcQ%22%2C%22connectId%22%3A%220ezw5emz8TpjZLkFG-Q3SndaEUyU13YRaXvzXRXXH8lV4q6EUhblAL2AfYBgCl_ImW-xH5_pPtbGTNNA65rOcQ%22%2C%22ttl%22%3A86400000%2C%22lastSynced%22%3A1716299344402%2C%22lastUsed%22%3A1716299344402%7D
.fox44news.com/	1970-01-21 06:06:35	Name: cto_bundle Value: 3MtIFl9JaUM1QWJOM0RnWTBFcGdtbjdWOGVWNHhqSldSM0lZc0w5ViUyQjQzQlBYcm1GZ0xzQ3pmN1VqSXZVUU1IVHdWNlI2RyUyRkdzYTdjOFVxS2ZZY2dpVzIzM1poYzglMkJUMmdKdW8yZzkzZmpJM1klMkI5VHZ4d0puMkl6cFFzTGwzcnpMSFZPU0pyM1NJZSUyQlNIJTJGJTJGSGJ4S0Y5TnZ0dyUzRCUzRA
.ads.pubmatic.com/	1970-01-20 20:46:25	Name: KCCH Value: YES
.pubmatic.com/	1970-01-20 22:54:35	Name: chkChromeAb67Sec Value: 3
.pubmatic.com/	1970-01-20 20:46:25	Name: pi Value: 0:4
.pubmatic.com/	1970-01-20 22:54:35	Name: DPSync3 Value: 1716854400%3A252_265%7C1717459200%3A263_201_262_261_260_259
.pubmatic.com/	1970-01-20 22:54:35	Name: SyncRTB3 Value: 1717459200%3A71_3_48_166_250_13_104_220_8_21_231_22_55_54_5_178%7C1717113600%3A63%7C1716854400%3A223_15_2
.sitescout.com/	1970-01-20 21:28:11	Name: _ssuma Value: eyI0NSI6MTcxNjI5OTM0NTMxNCwiMzkiOjE3MTYyOTkzNDIxMDUsIjciOjE3MTYyOTkzNDIxMDUsIjgwIjoxNzE2Mjk5MzQyMTA1fQ
.quantserve.com/	1970-01-20 22:54:35	Name: d Value: EKoBEgHzK_ijC_vLEA
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_188 Value: 3189-95cbe412-2814-47c6-9e65-966c0ef70952-664ca64e-5553&KRTB&23418-95cbe412-2814-47c6-9e65-966c0ef70952-664ca64e-5553
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_153 Value: 19420-GccRd07HEXECwBZ2SscIIReVRHICwUR2GsILTqSa&KRTB&23462-GccRd07HEXECwBZ2SscIIReVRHICwUR2GsILTqSa
.mxptint.net/	1970-01-21 06:20:59	Name: mxpim Value: R33647_115DEC487_2457C97E.1.0000000000000000664CA651
.kargo.com/	1970-01-21 05:30:35	Name: ktcid Value: 6b28dc54-2ae5-0c3d-5562-f1f1065bdd54
.pubmatic.com/	1970-01-20 21:28:11	Name: KRTBCOOKIE_52 Value: 22772-R33647_115DEC487_2457C97E&KRTB&23092-R33647_115DEC487_2457C97E
.turn.com/	1970-01-21 01:04:11	Name: uid Value: 9142286751188733869
.w55c.net/	1970-01-21 06:15:13	Name: wfivefivec Value: DhNw0OXr1S9pRv5
.thrtle.com/	1970-01-21 01:32:59	Name: mc Value: eyJpZCI6IjZlMjc5OThiLWEwNWUtNDIxOC04YjRmLWE1Yzk4NmM1MDNiOSIsImwiOjE3MTYyOTkzNDU0NTgsInQiOjF9
.pubmatic.com/	1970-01-20 21:28:11	Name: KRTBCOOKIE_22 Value: 14911-9142286751188733869&KRTB&23150-9142286751188733869&KRTB&23527-9142286751188733869
.taptapnetworks.com/	1970-01-21 05:30:35	Name: SONATA_ID Value: csonata_1ab4ae1f-ec5c-4bd8-bf9d-cf99857d0cd4
.w55c.net/	1970-01-20 21:28:11	Name: matchpubmatic Value: 5
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_107 Value: 1471-uid:DhNw0OXr1S9pRv5&KRTB&23421-uid:DhNw0OXr1S9pRv5
.dotomi.com/	1970-01-20 20:44:59	Name: DotomiTest Value: 696a27894c071562
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_466 Value: 16530-c83a9d81-0c14-4eb5-b205-5d6d843e90b5
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_32 Value: 11175-AAAGg6u1GQH0KwMCz7TaAAAAAAA&KRTB&22715-AAAGg6u1GQH0KwMCz7TaAAAAAAA&KRTB&23519-AAAGg6u1GQH0KwMCz7TaAAAAAAA
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_16 Value: 1550505354400
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_37 Value: 03a942df-5821-370c-9c59-4c3d9c1e4875
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_44 Value: LWGFQLTT-N-LW9P
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_45 Value: 6BFB0ED7-C32D-4E10-AC8B-217CE6612914
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_46 Value: 4861228025603095720
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_48 Value: f9215977-dd81-463e-85e7-406d06ce030f
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_49 Value: AAAG0_ZJpDcaMAMObHqiAAAAAAA
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_50 Value: cd63b860-5e34-4f74-b007-0170ff2ac0da
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_61 Value: 212614911327959
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_62 Value: 3592999756634872000V10
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_64 Value: rgzwMMrRBR_el2z8rfS737_t0O_eZ3mv
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_7 Value: dc0a211a-5581-4eda-9b05-0410e53d50a6
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_70 Value: 1670164501887-983826026107-007675-011-002667
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_73 Value: AAE2RE7MmU0AABRLhY-U5A
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_76 Value: RX-35caf9c2-4e5f-4fd9-906e-4775187802e7-003
.technoratimedia.com/	1970-01-20 20:49:18	Name: tads_uidp_77 Value: _RIFGNHbFGGGytYykODDhqua0SZ0iRyhV60GW-ePIyk
.technoratimedia.com/	1970-01-20 20:49:18	Name: tads_uidp_79 Value: eb2fb441-a011-4cef-ace0-f644ad5af14b
.technoratimedia.com/	1970-01-20 20:49:18	Name: tads_uidp_80 Value: y-T3RHqDhE2uF8cevtnpNgYm9VWq_Ay9tM~A
.technoratimedia.com/	1970-01-20 20:49:18	Name: tads_uidp_82 Value: ZkyV9NHM55IAACJwAQJZSQAA&1455
.technoratimedia.com/	1970-01-20 20:49:18	Name: tads_uidp_83 Value: BzKIS13TXEMI
.technoratimedia.com/	1970-01-20 20:49:18	Name: tads_uidp_88 Value: 1884307548425502549434
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uidp_90 Value: d61c15db-ca8e-422b-89fc-75ebf2d03234
.technoratimedia.com/	1970-01-20 20:49:18	Name: tads_uidp_91 Value: 6036790348656135630brt77751645033995481903ac
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uid Value: 50A76B23828746329B25E34B477CAC19
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_uid_cd Value: 20230301185801+0000
.technoratimedia.com/	1970-01-21 06:20:59	Name: tads_zora Value: 2
.technoratimedia.com/	1970-01-20 20:46:25	Name: envelope_liveramp.com Value: 1712525312635
.smartadserver.com/	1970-01-21 05:30:35	Name: csync Value: 127:AAE2RE7MmU0AABRLhY-U5A
.contextweb.com/	1970-01-21 05:30:35	Name: pb_rtb_ev Value: 3-1rhk\|7TZ.0.1\|7dN.0.AAE2RE7MmU0AABRLhY-U5A\|7dW.0.1
.contextweb.com/	1970-01-21 05:30:35	Name: pb_rtb_ev_part Value: 3-1rhk\|7TZ.0.1\|7dN.0.AAE2RE7MmU0AABRLhY-U5A\|7dW.0.1
.pubmatic.com/	1970-01-20 22:54:35	Name: KRTBCOOKIE_699 Value: 22727-AAE2RE7MmU0AABRLhY-U5A
.pubmatic.com/	1970-01-20 21:28:11	Name: PugT Value: 1716299346

1001 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/(Line 1596) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/(Line 1596) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://cdn.taboola.com/libtrc/nexstar-network/loader.js Message: Unrecognized feature: 'browsing-topics'.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
network	error	URL: https://cdn.segment.com/v1/projects//settings Message: Failed to load resource: the server responded with a status of 404 ()
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
network	error	URL: https://dyv1bugovvq1g.cloudfront.net/67/www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/.js Message: Failed to load resource: the server responded with a status of 403 ()
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
network	error	URL: https://weather.psg.nexstardigital.net/service/api/v3/alerts/getLiveAlertsByCounties?counties=48309,48041,48099,48333,48411,48281,48145,48331,48395,48293,48289,48051,48313,48027,48035,48217 Message: Failed to load resource: the server responded with a status of 404 ()
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.fox44news.com/business/press-releases/cision/20240521LA18851/dc-medicaid-becomes-the-first-medicaid-plan-to-cover-the-nerivio-ren-wearable-a-non-drug-treatment-for-migraine/ Message: Third-party cookie will be blocked. Learn more in the Issues tab.

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

3a6b0682-f3e1-4576-a706-5eb4101b9cc3.edge.permutive.app
530669c95bc3eeebe2a6fe934c989b34.safeframe.googlesyndication.com
a.teads.tv
aax.amazon-adsystem.com
ads.yieldmo.com
ak.sail-horizon.com
ams-pageview-public.s3.amazonaws.com
analyticssystems.net
api.rlcdn.com
api.sail-personalize.com
assets.adobedtm.com
at.teads.tv
ats-wrapper.privacymanager.io
axp.fox44news.com
bidder.criteo.com
blue.fox44news.com
bob.dmpxs.com
c.amazon-adsystem.com
c212.net
cdn-gl.imrworldwide.com
cdn.confiant-integrations.net
cdn.cookielaw.org
cdn.onesignal.com
cdn.segment.com
cdn.taboola.com
check.analytics.rlcdn.com
cm.g.doubleclick.net
cm.lotlinx.com
cm2.lotlinx.com
collector-pxcvbtpurj.px-cloud.net
config.aps.amazon-adsystem.com
cookies-data.onetrust.io
d15kdpgjg3unno.cloudfront.net
d2zqfs55y95cft.cloudfront.net
d3div1mtym39ic.cloudfront.net
d3plfjw9uod7ab.cloudfront.net
dyv1bugovvq1g.cloudfront.net
fastlane.rubiconproject.com
fonts.googleapis.com
fonts.gstatic.com
g2.gumgum.com
geo.privacymanager.io
geolocation.onetrust.com
get.civicscience.com
global.imrworldwide.com
gum.criteo.com
htlb.casalemedia.com
htlbid.com
ib.adnxs.com
jadserve.postrelease.com
launchpad-wrapper.privacymanager.io
launchpad.privacymanager.io
mab.chartbeat.com
match.prod.bidr.io
mma.prnewswire.com
nexstar.blueconic.net
nxst.megpxs.com
onesignal.com
pagead2.googlesyndication.com
ping.chartbeat.net
pixel.mathtag.com
pixel.wp.com
prebid.media.net
prod.us-east-1.cxm-bcn.publisher-services.amazon.dev
rt.prnewswire.com
s.amazon-adsystem.com
s.ntv.io
sb.scorecardresearch.com
secure-dcr.imrworldwide.com
securepubads.g.doubleclick.net
segment.psg.nexstardigital.net
sqs.us-east-1.amazonaws.com
static.chartbeat.com
static.criteo.net
stats.wp.com
sync.rtk.io
tlx.3lift.com
tpc.googlesyndication.com
ups.analytics.yahoo.com
weather.psg.nexstardigital.net
www.civicscience.com
www.fox44news.com
www.google.com
www.googletagmanager.com
www.nxsttv.com
pagead2.googlesyndication.com
sync.rtk.io
www.google.com
104.16.160.145
104.70.185.205
13.32.151.21
142.250.31.156
142.251.167.154
151.101.129.44
151.101.65.91
151.101.66.133
172.253.62.154
172.253.63.99
172.64.144.166
172.64.151.101
172.67.203.105
18.160.10.20
18.160.10.44
18.160.18.69
18.160.20.121
18.165.100.155
18.165.98.6
192.0.66.120
192.0.76.3
216.200.232.249
23.55.205.47
23.62.165.62
2600:1408:c400:e87::1e80
2600:9000:208f:9e00:13:a391:88c0:21
2600:9000:20aa:a600:5:82fd:2500:21
2600:9000:2199:f400:11:b309:9100:21
2600:9000:2305:1600:11:1ed0:3900:93a1
2600:9000:24f3:fe00:18:1fcd:354:4b41
2600:9000:24f4:4a00:2:42d9:3100:93a1
2600:9000:24f4:5200:f:c7b3:ce40:93a1
2600:9000:24f4:b200:2:42d9:3100:93a1
2602:803:c002:200::32
2606:4700:4400::6812:29aa
2606:4700:4400::ac40:9b3f
2606:4700:4400::ac40:9b77
2606:4700:4400::ac40:9b8d
2606:4700::6813:b134
2607:f8b0:4004:c08::5f
2607:f8b0:4004:c09::84
2607:f8b0:4004:c19::61
2607:f8b0:4004:c1b::5e
2607:f8b0:4004:c1d::84
2620:100:a00b::12
2620:100:a00b::4
2a04:4e42:600::714
3.162.103.38
3.20.52.199
3.208.91.57
3.223.52.218
3.233.167.98
3.236.169.12
3.5.27.142
34.107.165.188
34.120.63.153
34.194.130.13
34.198.96.69
34.199.54.80
34.200.65.202
34.238.186.72
35.190.10.96
44.214.246.0
52.202.142.82
52.21.84.14
52.35.121.22
52.46.143.56
52.71.30.37
52.85.151.43
52.85.151.80
52.85.151.91
63.140.38.112
68.67.179.87
74.119.117.6
99.83.154.140
99.84.191.89
99.84.208.120
99.84.208.28
99.86.191.237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www.fox44news.com Open in urlscan Pro 151.101.65.91 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Detected technologies

Page Statistics

209 Requests

94 %HTTPS

29 %IPv6

57 Domains

85 Subdomains

77 IPs

2 Countries

4081 kBTransfer

15436 kBSize

227 Cookies

47 Outgoing links

Page URL History

Redirected requests

209 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 5 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

www.fox44news.com Open in urlscan Pro
151.101.65.91 Public Scan

Screenshot
Live screenshot

Full Image

209
Requests

94 %
HTTPS

29 %
IPv6

57
Domains

85
Subdomains

77
IPs

2
Countries

4081 kB
Transfer

15436 kB
Size

227
Cookies

209 HTTP transactions
5 data transactions